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Abstract 
 
Many pathogenic bacteria use type III secretion systems (TTSS) to deliver effector 
proteins into the cytosol of target cells to subvert host cell functions. The actual secretion 
apparatus, called injectisome, consist of a basal body embedded in the bacterial membranes 
and a needle. The needle is thought to serve as a conduit for protein secretion. However, to 
cross the target cell membrane an additional translocation step is necessary. This 
translocation involves the formation of a pore in the target cell membrane, which is 
presumably connected to the needle. Three proteins are required for the assembly of this 
pore. In Yersinia, the three “translocators” are YopB and YopD, two putative membrane 
proteins, and LcrV a hydrophilic protein. LcrV is also known, since the mid-fifties, to represent 
the major protective antigen against plague infections. The aim of my thesis was to 
characterize the structure and function of the translocators. 
 
 
Infection of erythrocytes with wildtype Yersiniae causes hemolysis due to the formation 
of the translocation pore in the red blood cell membrane. We showed that the isolated 
membranes of these erythrocytes contain the hydrophobic translocators YopB and YopD, but 
not LcrV. Bacteria deprived of LcrV did not assemble a functional pore, but were still able to 
insert reduced amounts of YopB and YopD into the target cell membrane. This is in 
agreement with reports showing that purified YopB and YopD can oligomerize and insert into 
artificial membranes independently of LcrV. We showed further that polyclonal antibodies 
directed against LcrV interfere with the formation of a functional translocation pore by live 
bacteria. Based on these results, we hypothesized that LcrV acts as a platform or scaffold 
onto which the YopBD translocation pore assembles (Goure, Broz et al. 2005, Journal of 
Infectious Diseases 192:218-25). 
 
We purified needles and detected LcrV as well as YscF, the needle subunit, in these 
preparations. In parallel we analyzed these purified needles by STEM (scanning transmission 
electron microscopy) and found that the needle ends with a defined tip complex, that 
comprises a head, a neck and a base. We then showed that the tip complex is missing in lcrV 
mutant bacteria and can be restored after the mutation is complemented in trans. These 
results indicated that LcrV is involved in the formation of the tip complex. In addition, 
crosslinking of purified needles indicated that LcrV and YscF interact and thus the V-antigen 
might form the tip complex. Immunolabelling of wildtype needles with anti-LcrV antibodies 
showed a strong binding to the tip complex, anti-YscF antibodies bound to the bottom of the 
needle. Together these results demonstrate that LcrV forms the observed tip complex and 
explain why anti-LcrV antibodies can inhibit pore formation. In addition, these data reinforce 
the assembly platform hypothesis (Mueller, Broz et al. 2005, Science 310: 674-676). 
 
P. aeruginosa and A. salmonicida possess an injectisome closely related to that of 
Yersinia. Their respective LcrV orthologs, PcrV (32.3 kDa) and AcrV (40.2 kDa) are slightly 
different in size to LcrV (37.6 kDa). We demonstrated that PcrV as well as AcrV can 
functionally complement a lcrV deletion in Y. enterocolitica. The needles exhibited distinct tip 
complexes similar to those of wildtype needles but they were smaller in the case of PcrV and 
larger with AcrV (Mueller, Broz et al. 2005, Science 310: 674-676). Hybrids between the three 
proteins LcrV, PcrV and AcrV could complement an lcrV deletion in Y. enterocolitica in the 
hemolysis assay, but the level of complementation varied. The amino-terminus seemed to 
play an important role in the function of the protein. STEM analysis of tip complexes formed by 
different hybrid proteins allowed us to show that the aminoterminal domain of LcrV forms the 
base while the second globular domain forms the head of the tip complex. In addition we 
determined the stoichiometry of YscF and LcrV in purified needles and found that between 
three to six molecules of LcrV form the tip complex. Together, these results allowed us to 
propose an atomic modeling of the LcrV tip complex on top of the injectisome needle.  
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1 Introduction 
 
1.1 Type III secretion systems 
 
Interaction of bacterial pathogens or symbionts with host cells is mediated by factors 
that are located on the bacterial surface or are secreted into the extracellular space. Although 
these proteins are numerous and diverse, exhibiting a wide variety of functions that include 
proteolysis, hemolysis, cytotoxicity, protein phosphorylation and dephosphorylation, only a few 
pathways exist by which these proteins are transported from the bacterial cytoplasm to the 
extracellular space. Such secretion systems are classified into four major types: I-IV. 
Type III secretion, the subject of this work, is probably the most sophisticated export 
apparatus described so far and is found in many gram-negative bacteria, pathogenic for 
animals and plants, as well as in endosymbionts. The discovery of type III secretion (TTS) 
was made in the early 1990s, when a few groups, studying Yersinia, were trying to 
understand the mysterious phenomenon of Calcium-dependency: When incubated at 37°C in 
the absence of Ca2+-Ions, Yersinia bacteria stop growing and start to release large amounts of 
proteins, called Yops, into the culture medium (Michiels et al., 1990). Amino-terminal 
sequence analysis revealed that these Yop proteins must be secreted in a sec-independent 
manner and hence by a new pathway. 
This release, generally referred to as Yop secretion, is rather a massive leakage 
resulting from an artificial opening of an otherwise tightly controlled secretion apparatus. 
Despite the fact that this leakage is presumably artefactual, this observation turned out to be 
of great importance because it allowed to carry out genetic analysis that lead to the 
identification of more than 25 genes involved in the process of Yop secretion. These genes, 
encoded together with the yop genes on the 70 kb Yersinia virulence plasmid (pYV), were 
called ysc for Yop secretion (Fig. 1). Interestingly most of the inner membrane Ysc proteins 
are homologous to components of the flagellar biosynthesis apparatus, suggesting a common 
evolutionary origin with the flagellum. These similarities prompted the research groups led by 
J. Galan and S.I. Aizawa to apply extraction and visualization techniques of the flagellum 
basal body to the Salmonella enterica serovar Typhimurium TTS system, which allowed them 
to visualize the secretion apparatus (Fig. 2A, Kubori et al., 1998). This structure, called 
needle-complex (NC) or injectisome, is composed of a needle like portion that projects 
outward from the surface of the bacterial cell and a cylindrical basal body that anchors the 
structure to the inner and outer membranes. Since then electron micrographs of NCs from 
Shigella flexneri and enteropathogenic Escherichia coli (EPEC) have been produced (Fig. 2B-
D; Blocker et al., 1999; Sekiya et al., 2001; Tamano et al., 2000; Kimbrough and Miller, 2000; 
Daniell et al., 2001; Blocker et al., 2001; Ogino et al., 2006; Morita-Ishihara et al., 2006). 
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Lately a model of the NC from S. Typhimurium has been presented at a resolution of 1.7 nm 
(Fig. 2F; Marlovits et al., 2004). 
Little is known about the actual mechanism of export, but the structure of the 
injectisome implies that it serves as a hollow conduit across both bacterial membranes for the 
exported proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. The Y. enterocolitica pYV plasmid. Taken from “The 70-Kilobase Virulence Plasmid of 
Yersiniae”, Iriarte M. and Guy R. Cornelis, in “Pathogenicity Islands and Other Mobile Virulence 
Elements”, ASM press 1999. 
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Fig. 2. Electron micrographs of the flagellum and the needle complexes from different bacteria. 
(A) Purified needle complexes from S. Typhimurium (Kubori et al., 1998). (B) Purified needle complexes 
from S. flexneri (Tamano et al., 2000). (C) Purified needle complexes from EPEC (Sekiya et al., 2001). 
(D) Isolated flagella from EPEC (Sekiya et al., 2001).  (E) Surface rendering of the needle complex from 
S. flexneri assuming cylindrical symmetry (Blocker et al., 2001) (F) Surface rendering of the needle 
complex from S. Typhimurium (Marlovits et al., 2004). Scale bar represent 100 nm in (A, B, D) and 50 
nm in (C). 
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1.2 The concept of translocation 
 
The actual destination of effector proteins secreted by type III secretion systems is not 
the extracellular medium but the cytosol of eukaryotic cells, where they affect signaling or 
control pathways. Surprisingly the secreted Yop proteins have no cytotoxic effects on cultured 
cells, although live Yersiniae have such an activity. Cytotoxicity was found to depend on the 
capacity of the bacterium to secrete both YopE and YopD (Rosqvist et al., 1991). Moreover 
YopE alone was shown to be cytotoxic when microinjected into the cells. This suggested that 
YopD somehow helps the injection of the cytotoxin YopE into the target cell. In 1994, this 
hypothesis was demonstrated by two different methods, immunofluorescence and a reporter 
enzyme based strategy (Rosqvist et al., 1994; Sory and Cornelis, 1994) that allowed the 
detection of Yop-proteins in target cells. Thus, extracellular Yersinia bacteria do not only 
secrete YopE, but they also inject YopE into the cytosol of eukaryotic cells by a mechanism 
that involves at least one other protein, YopD. Later, YopB was shown to be required for the 
delivery of YopE and YopH (Boland et al., 1996; Hakansson et al., 1996). Finally, LcrV was 
shown to be also involved (Fields et al., 1999; Marenne et al., 2003; Pettersson et al., 1999). 
These observations and others lead to the present concept that the secreted Yop 
proteins consist of two groups, a collection of intracellular effectors and proteins that are 
required for the translocation of these effectors across the plasma membrane of the target 
cells. This general principle: secretion machinery, “effectors” and “translocators” (Fig. 1), 
applies to all type III secretion systems studied so far. While the secretion machinery is more 
or less conserved, the effectors vary considerably, depending on the particular needs of the 
bacteria. Among the animal pathogens, type III secretion systems have been most intensely 
studied in Yersinia spp., Shigella spp., Salmonella spp., Pseudomonas aeruginosa, EPEC and 
enterohemorrhagic E. coli. The best-studied system of a plant pathogen is the one of 
Pseudomonas syringae (for a review see, Mota et al., 2005b). 
 
 
1.3 The triplet of translocators 
 
As the concept of type III secretion evolved and more proteins were studied, it became 
evident that the group of the translocators generally consists of three proteins (YopB, YopD 
and LcrV in Yersinia). They have in common that knockout mutants in these proteins 
completely lose the ability to translocate effector proteins into target cells, while the secretion 
process itself is not affected (for a review see, Buttner and Bonas, 2002). Another general 
feature of the three translocators is that two have hydrophobic domains (YopB and YopD) 
while the third is clearly hydrophilic (LcrV) (Fig. 3). This applies to the type III secretion 
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translocators from P. aeruginosa (PopB, PopD and PcrV), Aeromonas salmonicida (AopB, 
AopD and AcrV), S. flexneri (IpaB, IpaC and IpaD), S. Typhimurium SPI-1 (SipB, SipC and 
SipD), EPEC (EspB, EspD and EspA) and S. Typhimurium SPI-2 (SseD, SseC and SseB). In 
several systems, the three translocators were reported to interact with each other (Chiu and 
Syu, 2005; Menard et al., 1994; Sarker et al., 1998a; Schoehn et al., 2003; Tucker and Galan, 
2000) and most translocators even contain coiled-coil domains, known to be involved in 
protein-protein interactions (Fig. 3). 
 
Fig. 3. Structural organization of the three type III secretion translocators found in different 
pathogenic bacteria. Schematic representation of putative transmembrane (TM) regions and coiled-coil 
(CC) regions in the hydrophobic translocators (A) and the hydrophilic translocators (B). TM regions were 
predicted with the TM-PRED program (http://www.ch.embnet.org/software/TMPRED_form.html; 17-33 
residues, scores >1000). CC regions were predicted with the MULTICOIL program 
(http://multicoil.lcs.mit.edu/cgi-bin/multicoil; probabilities >80%) or the COILS program 
(http://www.ch.embnet.org/software/COILS_form.html). 
 
In all type III secretion systems studied so far the three translocators were found to be 
encoded together in one large operon (Fig. 4). In addition to the translocators, this operon 
contains genes coding for proteins involved in the regulation of type III secretion and for small 
proteins that serve as chaperones for the hydrophobic translocators (see chapters 1.9 and 
1.10) 
The similarities between the translocators are not restricted to their function and genetic 
localization, but also extend to their sequence (Buttner and Bonas, 2002). The most closely 
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related homologs of YopB/YopD are PopB/PopD of P. aeruginosa and AopB/AopD of A. 
salmonicida. The homology goes so far that popB/popD can complement a mutation of the 
yopB/yopD genes in Yersinia when expressed from its native operon (Broms et al., 2003; 
Frithz-Lindsten et al., 1998). IpaB/IpaC from Shigella and SipB/SipC from Salmonella SPI-1 
also share homologies to YopB/YopB, especially in the hydrophobic domains (Hakansson et 
al., 1993).  
The hydrophilic translocators seem to be more diverse. The only sequence homologs of 
LcrV are PcrV of P. aeruginosa and AcrV of A. salmonicida. These proteins are so closely 
related that PcrV and AcrV complement a Yersinia lcrV mutation (Holmstrom et al., 2001; 
Mueller, Broz et al., 2005). Others, like IpaD, SipD, EspA and SseB, exhibit only low sequence 
homology to LcrV and should be rather considered as functional homologs. 
 
Fig. 4. Organization of the translocator operons from different TTS systems.  
 
 
                                                                                                                                           1 Introduction 
 9 
1.4 The role of the translocators during infection 
 
As mentioned above two of the translocators have hydrophobic domains. It was 
hypothesized that they could act as some kind of transmembrane proteins (Hakansson et al., 
1993). Early reports mentioned that YopB has a membrane disturbing activity (Hakansson et 
al., 1996) suggesting that the translocators may destabilize the membranes and thus allow 
translocation. Consistent with this YopB/YopD, PopB/PopD, IpaB/IpaC and EspB/EspD were 
found to be inserted in the membranes of erythrocytes after infection (Blocker et al., 1999; 
Goure et al., 2004; Goure, Broz et al., 2005; Ide et al., 2001). In addition YopB and YopD 
were reported to bind to artificial liposomes that were incubated with secreting Yersinia spp. 
(Tardy et al., 1999). Several in vitro studies were done with purified translocators to analyze 
their properties. It was shown that purified IpaB and SipB are able bind membranes, lead to 
release of Calcein from liposomes and have membrane fusion activity (De Geyter et al., 2000; 
Hayward et al., 2000; Hume et al., 2003). Other translocators, PopB/PopD and YopB/YopD, 
were also shown to bind to liposomes and insert into liposome membranes in vitro (Faudry et 
al., 2006; Schoehn et al., 2003), P. Broz unpublished data). On the basis of these results it 
was hypothesized that the hydrophobic translocators form the transmembrane part of the type 
III secretion translocon. 
To understand the role of the hydrophilic translocator was more difficult. The best-
studied example is LcrV. This protein was described already in the nineteen fifties as a 
soluble antigen involved in the virulence of Yersinia spp. (hence named V antigen) long before 
the concept of type III secretion was shaped (Burrows, 1956). Early studies reported that it 
was a protective antigen against plague infections (Lawton et al., 1963) and antibodies 
directed against LcrV protect cultured cells from Yersinia infections (Pettersson et al., 1999). 
In 1999 it was shown by immunogold electron microscopy that LcrV is exposed on the surface 
of Yersinia spp. before contact to target cells (Pettersson et al., 1999). Its functional 
counterparts IpaD and SipD are probably surface exposed as well (Turbyfill et al., 1998), but 
this was not formally demonstrated so far. These results suggested that the hydrophilic 
translocator is part of a structure that is preassembled on the bacterial surface. 
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1.5 Evidence for a pore formed by the translocators 
 
A feature, observed for most bacteria employing type III secretion systems is a contact-
dependent lytic activity on red blood cells. Erythrocyte lysis was reported for Yersinia spp., P. 
aeruginosa, S. flexneri, Salmonella spp. and EPEC and was dependent on the presence of 
the translocators (Blocker et al., 1999; Dacheux et al., 2001; Hakansson et al., 1996; 
Holmstrom et al., 2001; Ide et al., 2001; Miki et al., 2004; Neyt and Cornelis, 1999a; Shaw et 
al., 2001). This suggests that the translocation apparatus involves some kind of a pore in the 
eukaryotic cell membrane by which the effectors are injected into the target cell. For Yersinia, 
the hemolytic activity is higher when the effectors are deleted suggesting that the pore is 
normally filled with trafficking effectors (Hakansson et al., 1996). Osmoprotection experiments 
allowed the estimation of the size of this translocation pore, which is around 2-3 nm in 
diameter (Table 1; Blocker et al., 1999; Dacheux et al., 2001; Holmstrom et al., 2001; Ide et 
al., 2001; Miki et al., 2004; Shaw et al., 2001). The idea of a translocation pore is further 
supported by the observation that the membrane of macrophage-like cells infected with an 
effector polymutant Y. enterocolitica becomes permeable to small dyes (Neyt and Cornelis, 
1999a). If the macrophages are preloaded with a low-molecular-weight fluorescent marker, 
they release the marker but no cytosolic proteins, indicating that there is no membrane lysis 
but rather the insertion of a small pore into the macrophage plasma membrane (Neyt and 
Cornelis, 1999a). Finally the hypothesis of a channel was reinforced by the observation that 
artificial liposomes that have been incubated with Yersinia spp. contained channels, 
detectable by electrophysiology (Tardy et al., 1999). 
The formation of the translocation pore and the translocation of effector proteins are in 
all cases dependent on the presence of the three translocators. This suggests that the 
translocators form a pore in the target cell membrane. But, it could not be formally proved so 
far that the two events, translocation of effectors and formation of a channel, are linked. 
 
 Pathogen  Pore size  System  Method  Reference 
 Yersinia  1.2-3.5 nm  erythrocytes  osmoprotection  (Hakansson et al., 1996) 
  2.2-3.5 nm  erythrocytes  osmoprotection  (Holmstrom et al., 2001) 
  2.4-3.2 nm  erythrocytes  osmoprotection  P.Broz, unpublished data 
  1.6-2.3 nm  macrophages  dye release  (Neyt and Cornelis, 1999a) 
 P. aeruginosa  2.8-3.5 nm  erythrocytes  osmoprotection  (Dacheux et al., 2001) 
 S. flexneri  ~2.5 nm  erythrocytes  osmoprotection  (Blocker et al., 1999) 
 S. Typhimurium SPI-1  ~3.5 nm  erythrocytes  osmoprotection  (Miki et al., 2004) 
 EPEC  2.2-5 nm  erythrocytes  osmoprotection  (Ide et al., 2001) 
  2-3.2 nm  erythrocytes  osmoprotection  (Shaw et al., 2001) 
 
Table 1. Estimated sizes of the translocation pore from different type III secretion systems 
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1.6 Structure of the translocation pore 
 
As mentioned above it was hypothesized that the three translocators constitute a pore 
that mediates translocation. In agreement with their hydrophobic nature, two of the 
translocators would form the transmembrane part of the pore. How the third, hydrophilic 
translocator is involved, remained unclear. It was proposed that it could form the core of a 
membrane channel, stabilized by YopB and YopD (Holmstrom et al., 2001). 
The first study trying to visualize the translocation pore and analyze its components 
was published in 2001 (Ide et al., 2001). The authors incubated erythrocytes with 
concentrated culture supernatant from wildtype DA-EPEC bacteria and from a mutant 
deficient for type III secretion. They examined the membranes of these erythrocytes by 
negative stain TEM and observed segmented, pore like structures in the sample incubated 
with SN from wildtype bacteria (Fig. 5). These big rings had an outer diameter of 55-65 nm 
and rose up to 20 nm from the membrane plane. The inner diameter was estimated to be at 
least 8 nm, which is considerably bigger than the diameter of the translocation pore 
determined by osmoprotection. In addition, the authors demonstrated that EspD and EspB are 
associated to the membranes of the erythrocytes after incubation with SN from wildtype 
bacteria. They concluded that the observed structures might be the type III secretion 
translocon of EPEC, formed by EspD and EspB. The major drawback of this study was that it 
could not be shown that the observed rings are composed of the translocators EspD and 
EspB. Furthermore the inner diameter of the observed rings was far too big to be the 
translocation pore and the overall dimensions of these rings suggest that the authors had 
rather purified some porin-like structures. 
                                                                                                                                           1 Introduction 
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Fig. 5. Electron micrographs of red blood cell membranes incubated with concentrated 
supernatant from wildtype EPEC bacteria (Ide et al., 2001). Transmission electron micrographs (A) 
and etched replicas (B) viewed by electron microscopy. Ring-like structures are indicated (black 
arrowheads). Scale bar is 100 nm in (A) and 200 nm in (B). Three-dimensional image of a representative 
single pore-like structure (C) after Atomic Force Microscopy (AFM) analysis. 
 
The next study, using an in vitro approach to analyze the structure of the translocon, 
was published two years later (Schoehn et al., 2003). The authors expressed and purified the 
translocators PopB and PopD of P. aeruginosa together with their native chaperone PcrH. 
They found that at acidic pH the translocators could bind and disrupt artificial liposomes. 
Electron microscopy revealed ring-like structure on and next to these liposomes with an 
internal diameter of 4 nm and an external diameter of 8 nm (Fig. 6). What was puzzling was 
the observation that the incubation with PopB alone, PopD alone and an equimolar mix of 
PopB and PopD lead to the formation of comparable ring-like structures. The authors 
concluded that upon secretion the translocators PopB and PopD oligomerise, form ring-like 
structures and insert into the target cell membranes (Fig. 7). Even though the approach was 
new and ingenious, this study was incomplete and opened more new questions than it could 
answer. First, it was reported that purified PcrV had no influence on the ring-formation, even 
though PcrV is absolutely required for pore formation in vivo. Second, PopB alone, PopD 
alone and a mix of both formed similar ring-like structures. Third, the authors did not show that 
the rings represented functional pores. And finally, there is no evidence that the translocation 
pores formed by bacteria in vivo are the same as those formed by the translocators in vitro. 
A recent follow-up paper from the same group (Faudry et al., 2006) showed that 
liposomes incubated with purified PopB and PopD are permeabilized due to the formation of 
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pores. These pores were estimated to have a rather wide range of diameter from 3.4 to 6.1 
nm, which is in contrast to native pores formed by P. aeruginosa that have a defined size from 
2.8-3.4 nm (Dacheux et al., 2001). This suggests that the pores formed in vitro are a 
heterogeneous mix of pore-like structures with different diameters as observed for Yersinia (P. 
Broz, unpublished data), possibly due to the lack of LcrV/PcrV.  
Even though it is by now generally accepted that the hydrophobic translocators form the 
translocation pore, it could not be convincingly visualized so far. Therefore the structure and 
composition of the translocation pore remains one of the big mysteries of type III secretion. 
 
Fig. 6. Negative staining electron micrographs showing ring-like structures formed by the P. 
aeruginosa translocators upon interaction with liposomes at acidic pH (Schoehn et al., 2003). (A) 
PopB incubated with liposomes at pH 5.3, stained with uranyl acetate. (B) PopD incubated with 
liposomes at pH 5.3, stained with uranyl acetate. (C) Equimolar mixture of PopB and PopD incubated 
with liposomes at pH 5.3, stained with uranyl acetate. Scale bars are 50 nm. 
 
Fig. 7. Model of translocon formation by PopB and PopD in P. aeruginosa (Schoehn et al., 2003). 
(A) PcrH associates to both PopB and PopD while they remain in the bacterial cytosol preventing 
aggregation and/or activation. (B) The “in vivo switch”, which in vitro is mimicked by a decrease in pH 
leads to the formation of metastable oligomers. (C) PopB and PopD may associate into a homomeric 
and/or heteromeric ring-like structures that bind to membranes. (D) The rings insert into the membranes. 
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1.7 The role of the needle in the translocation process 
 
As mentioned above the secretion apparatus consists of a basal body, embedded in the 
bacterial membranes, topped by a needle-like structure. Electron micrographs of purified 
needle-complexes show that a central channel of 2-3 nm extends from the bottom set of rings 
all the way to the tip of the needle. This suggests that the secreted proteins have to travel in a 
partially unfolded way through this channel and emerge at the tip of the needle. Hoiczyk and 
Blobel proposed that the needle itself, powered by the oligomerization of the needle subunit 
YscF, would punch a hole in the target cell membrane thus placing its tip inside the host cell 
and thereby deliver the effector proteins (Hoiczyk and Blobel, 2001). Attractive as this model 
is, it neglected the fact that the translocators are essential for the delivery of the effector 
proteins. Still one could imagine that the hydrophobic translocators interact with the host cell 
membrane, destabilize it and hereby allow the needle to pierce into the target cell. The 
observed “translocation pores” might in fact just be needles that have been broken off, stay 
inserted in the membranes and thus allow the passage of molecules through a 2-3 nm wide 
channel. 
The Yersinia injectisome needle has a remarkably constant length of around 60 nm (+/- 
10 %) suggesting that it is genetically controlled. Journet et al. proposed that YscP acts as a 
molecular ruler, the length of the protein determining the length of the needle (Journet et al., 
2003). This opened the question, why it has to be controlled. Structures like the adhesin YadA 
and/or the LPS, found on the bacterial surface, determine the distance between the bacterium 
and the target cell, which have to be bridged by the needle. Indeed, it seems that the precise 
length of the needle has been evolutionary adjusted relative to the dimensions of the adhesin 
YadA (Mota et al., 2005a) and the LPS (West et al., 2005). If the needle is too short to bridge 
the distance between the bacterium and the target cell, the effector proteins cannot be 
translocated. 
Surprisingly, when the needle is too short the effectors are not lost in the extracellular 
space. Rather, they are not exported, meaning that the needle itself acts as a sensor to trigger 
export (Mota et al., 2005a). This suggests that the secretion and translocation of effectors is 
only triggered when the needle is long enough to reach the target cell membrane and the 
translocation pore is assembled. Furthermore it can be assumed that the pore is somehow 
connected to the needle, as no leakage of effectors can be observed during the infection. 
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1.8 How is the injectisome coupled to the translocation pore? 
 
One central question is how the pore, presumably consisting of the hydrophobic 
translocators, is connected to the needle of the injectisome. First clues to answer this question 
were provided, when the membranes of erythrocytes, infected with Yersinia, were analyzed. 
Wild type bacteria (lcrV+) formed functional pores and inserted YopB and YopD, but no LcrV 
into the erythrocyte membranes. On the other hand, ∆lcrV bacteria did not form pores, but still 
inserted YopB and YopD into the erythrocyte membranes. This suggested that LcrV mediates 
the assembly of the YopB/YopD translocation pore (Goure, Broz et al., 2005). In addition, 
protective antibodies directed against LcrV inhibited pore formation in infected erythrocytes, 
but not the insertion of the hydrophobic translocators YopB and YopD into the erythrocyte 
membranes (Goure, Broz et al., 2005). Similar observations were made with the LcrV 
orthologs, IpaD from S. flexneri (Picking et al., 2005) and PcrV from P. aeruginosa (Goure et 
al., 2004). These data support a model in which the hydrophilic translocator, acting as an 
extracellular chaperone or assembly scaffold, helps the hydrophobic translocators to integrate 
into the eukaryotic cell membrane and to form a functional pore (Goure, Broz et al., 2005). 
Protective antibodies inhibit the translocation by blocking the function of LcrV and thus 
prevent the assembly of the translocation pore.  
According to this model, the obvious localization of LcrV would be at the tip of the 
injectisome needle, where the secreted proteins are thought to exit the secretion machinery. 
This prompted Mueller, Broz and coworkers to closely analyze the needles of Y. enterocolitica 
(Mueller, Broz et al., 2005). They reported a novel structure, called the tip complex, at the 
distal end of wildtype needles (Fig. 8). Needles of lcrV mutant bacteria lacked this tip structure 
and it was restored when the mutation was complemented in trans. When the mutation was 
complemented with the LcrV orthologs, PcrV from P. aeruginosa or AcrV from A. salmonicida, 
the tip complex was brought back, resembling that formed by LcrV. As a final proof that the tip 
complex is composed of LcrV the authors showed that anti-LcrV antibodies bound specifically 
to the tip complex. This lead to the present model, in which the LcrV tip complex, localized at 
the tip of the needle, assists the assembly of the translocation pore, formed by the secreted 
translocators YopB and YopD (Fig. 9). At a later stage LcrV presumably connects the pore to 
the needle, forming a continuous channel from the bacterium to the cytoplasm of the 
eukaryotic cell. 
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Fig. 8. LcrV forms a structure at the tip of the injectisome needle (Mueller, Broz et al., 2005). (A) 
Transmission electron micrograph of Y. enterocolitica negatively stained with 2 % uranyl acetate. 
Needles protrude from the cell surface and have a distinct structure at their distal end. Scale bar is 40 
nm. (B) Scanning Transmission Electron Microscopy (STEM) images of negatively stained wt needles. 
The characteristic tip complex (white arrow) comprises a head, a neck and a base. Scale bar is 20 nm. 
(C) STEM images of wt needles incubated with anti-LcrV antibodies and negatively stained. The 
antibodies generally attached to the “head” domain of the tip complex. Scale bar is 20 nm. (D) Projection 
averages of the complexes formed by LcrV, PcrV and AcrV at the tip of the injectisome needle of Y. 
enterocolitica E40 (resolution 1.5 nm). A central channel permeates both the needle and the tip complex. 
Scale bar is 5 nm. 
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Fig. 9. Hypothetical model for the function of the LcrV tip structure in the assembly of the 
translocation pore formed by the translocators YopB and YopD (Mueller, Broz et al., 2005). (A) 
Before contact to a target cell. The injectisome is assembled and LcrV forms the tip complex on the 
distal end of the needle. (B) Contact to target cell. The translocation pore is assembled, forming a 
continuous channel from the bacterium to the host cell cytosol and allowing translocation of effector 
proteins. The LcrV tip complex serves as an assembly platform. (C) Situation in lcrV deletion mutant. 
The translocators YopB and YopD are secreted and insert into the target cell membrane. No 
translocation pore is formed due to the lack of the tip complex. (D) Presence of protective antibodies. 
The translocators are secreted and insert into the target cell membrane. No functional pore can be 
assembled, because anti-LcrV antibodies bind to the tip complex and block its function. 
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Accessory 
 
1.9 The chaperone of the hydrophobic translocators 
 
A hallmark of type III secretion is that efficient secretion or translocation of some 
substrate proteins requires the presence of small cytosolic chaperones. They are divided into 
three distinct classes: I, II and III. Chaperones of the hydrophobic translocators constitute the 
class II. The archetype of this chaperone class is SycD, the specific chaperone of both YopB 
and YopD from Yersinia (Neyt and Cornelis, 1999b; Wattiau et al., 1994). Homologs of SycD 
in other type III secretion systems usually serve as chaperone for two hydrophobic 
translocators as well (Fig. 4): PcrH for PopB and PopD (Allmond et al., 2003; Schoehn et al., 
2003), SicA for SipB and SipC (Kaniga et al., 1995; Tucker and Galan, 2000) and IpgC for 
IpaB and IpaC (Menard et al., 1994). In EPEC the situation seems to be more complex: 
Initially, CesD was reported to be the chaperone for the translocators EspB and EspD 
(Wainwright and Kaper, 1998). Meanwhile, a second chaperone for EspD, called CesD2, was 
discovered (Neves et al., 2003). In the SPI-2 system of S. Typhimurium, the sscA gene shares 
homology to sycD of Yersinia, but the protein has not been analyzed so far. 
 
1.9.1 Role as chaperone 
 
Immunoprecipitation experiments have shown that, in the cytoplasm of S. flexneri, IpgC 
is associated either with IpaB or IpaC (Menard et al., 1994). As IpaB and IpaC have been 
shown to form a complex after secretion it was proposed that the chaperone prevents the 
premature association of the two translocators (Menard et al., 1994). The same role has been 
attributed to SicA, the homolog of IpgC, in S. Typhimurium (Tucker and Galan, 2000). 
Consistent with this it could be shown that in Yersinia and P. aeruginosa, SycD/PcrH also 
associates independently with YopB or YopD, PopB or PopD respectively (Anderson et al., 
2002; Schoehn et al., 2003). In contrast to chaperones of the effectors (class I), chaperones 
of the translocators might not bind to a unique region on their substrates. YopD possesses 
two distinct SycD binding domains, one spanning the N-terminus and one encompassing the 
C-terminal amphipathic domain (Francis et al., 2000), while several binding sites were 
identified in YopB (Neyt and Cornelis, 1999b). In S. flexneri, however, a unique binding site for 
IpgC has been identified in the N-terminal part of both IpaB and IpaC (Page et al., 2001). So 
far no similarities between these regions could be identified. Only the crystallization of the 
chaperones together with their substrates will determine the nature of this interaction. 
When expressed in E. coli, IpaB is degraded in the absence of the chaperone IpgC, 
while IpaC is stable (Menard et al., 1994). When IpaB and IpaC are co-expressed both 
proteins are degraded but this can be prevented by the expression of IpgC. Thus in the 
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absence of IpgC the unstable IpaB associates to IpaC and leads to its degradation. In 
Salmonella, SipB is degraded in a sicA mutant, but not in a sicAsipC mutant, suggesting that, 
in the absence of SicA, SipC interacts with SipB and leads to its degradation (Tucker and 
Galan, 2000). In Yersinia also YopB and, to a lesser degree YopD, require SycD for its 
stability (Edqvist et al., 2006; Francis et al., 2000; Neyt and Cornelis, 1999b). In addition, if 
YopB is expressed in E. coli without the chaperone it leads to lysis of the bacteria, probably 
due to the interaction with membranes (Neyt and Cornelis, 1999b). Similar observations were 
reported for PopB and PopD from P. aeruginosa (Schoehn et al., 2003). No toxic effects are 
observed when the translocators are expressed with their chaperone.  
Altogether these results suggest that the function of class II chaperones is to prevent 
premature association of the translocators and also to stabilize their substrates. Because 
some of the translocators might have a deleterious effect on the bacteria, they are rapidly 
degraded if they are not bound to the chaperone. 
Structurally, class II chaperones are characterized by the possession of three tandem 
tetratricopeptide repeats (TPR’s), which are otherwise only found in eukaryotic molecular 
chaperones (Pallen et al., 2003). No class II chaperone has been crystallized so far, but the 
TPR’s allowed a homology modeling of SycD based on human protein phosphatase 5 (Fig. 
10, (Pallen et al., 2003). According to this, class II chaperones would have an all-alpha-helical 
domain structure in contrast to class I chaperones, which comprise alpha-helical and beta-
strand structures (Parsot et al., 2003). The mapping of residues critical for the interaction with 
the translocators revealed two distinct interaction interfaces in SycD, one for YopD and one 
for YopB (Fig. 10, (Edqvist et al., 2006). 
 
Fig. 10. Homology modeling of the hypothetical structure of the translocator chaperone SycD 
(Edqvist et al., 2006). The modeling is based on the TPR’s of the human protein phosphatase 5. 
Interaction interfaces with YopB and YopD were determined by mutagenesis and are indicated. 
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1.9.2 Role in regulation 
 
Initially, SycD was discovered as a negative regulator because a sycD mutation leads 
to increased yop gene expression and reduced growth in high calcium conditions; hence it is 
also called LcrH for “low Calcium response H” (Bergman et al., 1991; Price et al., 1989). 
Overexpression of SycD in Yersinia causes a decrease in Yop synthesis. Deletion of the yopD 
gene results in a constitutive production of Yops, similar to a sycD mutation. It was shown that 
the formation of a complex between YopD and SycD is necessary for the regulation of yop 
gene expression (Anderson et al., 2002; Francis et al., 2000). Mutants that could not form the 
complex could no longer regulate yop gene expression, even though YopD and SycD were 
both produced. Therefore it has been proposed that together with YopD, SycD/LcrH 
establishes a negative regulatory loop for the control of Yop synthesis (Francis et al., 2000).  
Homologs of SycD/LcrH from other system have been shown to be involved in 
regulation as well. In S. Typhimurium the chaperone SicA is necessary for the activation of the 
sicA, sigDE and sopE operons, which also depends on the presence InvF, a transcriptional 
activator of the AraC family (Darwin and Miller, 2001; Tucker and Galan, 2000). Co-
expression of SicA and InvF is sufficient to activate the promoters of these operons in E. coli 
(Darwin and Miller, 2001). In addition both proteins were shown to interact in E. coli, 
suggesting that SicA could act as co-activator of InvF. In S. flexneri, IpgC and MxiE, the 
homologs of SicA and InvF, are involved in the activation of effector genes, like ipaH (Mavris 
et al., 2002). Co-expression of both proteins in E. coli is sufficient to activate transcription from 
regulated promoters. Furthermore, overexpression of IpgC in wildtype S. flexneri leads to the 
activation of the regulated genes. Similar observations were made for SycB and YsaA from 
the Yersinia Ysa-Ysp system (Walker and Miller, 2004). The model proposed for this family of 
TTSSs states that, in non-secreting conditions, the chaperone is associated with the 
translocators and is not available for the AraC-like activator (Fig. 11). Upon secretion of the 
translocators the chaperone is released and can act as co-activator for the transcription of 
regulated promoters. This imposes a level of hierarchy between the translocators and the 
effectors. One could therefore speculate that the class II chaperones not only serve as 
chaperones for the hydrophobic translocators but also might ensure the secretion of the 
translocators at the right time, before the effectors. 
According to this model, the translocators have to be secreted before the effectors can 
be produced. However, it is known that effectors are synthesized and stored in the cytosol 
already before the system is triggered. Upon activation they are supposed to be secreted 
post-translationally. This implies that the translocators have to be detached from the 
chaperone already before the secretion is triggered. This suggest that, during the assembly of 
the injectisome, the translocators are secreted and/or stored somewhere in the injectisome. It 
could be possible that the needle is filled with the translocators. Purified needle preparations 
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from Yersinia contain YopD (Mueller, Broz et al., 2005) and recently it was reported for S. 
flexneri that IpaB is present in purified needle preparations (Espina et al., 2006). If these 
proteins are only contaminants of the needle preparations or indeed the needles were 
preloaded with translocators remains to be determined. 
 
 
 
Fig. 11. Simplified model of regulation of transcription by TTS apparatus activity in S. flexneri, S. 
Typhimurium SPI-1 and Y. enterocolitica Ysa-Ysp system. (A) Inactive secretion apparatus. The 
translocators (red) are bound to their chaperone (orange). The AraC-like activator (turquoise) cannot 
activate the transcription of effector genes. (B) Active secretion apparatus. Secretion of the translocators 
leads to the release of the chaperone. (C) The chaperone interacts with the AraC-like activator. This 
allows the transcription of effector genes (green). (D) The effectors are secreted. 
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1.10 The LcrG-LcrV complex regulates the secretion of effector Yops 
 
As mentioned above the operon encoding the translocators and SycD also encodes 
LcrG, a small cytosolic protein, which is also involved in the low Calcium response (LCR) of 
Yersinia. A mutant in lcrG exhibits a Calcium-blind phenotype, expressing and secreting Yop 
proteins independently of the presence of Calcium at 37°C (Perry et al., 1986; Price et al., 
1991; Skryzpek and Straley, 1993). LcrV, encoded in the same operon, is also involved in the 
LCR of Yersinia. But in contrast to lcrG mutants, lcrV mutants express and secrete severely 
reduced amounts of effectors and translocators and also do not show any growth inhibition 
when deprived of Calcium at 37° (Marenne et al., 2003; Skrzypek and Straley, 1995).  
LcrG and LcrV form a stable heterodimeric complex in the cytosol (Nilles et al., 1997). 
This complex-formation prompted the analysis of an lcrGV double mutant (Matson and Nilles, 
2001; Nilles et al., 1998) and it appeared that this mutant exhibited the same phenotype as an 
lcrG mutant, expressing and secreting Yop proteins independently of the presence of Calcium 
at 37°C. Providing lcrV in trans had no effect on the phenotype. On the other hand, 
complementation of the double mutant with lcrG completely abolished secretion and 
decreased expression of Yops at 37°C in the presence and the absence of Calcium. This 
indicated that LcrG could act as a negative regulator for Yop secretion. If the mutant was 
complemented with both genes (lcrG and lcrV) the wildtype phenotype was restored. These 
results lead to the so-called LcrG titration model for the regulation of Yop secretion that was 
first proposed by Nilles et al. (Fig. 12; Nilles et al., 1998). This model states that, before the 
machinery is active, LcrG is expressed and directly or indirectly blocks the secretion 
machinery, acting from within the bacterial cytoplasm. Contact with the target cell or Calcium 
chelation (in vitro) would lead to increased expression of LCR-regulated genes, including the 
positive regulator LcrV. Increasing levels of LcrV would lead to complex formation between 
LcrV and LcrG, thus removing LcrG from its secretion-blocking function. In agreement with 
this, mutant LcrG proteins that cannot longer interact with LcrV block secretion, mimicking an 
lcrV phenotype (Matson and Nilles, 2001). Although the titration model is appealing, it is hard 
to imagine how contact to the target cell increases the expression of LcrV and not of LcrG as 
both of them are in the same operon. It is also unknown how the LcrG-LcrV plug is connected 
to the YopN plug, which also controls secretion. 
Interestingly, it was shown that LcrG is also necessary for the efficient translocation of 
effectors into target cells, because when HeLa cell were infected with an lcrG mutant for 2 h, 
no cytotoxicity was observed (Sarker et al., 1998b). Only after prolonged infection (4 h) 
cytotoxic effects were observed (Nilles et al., 1998), suggesting that LcrG is not essential for 
translocation, but has a facilitating effect. This is consistent with the observation that LcrG 
might be required for maximal or efficient secretion of LcrV (Fields et al., 1999). These results 
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indicate that LcrG has a facilitating role in Yop targeting by promoting LcrV secretion, which is 
necessary to form the translocation pore. 
Based on these observation it has also been proposed that LcrG could be the 
chaperone of LcrV (Lee et al., 2000). This idea is in addition supported by the facts that LcrG 
is small and primarily cytosolic. Purified LcrV forms dimers and to a certain extend also 
multimers (Lawton et al., 2002). Upon addition of LcrG the LcrV-dimer is dissociated and 
LcrG-LcrV heterodimers are formed. This suggests that LcrG prevents the polymerization of 
LcrV. The observation that LcrV forms the tip complex, implies that it has to polymerize 
(Mueller, Broz et al., 2005). In addition crosslinking of purified needles indicates close 
interaction between LcrV molecules (Mueller, Broz et al., 2005).  
EspA, the ortholog of LcrV in EPEC, requires the chaperone CesA that keeps it in a 
monomeric form and prevents polymerization in the bacterial cytoplasm (Yip et al., 2005). 
Both LcrG and CesA have a basic pI, unlike class I chaperones that have an acidic pI. In 
contrast to EspA, LcrV does not require LcrG for its stability and secretion. The interaction 
between CesA and EspA is mediated via a coiled-coil motif, made of long alpha helices (Fig. 
13). LcrV is much bigger than EspA but also has two long alpha helices that form a coiled-coil, 
similar to EspA. Comparably, in the S. Typhimurium SPI-2 system the interaction of SseB and 
its chaperone SseA is mediated by a putative coiled-coil motif (Zurawski and Stein, 2004). 
Indeed it has been reported that the interaction between LcrG and LcrV is also mediated by 
coiled-coil domains (Lawton et al., 2002). These coiled-coils are formed by the two long alpha 
helices that connect the globular domains of LcrV (Fig. 13). It is possible that these 
hydrophilic translocators need the chaperone to prevent their polymerization by masking their 
coiled-coil motifs. 
                                                                                                                                           1 Introduction 
 24 
 
Fig. 12. The LcrG titration model (Nilles et al., 1998). (A) Non secreting condition: LcrG is expressed 
and blocks the secretion apparatus from within the bacterial cytosol. (B) Contact with the target cell 
membrane or Calcium chelation leads to increased LcrV synthesis. (C) Formation of LcrG-LcrV dimers. 
Removal of gating. (D) The channel is open and secretion of effectors is possible. 
 
 
Fig. 13. The coiled-coil motifs in EspA and LcrV. (A) Structure of CesA (blue) in complex with EspA 
(red) (Yip et al., 2005). The flexible central region of EspA is drawn as a dashed red line. Two extensive 
alpha helices of EspA (coiled-coil) interact closely with CesA in the protein complex. (B) Structure of 
LcrV (gray) as reported by Derewenda et al., 2004. The two long alpha helices that connect the globular 
domains and that are involved in the formation of coiled-coils and the interaction with LcrG are arranged 
in front (yellow). 
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1.11 Requirements on the membrane side 
 
Many pathogenic bacteria have been found to interact with specialized domains of the 
host membrane that are rich in cholesterol and sphingolipids and that are termed rafts. 
Cholesterol rich microdomains have been found to be necessary for type III secretion 
mediated uptake of S. Typhimurium (Garner et al., 2002) and S. flexneri (Lafont et al., 2002) 
(for a review see, Lafont and van der Goot, 2005). Cellular receptors that partition into 
microdomains cluster during Salmonella and Shigella entry and upon initial EPEC-host 
contact (Garcia-del Portillo et al., 1994; Lafont et al., 2002; Zobiack et al., 2002). As the 
translocators insert directly into host cell membranes it was speculated that the formation of 
the translocation pore could depend on the presence of certain lipids in the host cell 
membrane. Indeed it could be shown recently that cholesterol is required for the translocation 
of effector proteins into host cells by Salmonella, Shigella and EPEC (Hayward et al., 2005). 
In addition the authors show that purified Salmonella SipB and Shigella IpaB are cholesterol-
binding proteins and that cholesterol is the main binding determinant of purified SipB/IpaB to 
host cells (Hayward et al., 2005).  
In vitro, liposome fusion induced by purified SipB protein is enhanced when target 
liposomes contain cholesterol (Hayward et al., 2000). Cholesterol-containing liposomes have 
also been shown to weakly stimulate the Shigella TTSS, suggesting that raft-like lipids may 
trigger effector release (van der Goot et al., 2004). 
No cholesterol dependence has been reported for infections with P. aeruginosa so far, 
but the interaction of the P. aeruginosa translocators with artificial membranes has been 
studied (Schoehn et al., 2003). It was reported that purified PopB and PopD only bind to 
liposomes containing negatively charged phospholipids (phosphatidylserine) and that PopB 
and PopD can lyse liposomes containing cholesterol (Schoehn et al., 2003). The latter 
observation had to be revised in a later study (Faudry et al., 2006), as no lysis could be 
observed any more, even with liposomes containing cholesterol. Similar experiments with 
purified translocators from Yersinia suggested that negatively charged phospholipids (DOPS) 
are required for the association of YopB and YopD with liposomes and for their insertion into 
membranes, while cholesterol is dispensable (P. Broz, unpublished results). In vivo studies 
with Yersinia showed that the depletion of cholesterol has no influence on the infection of cells 
(L. J. Mota, unpublished results). 
Taken together, there is strong evidence that the interaction of several pathogens 
employing type III secretion systems, like Shigella, Salmonella and EPEC, is dependent on 
lipid rafts in the host cell membrane. Although some raft- or cholesterol-dependent events 
have been identified, the exact mechanisms at the molecular level remain obscure and will 
require further studies. However, not all type III secretion systems need to be triggered by the 
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same kind of lipids. Some bacteria have to act in seconds to escape macrophages, while 
others have more time to find the right spot to enter a target cell. 
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1.12 Other needle extensions 
 
As mentioned before the LcrV tip complex forms an extension of the needle structure 
and possibly connects the translocation pore to the needle. Another type of extension is the 
EspA filament found in EPEC (Fig. 14; Knutton et al., 1998). This filament is a polymer made 
of multiple copies of a single hydrophilic protein, EspA. This protein, together with the 
hydrophobic proteins EspD and EspB is necessary for translocation of effectors and the 
formation of the translocation pore. EM analysis of purified injectisomes of EPEC show that 
the EspA filament is firmly attached to a very short needle made by EscF (Fig. 14; Daniell et 
al., 2001; Sekiya et al., 2001), which is similar to needles observed in other type III secretion 
systems. So far it was not defined whether EspA polymerizes around or on top of the EscF 
needle. The length of the EspA-filament varies considerably and can reach up to 600 nm. The 
3D structure of EspA filaments at a resolution of 26 Å revealed that the structure comprises a 
helical tube with a diameter of 120 Å enclosing a central channel of 25 Å diameter (Daniell et 
al., 2003), which is similar to the diameter of the injectisome needle (25 Å). Furthermore the 
helical parameters of the EspA filament (5.6 subunits per turn, 4.6 Å axial rise per subunit, 
Daniell et al., 2003) resemble that of the needle (5.6 subunits per turn, 4.3 Å axial rise per 
subunit, Cordes et al., 2003) and the R-type straight flagellar filament of Salmonella (5.47 
subunits per turn, 4.69 Å axial rise per subunit, Mimori et al., 1995). In addition all three 
structures have five-fold symmetry. 
The EspA filament is thought to be a necessary adaptation to enable the pathogen to 
penetrate the thick glycocalyx layer and to reach the cells of the intestinal. The EspA filament 
would serve as a hollow conduit connecting the injectisome of EPEC with the translocation 
pore, formed by EspD and EspB. 
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Fig. 14. EspA forms a long filament, attached to the needle of the injectisome from EPEC. (A) 
Electron micrographs of osmotically shocked EPEC stained with 1 % PTA (Daniell et al., 2001). (B) 
Electron micrographs of negatively stained purified NCs from EPEC. The white arrow indicates NCs and 
black arrow indicates pilus-like structures (Sekiya et al., 2001). (C) Electron micrographs of negatively 
stained purified NCs from S. flexneri. The white arrows indicate NCs (Sekiya et al., 2001). (D) Alignment 
of EPEC NCs and comparisons to S. flexneri NCs. N and B indicate the needle and basal body of EPEC 
NCs (Sekiya et al., 2001). (E) Immunogold labeling of purified NCs from EPEC with anti-EspA 
antibodies. Only the filament is decorated with gold particles while the basal body and the thinner needle 
part is not labeled. Scale bars are 100 nm (Sekiya et al., 2001). 
 
 
A similar structure could exist in the SPI-2, the second T3SS of S. Typhimurium 
(Chakravortty et al., 2005). The three translocators of this system are SseB, SseC and SseD 
(Nikolaus et al., 2001). TEM analysis of S. Typhimurium grown in vitro revealed novel surface 
appendages (Fig. 15). These appendages are composed of a needle, 150 nm long, sheathed 
with an irregular proteinaceous structure. Immunogold analysis revealed that this sheath 
contains the translocators SseB and SseC. It is likely that these sheath structures, observed 
in vitro, are the result of prolonged secretion in the absence of contact to a target cell 
membrane. But, ultrathin section analysis of intracellular S. Typhimurium in macrophages 
revealed that in vivo similar needles are formed and have also a sheath-like structure but only 
at their distal end. This sheath contains SseB, the hydrophilic translocator of the SPI-2 type III 
secretion system. It still remains to be elucidated, how the sheath structure looks in detail, 
what is its function and whether the sheaths, formed in vivo, are not also just an artifact 
resulting from prolonged secretion. 
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Fig. 15. Electron micrographs of surface structures encoded by the S. Typhimurium SPI-2 
system (Chakravortty et al., 2005). (A, B) High magnification electron micrographs of surface 
appendages present on wildtype S. Typhimurium, grown in secreting conditions. The appendages 
consist of an inner cylindrical needle (black arrowhead) and different extends of a proteinaceus 
structure. (C, D) Double immunogold labeling with antibodies directed against the translocators SseB 
(arrowheads) and SseC (arrows) of the surface appendages on S. Typhimurium grown in vitro. The 
antibodies were detected with protein A coated gold-particles of 10 nm for SseB and 15 nm for SseC. 
Both translocators are part of the sheath-like structure. (E, F) Ultrathin section analysis of intracellular S. 
Typhimurium bacteria. Structures consisting of needle-like stem and a sheathed distal end can be seen 
(E). Immunogold labeling for SseB (F) of surface appendages formed in vivo stains the sheath structure. 
Scale bars are 25 nm in (A, B, E), 100 nm in (C, D) and 50 nm in (F). 
 
 
Recently, IpaD the functional ortholog of LcrV in S. flexneri, has been shown to be 
localized at the tip of the S. flexneri needle by immunogold electron microscopy (Espina et al., 
2006). What kind of structure it forms there could not be defined yet. 
The EspA filament and the putative SPI-2 needle sheath resemble, at a functional level, 
the LcrV tip structure of Yersinia. It can be hypothesized that the tip protein would have 
evolved to polymerize as a filament rather than a simple ring structure, but that it has probably 
kept its scaffolding property for the hydrophobic translocators (Fig. 16). 
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Fig. 16. Schematic representations of the flagellum (A) and different kinds of injectisomes (B, C, 
D). The flagellar hook, counterpart of the injectisome needle, is extended with a long filament made of 
FliC. The injectisomes of different species vary in the form of their needle extension. The needles of 
Yersinia spp., P. aeruginosa and A. salmonicida have a distinct tip complex at their distal end formed by 
LcrV, PcrV or AcrV respectively (B). The same is probably true for S. Typhimurium and S. flexneri (SipD 
and IpaD). The needle from EPEC is extended by the long EspA filament (C). The needle from the S. 
Typhimurium SPI-2 TTS system (D) is likely to be topped with an yet undefined sheat-like structure, 
containing SseB. 
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1.13 Double function as translocator and effector 
 
Type III secretion effectors are proteins that are injected into the eukaryotic cell, where 
they act on cellular signaling and control pathways. It appears that, in addition to the known 
effectors, some of translocators, namely IpaB, SipB, EspB and YopD are delivered into the 
eukaryotic cell.  
A feature of Shigella and Salmonella infections is the induction of the inflammatory 
response. It has been shown that IpaB as well as SipB activate the ICE cysteine protease, 
which converts pro-IL-1 to the mature proinflammatory cytokine IL-1 (Hersh et al., 1999; Tran 
Van Nhieu et al., 1997). In addition, IpaB leads to the activation of NF-kB, which is followed by 
the release of proinflammatory cytokines, such as IL-8 (Hobbie et al., 1997). Because ICE is 
also a caspase (casp-1), interaction with IpaB or SipB leads to apoptosis of macrophages. 
Inhibition of Casp-1 activity by a specific inhibitor blocks macrophage cytotoxicity, and 
macrophages lacking casp-1 are not susceptible to Salmonella induced apoptosis (Chen et 
al., 1996; Hersh et al., 1999; Hilbi et al., 1998). Shigella- and Salmonella-induced apoptosis is 
thus distinct from other forms of apoptosis, including that induced by Yersinia, in that it is 
uniquely dependant on Casp-1. 
The host cell cytoskeleton is a major target of effector proteins injected by pathogenic 
bacteria. The translocators IpaC from Shigella and SipC from Salmonella were shown to act 
on cytoskeletal dynamics and promote the entry of the bacteria into nonphagocytic cells. IpaC 
induces rearrangements of the subcortical cytoskeleton via small GTPases of the Rho family, 
leading to the formation of protrusions and membrane ruffling at the bacterial entry site (Tran 
Van Nhieu et al., 1999). Purified SipC nucleates actin polymerization and bundles actin into 
cables (Hayward and Koronakis, 1999). 
EspB, one of the translocators from EPEC, is as well targeted to the host cell cytosol 
(Taylor et al., 1998; Wolff et al., 1998), where it modulates the cell actin cytoskeleton (Taylor 
et al., 1999). Also YopD from Yersinia was shown to be localized in eukaryotic cells after 
infection (Francis and Wolf-Watz, 1998), but no function as effector could be attributed yet. As 
the translocators are probably internalized during the recycling of membranes, this may 
explain why YopD is found in the eukaryotic cell, even though it is no effector.  
Taken together, these observations indicate that depending on the system, the 
translocators are not necessarily restricted to the contact area between the bacteria and 
eukaryotic cells, but that they may traffic inside the target cell and act themselves as effectors, 
possibly in association with membranes. 
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2 Aim of the thesis 
 
The three proteins YopB, YopD and LcrV have been shown to be necessary for the 
translocation of effectors into target cells by the TTSS of Yersinia. It has been hypothesized 
that the translocators form a pore in the target cell membrane, but this pore has not been 
visualized so far. The role of the different translocators YopB, YopD and LcrV in the assembly 
of the translocon was unknown. The hydrophobic domains found in YopB and YopD 
suggested that they might be transmembrane proteins, facilitating the translocation. In 
addition, the role of LcrV, the major protective antigen, remained mysterious. The aim of my 
thesis was to characterize the type III secretion translocon of Y. enterocolitica in different 
aspects.  
First the role of the hydrophilic LcrV had to be clarified. Second we wanted to find a way 
to isolate the translocation pore formed by the translocators, analyze its composition and 
visualize it by electron microscopy. And third we wanted to determine if certain lipids of the 
target cell membrane, in particular those found in lipid rafts, play a role during the formation of 
the translocation pore from Y. enterocolitica.  
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Summary 
 
The Yersinia injectisome needle has a remarkably constant length of around 60 nm 
suggesting that it is genetically controlled. Mutants affected in the yscP gene display 
abnormally long needles, indicating that the needle length is indeed regulated and that YscP 
is involved in this process, as it is the case for its counterparts in other TTSS. To determine 
how YscP is exerting its length control function, we engineered a set of deletions and 
insertions in the protein. Deletions affecting either the extreme N-or C-term lead to needles of 
deregulated lengths suggesting that they are required for the length-control of the needles. In 
contrast, the central part can be shortened or lengthened without the loss of function. 
Moreover, deletions or insertions in this central part give rise to shorter or longer needles, 
respectively and a strict linear relationship between the number of residues of YscP and the 
needle length can be observed. Analysis of purified needles indicated that YscP is found in 
the purified needle fraction in non-secreting conditions but not any more in secreting 
conditions. Altogether these results demonstrate that YscP is acting during the assembly of 
the injectisome as a molecular ruler to determine needle length. 
 
 
Statement of my work 
 
I contributed to this paper by providing the electron micrographs of the yscP mutant 
strain, the needle purification protocol and the analysis of purified needles. I also contributed 
by preparing figures (Fig. 1, 3 and 4) and I was involved in the writing of the manuscript. 
 
lines was 1.23 and 1.26 mm, whereas it was 1.23
mm for the ds2M line (Wilcoxon rank-sum test
P ! 0.1 for all comparisons, sample sizes N "
18). If anything, one of the ds2Z lines shows an
effect in the wrong direction.
Lack of sex specificity of the influence of
ds2 on both starvation and cold tolerance
suggests that this effect is not due to differ-
ences in cuticular hydrocarbons per se. Per-
haps it is due to an influence of ds2 on
phospholipid composition, as in many other
organisms (22). Whatever the exact mecha-
nism of ds2 action, our results strongly sug-
gest that it is involved in stress resistance.
Note, however, that the ds2M allele appears to
be the derived one (6). Consequently, we
have restored the ancestral state at the ds2
locus of the Cosmopolitan line, whereas the
actual adaptation involved the loss of the
ds2Z allele from the African population.
The possibility that ecologically driven adap-
tation at the ds2 locus results in sexual isolation
as a pleiotropic by-product is certainly intrigu-
ing. The role ds2 may play in Z-M sexual isola-
tion is being debated. The genetic basis of Z
behavior is complex (12, 39). Thus, ds2 cannot
be the only gene involved and, because the Ca-
ribbean flies carry the African ds2Z allele but
exhibit M-type behavior, the locus has initially
been excluded as a candidate sexual isolation
gene (4). However, this lack of association
across genetic backgrounds is inconclusive. A
comparison within populations, in which the ge-
netic background is randomized, is more infor-
mative. Indeed, when three African populations
polymorphic for both Z behavior and ds2 were
tested, a positive correlation between the pres-
ence of ds2Z and the strength of female Z behav-
ior was found in all of them (11). Thus, loss of
ds2Z from the average African background may
reduce Z-M sexual isolation.
Although the role of ds2 in premating
isolation remains to be firmly established, we
have identified a potential ecological basis
for the maintenance of pheromone polymor-
phism as a result of strong geographical dif-
ferentiation at the ds2 locus. Our ability to
detect the role of ds2 in differential adapta-
tion depended crucially on manipulating the
gene at its locus while leaving the rest of the
genome intact. The phenotypic differences
associated with ds2 allele replacement are
small enough to be drowned out by the noise
introduced by the genetic background in con-
ventional genetic analyses. Precise allele sub-
stitution thus promises to lead to insights into
the molecular and evolutionary mechanism of
adaptation and speciation.
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The Needle Length of Bacterial
Injectisomes Is Determined by a
Molecular Ruler
Laure Journet, Ce´line Agrain, Petr Broz, Guy R. Cornelis*
Size determination represents a fundamental requirement for multicomponent
biological structures. Some pathogenic bacteria possess a weapon derived from
the flagellum. Like the flagellum, this type-III secretion apparatus, called the
injectisome, has a transmembrane basal body, but the external component is
a needle-like structure instead of a hook and a filament. Here, we provide
evidence that the length of this needle is determined by the size of a protein,
YscP, acting as a molecular ruler.
Yersinia pestis and Y. enterocolitica, the infec-
tious agents of bubonic plague and gastroenter-
itis, respectively, share a common plasmid-en-
coded type-III secretion system consisting of the
Ysc (Yop secretion) injectisome and the Yops
(Yersinia outer proteins) that are secreted by this
apparatus (1). The injectisome, made of 27 Ysc
proteins, is thought to resemble those of Salmo-
nella enterica and Shigella flexneri. These injec-
tisomes, or “needle complexes,” appear as two
pairs of rings that are anchored to the inner and
outer membranes of the bacterial envelope,
joined by a central rod and supporting a hollow
needle about 10 nm thick and 60 nm long (2–4).
It is thought that the injectisome serves as a
hollow conduit through which the secreted pro-
teins travel across the two bacterial membranes
and the peptidoglycan in one step.
Several Ysc proteins that are anchored in
the inner membrane and form the core of the
secretion apparatus are similar to proteins
from the basal body of the flagellum, sug-
gesting a common evolutionary origin (5).
Not surprisingly, the Salmonella and Shigella
injectisomes resemble the flagellar basal
body (6) except that they are topped by a
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needle instead of a hook and a flexible fila-
ment. The length of the flagellar hook (55
nm) is genetically controlled. Mutations in
the gene fliK give rise to hooks of indefinite
length (7), but it is unclear how FliK exerts
its control. The fact that all truncated FliK
proteins engineered so far lead to longer
hooks rather than shorter hooks is presented
as an argument that FliK cannot act as a
simple molecular ruler (8). In addition,
certain mutations in genes that encode the
cytoplasmic ring lead to shorter hooks (8),
supporting an elegant model in which this
structure controls the hook length by acting
as “a quantized measuring cup,” storing the
subunits before their export (8). In this mod-
el, the role of FliK would be to terminate
hook elongation by changing the secretion
mode from hook-monomer to flagellin-
monomer secretion (8). As for the injecti-
some of Salmonella and Shigella, mutants
affected in a gene called invJ or spa32, re-
spectively, display needles of various lengths,
ranging from normal (60 nm) to as long as 1
#m (2, 9, 10). Thus, InvJ and Spa32 behave
as FliK homologs, although they do not share
any substantial sequence homology with
FliK.
Here, we address the question of what
controls the injectisome needle length in Yer-
sinia. We first examined by electron micros-
copy Y. enterocolitica E40 bacteria incubated
under conditions that artificially induce se-
cretion of the Yops (11). We observed many
needle-like structures that were about 6 to 7
nm thick and 60 nm long (12). Many of these
needles were detached from the bacterial
body (Fig. 1). We purified these detached
needles and confirmed that they were made
of the 6-kD YscF protein (12). Because it is
difficult to define the exact insertion point of
needles on bacteria, we measured only the
detached needles. The length was distributed
with an average of 58 $ 10 nm (Fig. 1),
suggesting that the needles either detached or
broke at a precise point close to the bacterial
surface. Next, we examined Y. enterocolitica
with a large deletion (codons 97 to 465 out of
515) in yscP (yscP%97–465) (13). This gene is
synthenic to spa32 and invJ, but its product
has no substantial sequence identity with
Spa32, InvJ, or FliK. The yscP%97–465 mutant
bacteria produced needle-like structures with
an indefinite length ranging from 45 nm up to
1570 nm (Fig. 1). When the yscP%97–465
mutation was complemented with the yscP&
allele, control of the length was restored
(55 $ 8 nm), indicating that YscP played an
essential role in length control.
YscP from Y. enterocolitica E40
(YscPentero) carries a duplication of 60 central
residues (13) (Fig. 2). YscP from Y. pestis
KIM5 (YscPpestisKIM5) is 90% identical in se-
quence to YscPentero, but it is shorter (455 res-
idues) because of the lack of such repetition
(14). To explore whether the two proteins lead
to needles of the same length, we complement-
ed the Y. enterocolitica yscP%97–465 mutation
with the yscPpestisKIM5
& gene (15). The shorter
Y. pestis gene restored length control but pro-
grammed shorter needles (41$ 8 nm) (Fig. 2).
To investigate whether the needle length
reduction was a result of the shortening of
YscP and not subtle residue changes, we
complemented the yscP%97–465 mutation with
Fig. 1. YscP is required for needle-length control. Electron micrographs of Y. enterocolitica wild type
(wt) (A) and yscP%97–465 mutant (C) showing the needles of the injectisomes. Detached needles
were measured at the vicinity of at least 10 to 15 different bacteria. Histograms of lengths
are given in (B) (for wild type) and (D) (for yscP%97–465 mutant). Note the altered distribution of
lengths in the mutant. M, mean of the lengths; N, number of needles measured.
Fig. 2. YscP is shorter in Y. pestis than in Y. enterocolitica and
determines shorter needles. (A) Residues 222 to 236 and 261 to 306
from YscP are duplicated in Y. enterocolitica E40 and W22703 but not
in Y. pestis KIM. The yscP gene from Y. pestis KIM and the yscP gene
from Y. enterocolitica deprived of these repeats were cloned down-
stream from an arabinose-inducible promoter and expressed in the Y.
enterocolitica yscP%97–465 mutant. The figure marked with an asterisk
includes a few amino acids inserted to generate the deletion. (B)
Histograms of the needle lengths from recombinant Y. enterocolitica
bacteria.
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the allele yscPentero%222–306
& encoding
YscPentero without its repeat. The truncated
YscPentero%222–306 programmed short needles
(42.5 $ 8 nm) (Fig. 2), suggesting that the
needle length indeed correlated with the size
of YscP. To further investigate this hypothe-
sis, we engineered a set of deletions within
the cloned yscPentero gene and used them to
complement the yscP%97–465 mutation (Fig.
3). Proteins truncated within the first 35 or
the last 130 residues were unable to control
the length, even though their expression lev-
els were comparable to that of the wild type
(Fig. 3). In contrast, YscP with deletions up
to 126 amino acids between residues 36 and
306 retained length control but programmed
shorter needles. Moreover, the length of the
needles was proportional to the size of the
YscP protein (Fig. 3). We then inserted a
second copy of residues 307 to 381 or 222 to
381 after residue 49, thus generating YscP
proteins containing the same 60-residue se-
quence three or four times (Fig. 3). These
mutants programmed longer needles with
lengths of 72 $ 10 nm and 88 $ 12 nm,
respectively. Insertion of residues 147 to 265
from FliK at the same position also resulted
in a functional protein but longer needles
(75 $ 14.5 nm). Thus, a strict linear relation-
ship existed between needle length and the
number of amino acids in YscP, with 1.9 Å
per YscP residue (Fig. 3). To rule out bias as
a result of an inadequate gene dosage or gene
expression of the complementation plasmids,
we replaced the wild-type yscP allele on the
virulence plasmid by two truncated alleles
(yscP%46–96 and yscP%222–306). In this native
genetic environment, the two alleles again
programmed shorter needles than those of the
wild type (47.5 $ 10 nm and 44 $ 8.5 nm,
respectively). Thus, YscP appeared to serve
as a ruler determining the length of the nee-
dle. This is unprecedented in bacteria but it
evokes the molecular rulers controlling the
length of bacteriophage tails (16–18), which
are structures resembling the needle in mor-
phology, size, and even function. A differ-
ence between the two systems is that tails do
not assemble in the absence of the ruler
whereas needles are of undetermined length
in the absence of YscP. The length per resi-
due is also slightly different for tail rulers (1.5
Å per ruler residue).
If YscP acts as a ruler measuring the grow-
ing needle, one might expect it to be associated
Fig. 3. The needle length is proportional to the number of residues in YscP.
(A) Various deletions and insertions were introduced in yscPenteroE40, cloned
downstream from the arabinose promoter. Insertions occurred in a restric-
tion site inserted after residue 49 ('). The dotted arrow spans the region
where deletions and insertions modify the needle length. (B) Needle length
measurements. N. aa, number of amino acids; Nr, number. (C) Expression of
the various constructs in Y. enterocolitica yscP%97–465, monitored by West-
ern blotting. (D) Plot of the lengths versus the number of residues in YscP.
Fig. 4. Association of
YscP with the needles.
Y. enterocolitica E40
deprived of the effec-
tors (%HOPEMT ) was
grown in conditions
that are (S&) or are
not (S–) permissive for
Yop secretion (11).
Detached needles pu-
rified from 2 ( 109
(S&) or 1010 (S–) bac-
teria were analyzed by
silver stained SDS–
polyacrylamide gel
electrophoresis (SDS-
PAGE) and Western
blotting (WB) (left).
Needle samples pre-
pared from S& bacte-
ria contain YscF (bot-
tom arrows) and
flagellin (middle) as a
contaminant but no
YscP (top). In contrast,
needle samples pre-
pared from S– bacte-
ria contain YscF, YscP
(top arrow), flagellin,
and unidentified contaminants (dots). Proteins from the supernatant from 108 bacteria from the
same cultures were analyzed by Coomassie-stained SDS-PAGE and WB (right). YscP is visible as a
faint band in both the S& and the S– supernatants (arrows). The darkest band stained in the S&
supernatant is YopB&D. YscF is not visible by Coomassie staining. The prominent bands in the
supernatant of S– are cellular contaminants.
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with the needle, at least during the needle elon-
gation stage. To test this, we purified needles
from Y. enterocolitica incubated in conditions
that are either nonpermissive or permissive for
secretion (11). Under nonpermissive condi-
tions, some YscP was found in the needle frac-
tion as well as in the culture supernatant, where-
as under secretion-permissive conditions YscP
was found only in the culture supernatant and
not in the needle fraction any more (Fig. 4).
These data, fitting with previous reports on the
localization of YscP (13, 14), show that YscP is
associated with newly synthesized needles that
are not secreting Yops but not with needles that
are secreting Yops.
We propose that YscP controls the length
of the needle by acting as a molecular ruler
during the stepwise assembly of the injecti-
some. Because deletions affecting both N-
and C-termini of YscP lead to a loss of length
control, we hypothesize that the two ends of
YscP act as anchors. One end would be at-
tached to the basal body, whereas the other
would be connected to the growing tip of the
needle. Whatever the anchor mechanism may
be, when the needle reaches its mature length,
YscP would be fully stretched and signal, via
its internal anchor, to the secretion apparatus,
which would stop exporting YscF and switch
to other substrates. This model (fig. S1) does
not contradict the switch function of YscP (8,
19, 20) but rather includes it in a more com-
plex dual function, which may also exist in
some phage tail rulers (21). Taking into ac-
count the length of 1.9 Å per residue, the
ruler domain of YscP would consist of about
300 to 350 residues, leaving more than 150
residues for anchoring and signaling. The fact
that YscP is secreted also fits the model,
because an internal ruler would be expected
to obstruct the 2- to 3-nm-wide secretion
channel (22). This evokes again the phage tail
rulers, which are thought to exit the tail be-
fore the tail exerts its function (21, 23). Given
the similarity between all the type-III secre-
tion systems (5) and the fact that Spa32 (9,
10) InvJ (24), and FliK (25) are also secreted
proteins, it is likely that the mechanism dem-
onstrated here for YscP may apply to the
control of the needle length in the other bac-
teria as well as the length of the flagellar
hook. The proposed organization of FliK in
three regions—export, hinge(147–265), and
switch (25)—is also compatible with this
view. Finally, the fact that YscP, InvJ, Spa32,
and FliK diverged more during evolution
than other proteins from type-III secretion
suggests that rulers are subjected to fewer
constraints. They nevertheless have to share
intrinsic properties still to be discovered.
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Inflammatory Blockade Restores
Adult Hippocampal Neurogenesis
Michelle L. Monje, Hiroki Toda, Theo D. Palmer*
Cranial radiation therapy causes a progressive decline in cognitive function that
is linked to impaired neurogenesis. Chronic inflammation accompanies radia-
tion injury, suggesting that inflammatory processes may contribute to neural
stem cell dysfunction. Here, we show that neuroinflammation alone inhibits
neurogenesis and that inflammatory blockade with indomethacin, a common
nonsteroidal anti-inflammatory drug, restores neurogenesis after endotoxin-
induced inflammation and augments neurogenesis after cranial irradiation.
The birth of new neurons within the hip-
pocampal region of the central nervous sys-
tem continues throughout life, and the
amount of neurogenesis correlates closely
with the hippocampal functions of learning
and memory (1, 2). The generation of new
neurons within the hippocampus is mediated
by proliferating neural stem or progenitor
cells (NPC) (3–5) that are widespread within
the adult brain but instructed by local signal-
ing to produce neurons only in discrete areas
(6, 7). Alterations in the microenvironment of
the stem cell may allow ectopic neurogenesis
to occur (8, 9) or even block essential neuro-
genesis, leading to deficits in learning and
memory (10–12) such as that observed in
patients who receive therapeutic cranial radi-
ation therapy (13). In animal models, cranial
irradiation ablates hippocampal neurogen-
esis, in part by damaging the neurogenic
microenvironment, leading to a blockade of
endogenous neurogenesis (12, 13). Injury in-
duces pro-inflammatory cytokine expression
both peripherally and within the central ner-
vous system and induces stress hormones,
such as glucocorticoids, that inhibit hip-
pocampal neurogenesis (10). The extensive
microglial inflammation and release of pro-
inflammatory cytokines that accompanies
this irradiation-induced failure suggests that
inflammatory processes may influence neural
progenitor cell activity (12, 14, 15).
To determine the effects of inflammation
on adult hippocampal neurogenesis, we in-
jected bacterial lipopolysaccharide (LPS) into
adult female rats to induce systemic inflam-
mation (16–19). The intraperitoneal (i.p.) ad-
ministration of LPS causes a peripheral in-
Stanford University, Department of Neurosurgery,
MSLS P309, Mail Code 5487, 1201 Welch Road, Stan-
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Materials and Methods 
Yersinia enterocolitica MRS40(pYV40) (S1), an ampicillin-sensitive 
derivative of E40(pYV40)(S2) was used for genetics and electron microscopy.  An 
effector multimutant, called ∆HOPEMT,  MRS40(pIML421)(S3) was used to prepare 
needles. The various pYV plasmid mutants and the expression plasmids are listed in 
Table S1. The oligonucleotides used for genetic constructions are given in table S2. 
Bacteria were routinely grown on Luria-Bertani agar plates and in liquid 
Luria-Bertani medium. For the induction of the yop regulon, Y. enterocolitica bacteria 
were inoculated to an OD600 of 0.1 and cultivated in brain-heart infusion (BHI; 
Remel) supplemented with 4 mg/ml glycerol, 20 mM MgCl2 and 20 mM sodium 
oxalate (BHI-Ox) for 2 h at 28 °C, then shifted to 37 °C and incubated for 4 h(S4).
Expression of the different yscP  genes cloned downstream from the pBAD promoter 
was induced by adding 0.2 % arabinose to the culture just before the shift at 37 °C, 
and again two hours later. Ampicillin was used at a concentration of 200 µg/ml to 
select for the expression plasmids.  
Alleles to be inserted in the pYV plasmids were subcloned into the pKNG101 
suicide vector and the allelic exchange was selected by plating diploid bacteria on 
sucrose(S5).   
Proteins from the supernatant were precipitated overnight at 4°C with 
trichloroacetic acid 10% (w/v) final. Electrophoresis was carried out in 12 % or 15 
%(w/v) polyacrylamide gels in the presence of SDS (SDS-PAGE). Proteins secreted 
by 3x108 bacteria were loaded by lane. For the total bacterial cells, the proteins from 
107 bacteria were loaded by lane. After electrophoresis, proteins were stained with 
Coomassie brilliant blue (Pierce) or transferred by electroblotting to a nitrocellulose 
membrane. Immunoblotting was carried out using rabbit polyclonal antibodies (anti-
YscP(S6)), polyclonal anti-YscF antibodies raised against the synthetic YscF peptide 
(NFSGFTKGNDIADLDAVAQTLK) (Centre d’Economie Rurale, Marloie, 
Belgium). Detection of immunoblots was performed with secondary antibodies 
conjugated to horse-radish peroxidase (1:2000; Dako) before development with 
supersignal chemiluminescent substrate (Pierce).  
Visualization of the needle-like structures at the cell surface of the bacteria 
was done by electron microscopy as described by Hoiczyk and Blobel(S7). After 4 
hours of induction at 37 °C, bacteria were harvested at 2,000 x g and resuspended 
gently in Tris-HCl, pH 7.5. Droplets were applied for 1 min to freshly glow-
discharged, formvar-carbon coated grids, and negatively stained with 1% (wt/vol) 
uranylacetate. Bacteria were visualized in a Philips Morgagni 268D electron 
microscope at a nominal magnification of x 44,000 and an acceleration voltage of 80 
kV.  Sizes were measured with the “Soft Imaging System” software (Hamburg, 
Germany).  The corresponding cells were analysed in parallel for the presence of 
YscF by immunoblot. 
In order to purify needles, bacteria were cultivated for 2h at 28 °C in BHI-Ox 
or BHI-Ca2+, then shifted to 37 °C and incubated for 4h(S4). Bacteria were harvested 
by centrifugation (10 min at 5’700 x g) and washed once in 1/30 of the culture volume 
with 20 mM TrisHCl (pH 7.5). The washing supernatant was passed through a 0.45 
µm mesh filter and centrifugated for 30 min at 17’500 x g. The pellet was 
resuspended in 1/60 of the initial culture volume of TrisHCl 20 mM (pH 7.5), CHAPS 
0.1% (w/v) and centrifuged again for 30 min at 17’500 x g.  The supernatant was 
collected and the needles were precipitated for one hour one ice with polyethylene 
glycol 6000 (10% w/v) and  NaCl (100 mM).   The needles were then collected by 30-
min centrifugation at 17’500 x g and resuspended in 1/300 of initial culture volume of 
20 mM TrisHCl (pH 7.5).  
Figure S1 
Legend to fig S1 
Proposed model for the control of the YscF-needle length by the YscP ruler.  
Table  S2: Oligonucleotides used in this study 
Oligo 
code 
Oligonucleotide sequence Underlined 
3072 gatcccatggccaataaaatcaccactcgt NcoI
3073 gatcgaattcttattcttcagcctcccactc EcoRI 
3066 ttcatactcaggttctaatgg  
3067 gcacgtgccgattttgagcaa  
3068 ttgcaaatcatgatgcagctt  
3069 cataataataagggtaatcgt  
3070 caacagcgcttgctcaaaatc  
3071 gaagagccgcgtagacctgta  
3078 gtcagcggccgcttgtctagacgaagaaccgttacctctt NotI, XbaI
3079 gtcagcggccgcatacatctccagcaaggt NotI
3124 tttgggatgacgattacc  
3126 catgatttaaacttatct  
3187 gatcgcggccgcaatctctagacgcggctcttct NotI, XbaI
3188 gatcgcggccgctagacctgtacgtccgcatgac NotI
3239 gtcatggcggacgtacaggtc  
3240 gaagaaccgttacctcttca  
3242 agacaaggaatacatctc  
3243 ctgcgcggcggctcatcc  
3244 ttctagttctaccgctag  
3245 gaagctttaagaatttta  
3083 gtcagcggccgcttgtctagagctgcccggacaacctgtc NotI, XbaI
3084 gtcagcggccgctaacggcgcgctgagtac NotI
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S2. M. P. Sory, G. R. Cornelis, Mol. Microbiol. 14, 583 (1994). 
S3. M. Iriarte, G. R. Cornelis, Mol. Microbiol. 29, 915 (1998). 
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Summary 
 
Pathogenic Yersinia species and P. aeruginosa share a similar type III secretion 
system. The translocon consists of the proteins YopB/PopB, YopD/PopD and LcrV/PcrV; the 
latter is known to be a protective antigen. The translocators cause hemolysis of erythrocytes 
infected with wildtype P. aeruginosa. Wildtype Y. enterocolitica is only slightly hemolytic, but a 
multiknockout mutant deprived of all the effectors and of YopN (∆HOPEMN) is hemolytic. We 
showed that anti-PcrV and also antibodies directed against LcrV from Y. pestis protect 
erythrocytes from P. aeruginosa caused lysis, while anti-PopB and anti-PopD antibodies have 
no effect. Similarly the anti-LcrV antibodies inhibited the hemolytic activity of ∆HOPEMN Y. 
enterocolitica.  
Wildtype Yersinia inserted the translocators YopB and YopD into erythrocyte 
membranes but no LcrV could be detected. A mutant in lcrV (∆HOPEMNV) inserted reduced 
amounts of YopB and YopD into erythrocyte membranes but could not assemble a functional 
pore. The assembly of the translocation pore, composed of the translocators YopB/YopD and 
PopB/PopD was disturbed in immunoprotected membranes mimicking the phenotypes of V 
knockout mutants. Thus, protective antibodies against the V antigens of Yersinia and P. 
aeruginosa act at the level of the formation of the translocation pore in membranes of infected 
host cells by blocking the function of the V antigen. The V antigen could act as an 
extrabacterial chaperone or assembly scaffold for the translocation pore. 
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M A J O R A R T I C L E
Protective Anti-V Antibodies Inhibit
Pseudomonas and Yersinia Translocon
Assembly within Host Membranes
Julien Goure,1,a Petr Broz,3,a Olivier Attree,2 Guy R. Cornelis,3 and Ina Attree1
1Biochimie et Biophysique des Syste`mes Inte´gre´s, CEA-Grenoble, UMR5092 CNRS, Grenoble, and 2Centre de Recherches
du Service de Sante´ des Arme´es, La Tronche, France; 3Biozentrum der Universita¨t Basel, Switzerland
Pathogenic Yersinia species and Pseudomonas aeruginosa share a similar type III secretion/translocationsystem.
The translocation system consists of 3 secreted proteins, YopB/PopB, YopD/PopD, and LcrV/PcrV; the latter
is known to be a protective antigen. In an in vitro assay, the translocation system causes the lysis of erythrocytes
infected with wild-type (wt) P. aeruginosa. wt Y. enterocolitica is not hemolytic, but a multiknockout mutant
deprived of all the effectors and of YopN (DHOPEMN) is hemolytic. In the presence of antibodies against
PcrV and Y. pestis LcrV, the hemolytic activity of P. aeruginosa was inhibited. Similarly, the hemolytic activity
of DHOPEMN was inhibited in the presence of anti-LcrV antibodies. The assembly of the translocon, composed
of PopB/D and YopB/D proteins, was disturbed in immunoprotected erythrocyte membranes, mimicking the
phenotypes of V knockout mutants. Thus, protective antibodies against the V antigens of Yersinia species and
P. aeruginosa act at the level of the formation of the translocon pore in membranes of infected host cells by
blocking the function of LcrV/PcrV. The hemolysis assay could be adapted for high-throughput screening of
anti-infectious compounds that specifically target the type III translocon.
Injectisomes are complex nanomachines that allow path-
ogenic or symbiotic bacteria to inject proteins across the
membrane of eukaryotic host cells. They consist of a
basal body that contains a type III secretion (T3S) ap-
paratus and a stiff needle that can be extended by a
flexible pilus or filament [1, 2]. Upon contact with a
eukaryotic cell membrane, the injectisome secretes, pre-
sumably in a sequential manner, a set of proteins called
“translocators” and “intracellular effectors” [3, 4]. The
translocators are a group of, generally, 3 proteins that
are absolutely required for the proper delivery of the
effectors across the host cell membrane [3–12].
Pathogenic members of the genus Yersinia—for ex-
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ample, Y. pestis (the causative agent of plague) and the
enteric pathogens Y. enterocolitica and Y. pseudotuber-
culosis—share a common injectisome called “Ysc” and a
common set of translocators and effectors called “Yops.”
The translocators are called “YopB,” “YopD,” and “LcrV.”
The latter is a bona fide Yop; it has a different name
because it was discovered as a soluble protective antigen
linked to virulence (hence, it is named “V antigen”) 140
years ago [13, 14], long before the concept of T3S had
been shaped [15]. Interestingly, the opportunistic path-
ogen Pseudomonas aeruginosa, which is evolutionarily re-
mote from enterobacteriaceae, has a very similar injec-
tisome called “Psc” and a set of similar translocators
called “PopB,” “PopD,” and “PcrV” [16–18]. Both sets
of translocators have been shown to form pores in eryth-
rocytes (red blood cells [RBCs]) [5, 9], in eukaryotic cell
membranes [19, 20], and in liposomes [21]. Formation
of pores is readily detectable with wild-type (wt) P. aeru-
ginosa but not with wt Y. enterocolitica. Only Y. entero-
colitica mutants that are devoid of the effectors or of the
control protein YopN form readily detectable pores [5,
11, 20]. An interpretation of this observation is that trans-
located Yop effectors obstruct the translocation chan-
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Table 1. Bacterial strains.
Strains Relevant genotype or phenotype Reference
P. aeruginosa, CHA Mucoid, cytotoxic cystic fibrosis isolate [32]
Y. enterocolitica
E40 Wild-type strain with the plasmid pYV40 [39]
DHOPEMN pYV40 yopE21 yopHD41–352 yopOD65–558 yopP23 yopM23 yopN45 [11]
DHOPEMNV pYV40 yopE21 yopHD41–352 yopOD65–558 yopP23 yopM23 yopN45 lcrVD6–319 [11]
DHOPEMNVQ pYV40 yopE21 yopHD41–352 yopOD65–558 yopP23 yopM23 yopN45 lcrVD6–319 yopQ17 [20]
DHOPEMNB pYV40 yopE21 yopHD41–352 yopOD65–558 yopP23 yopM23 yopN45 yopBD89–217 [20]
DHOPEMND pYV40 yopE21 yopHD41–352 yopOD65–558 yopP23 yopM23 yopN45 yopDD121–165 [20]
DN pYV40 yopN45 [6]
NOTE. P. aeruginosa, Pseudomonas aeruginosa; Y. enterocolitica, Yersinia enterocolitica.
nel [5, 20]. However, it has also been shown that the Rho-GAP
activity of YopE prevents membrane damage in cells infected
with wt bacteria [22]. When YopN is missing, secretion is con-
tact independent and effectors are not efficiently translocated
[11]. The structure of the translocation pore, the stage during
which the translocation pore is inserted, and how it is connected
to the needle of the injectisome are not clear yet. It is tempting
to consider the translocation pore as an integral part of the
injectisome, but, unlike the needle, it could be assembled only
after contact with a target cell. It has been shown that PopB
and PopD are able to oligomerize in vitro and that their in-
teraction with lipids promotes the formation of ringlike struc-
tures with external and internal diameters of 80 and 40 A˚,
respectively [23]. Although PcrV is unable to interact with lipids
either in vitro or in vivo [9, 23], it is required for proper
assembly of the PopB/D translocon in membranes of infected
erythrocytes [9].
Y. pestis LcrV possesses a highly protective antigenic char-
acter, and antibody therapy against bubonic and pneumonic
plague has been shown to be effective when tested in animal
models of disease [24–26]. Similarly, in animal models, active
immunization with PcrV or passive immunization with anti-
V antibodies provides a high level of protection against lethal
P. aeruginosa infections [7, 27]. Furthermore, administration
of anti-PcrV F(ab′)2 in a P. aeruginosa–provoked sepsis model
reduced the inflammatory response and bacteremia levels [28].
Although the mechanism of action is not known, even in vitro,
anti-V antibodies prevent the cytotoxicity of bacteria toward
cultured cells [7, 29, 30].
In the present study, we examined the action of anti-V an-
tibodies on formation of the translocation pore in P. aeruginosa
and Y. enterocolitica hemolysis assays. It has already been shown
with P. aeruginosa that a high level of hemolysis can be obtained
at a low MOI (MOI, 1) within 1 h of coincubation. Another
advantage of this model is that RBCs are not a limiting factor,
and their membranes can be isolated after infection and ana-
lyzed for translocon proteins without being contaminated with
infecting bacteria [9, 31]. In the present study, we applied the
RBC assay to Yersinia species by using poly-Yop effector mu-
tants of Y. enterocolitica [20]. We demonstrate that the anti-
bodies against the V antigens, through their direct interaction
with V proteins, inhibit bacteria-induced hemolysis by acting
at the level of type III translocon assembly in host cell mem-
branes, for both pathogenic species.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains
used in the present study are listed in table 1. The P. aeruginosa
strain used was the cytotoxic cystic fibrosis isolate CHA [19,
32]. P. aeruginosa were grown either on Pseudomonas isolation
agar (Difco) plates or in liquid Luria broth (LB) medium at
37C with agitation. All the mutants of Y. enterocolitica used
were derived from the strain E40, a strain from serotype O:9
[4, 11]. Y. enterocolitica strains were inoculated to an OD600 of
0.1 and cultivated in brain-heart infusion broth (ICN) for 3 h
at 37C. In vitro, secretion of Y. enterocolitica was triggered by
sodium oxalate [11].
Production and purification of antibodies. The produc-
tion and purification of the rabbit-derived anti-PcrV, anti-
PopB, and anti-PopD polyclonal antibodies (PAbs) have been
described elsewhere [9, 23]. MAb166 [27] was provided by D.
W. Frank (Medical College of Wisconsin). The LcrV coding se-
quence was obtained from genomic DNA of the Y. pestis strain
EV76 (gift from E. Carniel, Pasteur Institute, Paris) by poly-
merase chain reaction (PCR) using the primers 5′-GATAAGAA-
TTCGAGCCTACGAACAAAACCCA-3′ and 5′-AAGGATCGT-
CGACTTACATAATTACCTCGTGTCA-3′. The PCR product
was digested with EcoRI and SalI and cloned into the expression
plasmid pGEX-6P-2 (Amersham Biosciences). A soluble gluta-
thione-S-transferase (GST)–LcrV fusion was produced in Esch-
erichia coli and purified on GSTrap (Amersham Biosciences). The
GST-LcrV protein fusion bound on the column was cleaved with
PreScission Protease (Amersham), resulting in the elution of pu-
rified LcrV. Three CD1 mice were immunized with 100-mL in-
tramuscular injections of 10 mg of purified LcrV in PBS con-
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Figure 1. Immunoprotection of red blood cells (RBCs) against Pseudomonas aeruginosa–induced hemolysis. A, Lysis of RBCs by type III secretion
of P. aeruginosa (MOI, 1) at 37C, after 1 h in the presence of different antibodies added to the bacteria before coincubation. Anti-PcrV and anti-
PopB polyclonal antibodies (PAbs) were affinity purified from rabbit serum, anti-LcrV PAbs were purified on protein A from mouse serum, and anti-
PopD was total rabbit serum. MAb166 is a protective monoclonal antibody against PcrV [27]. B, Titration of protective antibodies by recombinant LcrV
(rLcrV) or PcrV (rPcrV). The hemolysis assay was performed in the presence of immunoprotective anti-PcrV PAbs added in quantities necessary to
achieve 90%–100% protection. Purified rPcrV and rLcrV proteins were added to the assay, and hemolysis was measured after 1 h of incubation.
taining 2% alhydrogel (Superfos Biosector) and 10 mg of CpG
oligonucleotide [33] as adjuvant. In each mouse, after 2 im-
munizations separated by a 2-week interval, the ELISA titer (the
highest dilution giving twice the optical density obtained with
naive CD1 serum) of anti-LcrV serum antibodies was 11:50,000.
For production of anti-LcrV PAbs, the best-responding mouse
was given an intraperitoneal (ip) booster injection of the same
respective amounts of LcrV, alhydrogel, and CpG, followed 5
days later by a final ip injection containing LcrV, CpG, and
TG180 sarcoma cells. The ascitis fluid was collected 155 10
week later, and IgG was purified on protein A (Mab Trap; Amer-
sham). The BCA protein assay kit (Pierce) was used to determine
the concentration of purified antibodies.
Hemolysis assays and immunoprotection experiments. He-
molysis assays were performed as described elsewhere [9].
Briefly, sheep RBCs (Eurobio) were washed 3 times in PBS (pH
7.4) (150 mmol/L NaCl) and resuspended in RPMI 1640 me-
dium (Sigma) at RBCs/mL at 4C. Bacteria were grown85 10
in LB to an OD600 of 1.0, centrifuged, and resuspended in RPMI
1640 at bacteria/mL. Hemolysis assays were initiated85 10
by mixing 100 mL of RBCs and 100 mL of bacteria in round-
bottom 96-well plates, which were then centrifuged at 2000 g
for 10 min and incubated for 1 h at 37C. The release of
hemoglobin was measured, and the percentage of hemolysis
was calculated as described elsewhere [31]. Immunoprotection
experiments were performed by incubating bacteria for 45 min
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Figure 2. Assembly of the Pseudomonas aeruginosa PopB/D translocon in immunoprotected red blood cell (RBC) membranes. A, RBC membranes
isolated on sucrose density gradients after performance of hemolysis assays in the presence of either protective anti-PcrV polyclonal antibodies (PAbs)
or anti-PopB PAbs. B, RBC membranes isolated after hemolysis assay with the wild-type (wt) and the pcrV mutant (DV) [9]. The translocon content
of PopB, PopD, and PcrV within membranes was analyzed by Western blotting.
with different concentrations of antibodies at room tempera-
ture, before the standard hemolytic assay. Negative controls
included corresponding preimmune rabbit serum. In titration
experiments, a constant concentration of 5 ng/mL PAbs was
added to bacteria, then increasing amounts of the recombinant
PcrV or LcrV were incubated with the bacteria-PAb mixture
for 45 min at room temperature.
RBC membrane isolation. RBCs were resuspended in Tris-
saline (30 mmol/L Tris and 150 mmol/L NaCl [pH 7.5]) at
cells/mL. Before the infection, bacteria were10 91 10 3 10
incubated with 180 mg of PAbs in 700 mL of Tris-saline buffer
for 45 min at room temperature. Then, hemolytic reactions
were prepared in 50-mL conical tubes. The mixture of bacte-
ria and antibodies was mixed with 300 mL of RBCs at 11010
cells/mL and 1 mL of a 2 protease inhibitor cocktail (Com-
plete; Roche). Samples were centrifuged at 2000 g for 10 min
at room temperature and incubated for 1 h at 37C. Hemolysis
was assessed spectrophotometrically, as described above. Then,
3 mL of distilled water at 4C was added to each sample to
lyse all RBCs, and these were vortexed and centrifuged again
to remove bacteria. The RBC membranes were isolated by flo-
tation on a sucrose density gradient, as described elsewhere [9].
The material at the 44%/25% sucrose interface was collected,
diluted in Tris-saline, and concentrated by centrifugation in a
TLA-100.3 rotor (Beckman) at 450,000 g for 20 min at 4C.
The pellets were resuspended in Laemmli sample buffer and
analyzed by Western blotting.
Immunoblotting analysis. Immunoblotting analysis was
performed with primary PAbs against YopB (gift from A˚. Fors-
berg, Umea˚ University), PopB, PopD, and PcrV [9]; monoclo-
nal antibodies (MAbs) against YopD [20] and LcrV [11]; and
a secondary antibody conjugated to horseradish peroxidase (Sig-
ma). Membranes were developed by use of an enhanced chem-
iluminescence kit (Amersham Biosciences).
RESULTS AND DISCUSSION
Since PcrV has been found to be necessary for assembly of
PopB/D pores in RBC membranes [9], we asked whether an-
tibodies against PcrV would interfere with the PopB/D-depen-
dent hemolysis induced by cytotoxic P. aeruginosa strain CHA.
Affinity-purified PAbs against translocator proteins PopB and
PopD did not inhibit hemolysis. Concentrations of both an-
tibodies up to 50 ng/mL had no protective effect. In contrast,
affinity-purified anti-PcrV PAbs [9] mixed with either bacteria
or RBCs before infection inhibited hemolysis in a dose-depen-
dent manner (figure 1A). Concentrations of antibodies as low
as 0.25 ng/mL were able to reduce P. aeruginosa–induced lysis
by 50%. Increasing the concentration of antibodies up to 10
ng/mL in the infection assay resulted in complete protection of
RBCs from lysis. MAb166 is an anti-PcrV MAb that has been
shown to protect mice from lethal P. aeruginosa infection [27].
In the hemolysis assay, MAb166 prevented hemolysis, but an
18-fold greater concentration of MAb166 than of PAbs was
required to obtain 50% inhibition. The higher neutralization
activity of the PAbs could be due to the binding of several PcrV
epitopes or to a higher affinity of some antibody component,
compared with MAb166. The former hypothesis is favored be-
cause, in a competition ELISA, a 100-fold excess of PAb did
not hinder the binding of MAb166 to recombinant PcrV (rPcrV)
(data not shown). This could have practical importance, be-
cause efficient neutralization of PcrV by MAbs would then re-
quire a combination of several MAbs, as seems to be the case
for botulinum toxin type A [34].
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Figure 3. Lysis of red blood cells (RBCs) by the Ysc-Yop type III
secretion system from Yersinia enterocolitica. The removal of YopQ min-
imizes the negative effect of the lcrV deletion on synthesis of YopB and
YopD [11]. A, Percentage hemolysis after 1 h of contact (MOI, 1). B, C,
and D, Western blot analysis of YopB, YopD, and LcrV performed on
intrabacterial proteins (B), the total amount of proteins secreted by the
bacteria during the infection (C), and proteins inserted into the membranes
of erythrocytes (D). wt, wild-type bacteria; DHOPEMN, a multi-effector
Ca2+-blind knockout [20]; DHOPEMNB, DHOPEMN lacking translocator
YopB [20]; DHOPEMND, DHOPEMN lacking translocator YopD [20];
DHOPEMNV, DHOPEMN lacking translocator LcrV [11]; DHOPEMNVQ,
DHOPEMNV lacking YopQ; DN, wt lacking regulator YopN [6].
LcrV from Yersinia species and PcrV from P. aeruginosa share
41% amino acid identity [16], and they most likely share the
same function in the assembly of the translocon. We raised mouse
PAbs against recombinant LcrV (rLcrV) from Y. pestis. Similar
to anti-PcrV PAbs and MAb166, anti-LcrV PAbs inhibited P.
aeruginosa–induced hemolysis (i.e., 50% inhibition was obtained
with 10 ng/mL anti-LcrV PAbs). In summary, these data show
that the PAbs against PcrV and LcrV, as well as the protective
MAb166, hinder cytotoxic P. aeruginosa from lysing RBCs.
LcrV and PcrV are surface-exposed antigens ([29, 35] and I.A.,
unpublished data) and, therefore, are probably accessible to an-
tibodies. To further confirm that the protection against hemolysis
was due to the direct interaction between antibodies and the
antigen during the infection process, we set up competition ex-
periments in which the antibodies necessary to achieve 90%–
100% protection were kept constant and increasing amounts of
the recombinant antigen were added to the infection mixture.
With rPcrV, as few as 3–4 molecules/10 molecules of antibodies
were sufficient to restore 50% hemolysis, showing that the pro-
tection is due to direct PcrV/antibody interaction (figure 1B).
RBC lysis occurs by osmotic shock following the formation
of PopB/D pores within erythrocyte membranes. Since PcrV is
required for formation of functional Pop pores, we addressed
the question of whether PopB/D inserts into membranes in the
presence of anti-V antibodies. The hemolysis assay was scaled
up, and antibodies were added at levels necessary to achieve
90%–100% protection. After 1 h of incubation, the RBCs were
lysed by the addition of water, and the membranes were purified
by sucrose density gradient, as described elsewhere [9]. The
purified membranes were examined for the presence of Pop
translocators by Western blotting. P. aeruginosa–infected RBC
membranes contained both translocators, PopB and PopD, as
reported elsewhere (figure 2) [9]. Notably, in the presence of
anti-PcrV PAbs, PopD protein was absent from infected RBC
membranes (figure 2), corroborating the phenotype of the PcrV
knockout bacteria that were unable to assemble the functional
translocon (figure 2) [9]. It should be noted that systematically
less PopB could be detected in membranes purified from these
immunoprotection experiments. Antibodies against PopB were
not able to disturb PopB/D pores inserted into host membranes
(figure 2), which is in agreement with the incapacity of these
antibodies to immunoprotect infected RBCs. These results show
that anti-PcrV antibodies either block the proper insertion of
pore-forming proteins or destabilize them within membranes.
That PopB was still found in immunoprotected membranes, al-
though it was unable to form functional pores, suggests that
protective antibodies do not prevent contact between the host
cell and the bacterial injectisome.
Since the serum raised against the Y. pestis rLcrV prevented,
to some degree, P. aeruginosa T3S–induced hemolysis, we ap-
plied the hemolysis test to several Y. enterocolitica strains. As
was already reported by several authors [5, 20], the wt Yersinia
strains had very low hemolytic activity, even when the bacteria–
host cell contact was forced with centrifugation. Indeed, no
detectable hemolysis could be observed at 1 h after infection
(figure 3A). Neyt et al. [20] and Marenne et al. [11] reported
that, in contrast to the wt strain, the mutant strainDHOPEMN,
which lacks T3S effectors (YopH, -O, -P, -E, and -M) as well
as the control protein YopN [36], provokes macrophage cell
lysis through the formation of pores presumably constituted
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Figure 4. Immunoprotection of red blood cells (RBCs) fromDHOPEMN-
induced hemolysis, by use of anti-LcrV or anti-PcrV antibodies. A, Per-
centage hemolysis in the presence of various amounts of affinity-purified
anti-PcrV polyclonal antibodies (PAbs) and protein A–purified anti-LcrV
PAbs. B, Western blot analysis of YopB, YopD, and LcrV performed on
the membranes of erythrocytes either not protected or protected by anti-
LcrV antibodies. DHOPEMN, a multi-effector Ca2+-blind knockout [20].
by the translocators YopB and YopD. Notably, in the standard
RBC assay, DHOPEMN bacteria lysed ∼30% of the erythrocytes
within 1 h of coincubation (MOI, 1), a value lower than that
observed with cytotoxic P. aeruginosa but still very significant
(figure 3A). DHOPEMN-induced hemolysis was dependent on
the presence of LcrV, since the mutant DHOPEMNV showed
only a basal level of hemolysis. In addition, LcrV was not di-
rectly hemolytic to RBCs, since the mutants DHOPEMNB and
DHOPEMND, which secrete the same amounts of LcrV as wt
bacteria, were not hemolytic. This result is in agreement with
data showing that P. aeruginosa strains that secrete PcrV are
nonhemolytic [9]. lcrV mutants are known to produce less YopB
and YopD, compared with wt bacteria [37–39], and this effect
can be attenuated by also mutating yopQ (figure 3C) [11]. We
thus also tested a DHOPEMNVQ mutant in the hemolysis
assay, and it was also found to be nonhemolytic (figure 3A),
showing that the lack of hemolysis observed withDHOPEMNV
was not due to insufficient secretion of YopB and YopD but
was directly due to the absence of LcrV (figure 3C).
Since PcrV is required for correct formation of PopB/D
pores, we addressed the function of LcrV in Y. enterocolitica.
RBC membrane fractions were examined for the presence of
the translocators after infection with the same strains of Y.
enterocolitica (figure 3D). Only YopD was readily detectable in
membranes of RBCs infected with wt bacteria. In contrast, YopB
and YopD were readily detectable in membranes of RBCs in-
fected with DHOPEMN and DN bacteria. This difference re-
flects the fact that wt bacteria produce and secrete less Yops on
contact with RBCs than do yopN mutant bacteria, which are
deregulated for Yop secretion (figure 3B and 3C) [36]. This
shows that centrifugation-achieved contact with RBCs does not
trigger optimal Yop secretion of wt bacteria. Both YopB and
YopD were detected in membranes of RBCs infected with
DHOPEMNVQ, but the amount of both translocators, espe-
cially YopB, was reduced, compared with that in DHOPEMN
orDN bacteria. This may simply reflect the fact thatDHOPEMNVQ
bacteria secrete less YopB/D than do DHOPEMN bacteria, but
it should be noted that they secrete at least as much YopB as
do wt bacteria (figure 3C). Nevertheless, although both YopB
and YopD were detected in the membrane, no pore was formed.
This suggests that, although LcrV is necessary for the proper
assembly of the YopB/D pore in the host cell membrane, it is
not necessary for the insertion of the translocators within host
membranes.
Anti-LcrV antibodies and anti-PcrV antibodies were then
tested for their capacity to protect erythrocytes from hemolysis
by DHOPEMN. As can be seen in figure 4A, anti-LcrV PAbs
were capable of protecting RBCs. The specific anti-LcrV serum
was as immunoprotective as were the PcrV PAbs in the P. aeru-
ginosa/RBC assay. However anti-PcrV PAbs had no protective
effect on DHOPEMN-induced hemolysis, suggesting that, al-
though some epitopes are shared by LcrV and PcrV, other neu-
tralization epitopes are unique to LcrV.
Next, we addressed the question of whether YopB/D pores
are formed in the presence of anti-LcrV antibodies.DHOPEMN
bacteria were preincubated for 30 min with antibodies at levels
necessary to achieve 90%–100% protection. Immunoprotected
membranes were purified and examined for the presence of the
translocators by Western blotting. The amount of YopB was se-
verely reduced in the presence of protective antibodies. It should
be noted that less YopD could be detected in immunoprotected
membranes (figure 4B). This suggests that anti-LcrV antibodies,
similar to anti-PcrV antibodies, prevent the assembly of the
functional translocation pore.
PcrV/LcrV protective antigens would thus act as extrabac-
terial chaperones or scaffolds in the sense that they would bind
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unfolded PopB/YopB and PopD/YopD emerging from the bac-
terium and ensure their correct folding and assembly into a
functional pore. This hypothesis, which is supported by the
fact that the T3S apparatus exports unfolded proteins [40], is
compatible with the known localization of LcrV at the bacterial
surface [29, 35]. It implies that the V antigen interacts, at least
transiently, with the B and D antigens, which is in agreement
with the observation of Sarker et al. [39]. However, it does not
imply that the V antigen remains bound to the assembled pore
and, thus, is not contradictory to results showing the absence
of direct interactions between PcrV and Pop proteins folded
in vitro [9, 23]. Finally, although it is inconsistent with the idea
that the purified LcrV forms channels on its own, the chaperone
or scaffold hypothesis is compatible with the observation that
LcrV determines the size of the pore [10, 18].
In conclusion, we have demonstrated that the protective an-
tibodies against the V antigens (PcrV and LcrV) of P. aeruginosa
and Yersinia species act by preventing the assembly of a func-
tional type III translocon in host cell membranes. In addition,
our work has shown that the hemolysis assay is well suited for
study of the function of the type III translocon and could be
adapted for screening of anti-infectious molecules that specif-
ically target bacterial toxin translocons.
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Summary 
 
The V-antigen of Yersinia and P. aeruginosa are required for the correct assembly of a 
functional TTS translocation pore in the target cell membrane. Further, antibodies against the 
V-antigen prevented the formation of the translocation pore and inhibited effector 
translocation. Thus the V-antigens were proposed to act as an extrabacterial chaperone or 
assembly platform for the formation of the translocation pore. The obvious location for such a 
protein would be at the tip of the injectisome needle, where the secreted proteins are 
supposed to emerge.  
Transmission electron micrographs of wildtype Y. enterocolitica indicated that the 
needles protruding from the bacterial surface end with a well-defined structure. STEM analysis 
of purified needles revealed that this so-called “tip complex” comprises a head, a neck and a 
base. The tip complex is the same in secreting as well as in non-secreting conditions. To 
determine the components of the needle fraction we analyzed purified needles. The two 
translocators LcrV and YopD, as well as YscF the needle subunit were found. Crosslinking of 
purified needles suggested that YscF and LcrV interact, thus LcrV might be a structural 
component of the needle. 
The tip complex was absent on needles from bacteria deprived of LcrV (∆HOPEMNVQ) 
and could be brought back by complementing the mutation in trans. Control needles (mutants 
in yopN, yopQ or yopBD) exhibited a wildtype tip complex. Thus the formation of the tip 
involved LcrV, but not YopQ, YopN or YopBD. 
Immunogold labeling of wildtype needles with anti-LcrV antibodies demonstrated a 
strong binding to the tip complex. Antibodies against YopB and YopD did not label the tip 
complex and anti-YscF antibodies bound to the needle itself. Together these results clearly 
proved that LcrV forms the observed tip complex. 
P. aeruginosa and A. salmonicida possess an injectisome closely related to that of 
Yersinia. Their respective LcrV orthologs, PcrV (32.3 kDa) and AcrV (40.2 kDa) are different 
in size to LcrV (37.6 kDa). We demonstrated that PcrV as well as AcrV could functionally 
complement an lcrV deletion in Y. enterocolitica. The needles exhibited distinct tip complexes 
similar to wildtype needles that were smaller in the case of PcrV and larger with AcrV. 
Altogether these results shown that the injectisome needle is topped with a distinct 
structure called the “tip complex” that is formed by the major protective antigen of Yersinia, 
LcrV.  
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simple orogastric administration. Thus, identi-
fication of inhibitors of virulence represents a
path to anti-infective discovery that is quite dif-
ferent from conventional approaches that target
only bacterial processes that are essential both in
vivo and in vitro. We further predict that drugs
such as virstatin may act synergistically with
conventional antibiotics, because they act
through independent mechanisms to block in
vivo bacterial replication or survival.
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The V-Antigen of Yersinia Forms a
Distinct Structure at the Tip of
Injectisome Needles
Catherine A. Mueller,1* Petr Broz,1* Shirley A. Mu¨ller,1,2
Philippe Ringler,1,2 Franc¸oise Erne-Brand,1,2 Isabel Sorg,1
Marina Kuhn,1 Andreas Engel,1,2 Guy R. Cornelis1.
Many pathogenic bacteria use injectisomes to deliver effector proteins into
host cells through type III secretion. Injectisomes consist of a basal body
embedded in the bacterial membranes and a needle. In Yersinia, translocation
of effectors requires the YopB and YopD proteins, which form a pore in the
target cell membrane, and the LcrV protein, which assists the assembly of
the pore. Here we report that LcrV forms a distinct structure at the tip of the
needle, the tip complex. This unique localization of LcrV may explain its crucial
role in the translocation process and its efficacy as the main protective antigen
against plague.
Type III secretion (T3S) is commonly used by
Gram-negative pathogenic bacteria to intro-
duce effector proteins into target host cells (1).
Yersinia pestis and Y. enterocolitica, causing
bubonic plague and gastroenteritis respec-
tively, share the same T3S system consisting
of the Ysc (Yop secretion) injectisome, or
Bneedle complex,[ and the secreted Yop
(Yersinia outer protein) effector proteins.
Three translocator proteins, YopB, YopD, and
LcrV, are necessary to deliver the effectors
across the target cell membrane (2–5). LcrV is
required for the correct assembly of the
translocation pore formed by YopB and YopD
in the membrane of the target cell (2, 6). LcrV
(also known as V antigen) is a soluble protein
important for virulence (7) and is a protective
antigen against plague (8). Antibodies against
LcrV prevent the formation of the translocation
pore (6) and block the delivery of the effector
Yops (9). The injectisome is composed of a
basal body resembling that of the flagellum
and a needle (10). The needle has a helical
structure (11) and in Yersinia is formed by
the 9.5-kD protein YscF (12, 13).
Transmission electron micrographs of the
surface of Y. enterocolitica E40 bacteria sug-
gested that the injectisome needle ends with a
well-defined structure (fig. S1). To characterize
this structure, we purified needles from multi-
effector knockout bacteria (strain DHOPEMT)
that had been incubated under either secretion-
permissive or -nonpermissive conditions (14),
then analyzed them by scanning transmission
electron microscopy (STEM). A distinct Btip
complex[ was observed for the wild-type
needles, comprising a head, a neck, and a base
(Fig. 1A, arrow, and fig. S2A). The tip structure
was the same in both cases, but more needles
were produced under secretion-permissive
conditions (15). The purified needle fraction
from secreting bacteria was analyzed to deter-
mine the components of the tip complex (fig.
S3A). LcrV, YopD, and the needle subunit
YscF were found. Other proteins included
flagellins, which are usual contaminants of
needle preparations (13). Upon cross-linking of
purified needles, products formed between YscF
and LcrV, suggesting that the latter is a struc-
tural component of the needle (fig. S3B).
The tip complex observed for wild-type
needles was absent from needles prepared from
bacteria deprived of LcrV (DHOPEMNVQ)
(table S1) (16). Instead, this end of the needle
was distinctly pointed (Fig. 1B, asterisk, and fig.
S2B). The tip complex was restored after the
mutation was complemented in trans with lcrVþ
(Fig. 1B, right, and fig. S2B). Needles from
single yopN or yopQ knockout bacteria were
analyzed as controls and displayed the same tip
complex as the wild-type needles (fig. S4).
Thus, the formation of the tip complex involved
LcrV but not YopN or YopQ.
Needles from a yopBD double mutant (15)
were analyzed to exclude the possibility that
YopD and, although not detected on the gels,
the third translocator protein YopB were tip
complex components. The appearance of the
tip complex was unchanged (fig. S4).
When wild-type needles were incubated
with affinity-purified polyclonal antibodies to
LcrV, the latter specifically bound to the tip
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complex, and we observed many examples of
two needles joined tip to tip by a single anti-
body (Fig. 2). No antibodies to LcrV attached
to needles purified from the lcrV mutant strain
(DHOPEMNVQ). Furthermore, antibodies di-
rected against YopB or YopD did not bind to
wild-type needles (17). In contrast, affinity-
purified polyclonal antibodies against YscF
bound to the needle end opposite the tip com-
plex (fig. S5). Together, these results clearly indi-
cate that LcrV forms the observed tip complex.
Pseudomonas aeruginosa and Aeromonas
salmonicida possess an injectisome closely re-
lated to that of Yersinia. Their respective LcrV
orthologs, PcrV (32.3 kD) and AcrV (40.2 kD),
are different in size to LcrV (37.2 kD). The
pcrVþ and acrVþ genes were used to comple-
ment the lcrV deletion in Y. enterocolitica E40
(DHOPEMNVQ). The recombinant bacteria
could assemble translocation pores. Their needles
contained proteins with the size of PcrV and
AcrV (fig. S6) and exhibited distinct tip com-
plexes (Fig. 3). The head and neck domains of
the tip complex formed by PcrV (Fig. 3A, cen-
ter) were similar to those formed by LcrV, but
the base was narrower (fig. S7). The tip com-
plex formed by AcrV was larger (Fig. 3A, right,
and fig. S7), more variable in shape, and more
fragile, being absent or altered for many
needles. This is reflected by the lower resolution
of the AcrV average. In all three cases, a central
channel seemed to permeate both the needle
and the tip complex (Fig. 3B and fig. S7).
That the needle has a defined tip structure
at its distal end, comprising LcrV, is in agree-
ment with previous reports showing that LcrV
is surface-exposed (3, 4) and essential for the
assembly of a functional translocation pore
(6). LcrV may act as an assembly platform for
this pore (fig. S8) (6). The IpaD protein from
Shigella may function in an analogous fashion
(18), although it has no clear sequence homol-
ogy to LcrV. LcrV can also be compared to
the EspA filament of enteropathogenic Esch-
erichia coli, which forms a physical bridge
between the needle and the host cell (19). The
EspA homolog, SseB of Salmonella SPI-2,
forms an undefined sheathlike structure on the
distal end of the T3S needle (20).
The localization of LcrV at the tip of the
needle and its role in the assembly of the pore
may explain the protective action of anti-
bodies to LcrV. Possibly, the antibodies in-
terfere with the function of the tip complex,
impairing the translocation process.
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Bats Are Natural Reservoirs of
SARS-Like Coronaviruses
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Severe acute respiratory syndrome (SARS) emerged in 2002 to 2003 in southern
China. The origin of its etiological agent, the SARS coronavirus (SARS-CoV),
remains elusive. Here we report that species of bats are a natural host of
coronaviruses closely related to those responsible for the SARS outbreak. These
viruses, termed SARS-like coronaviruses (SL-CoVs), display greater genetic
variation than SARS-CoV isolated from humans or from civets. The human and
civet isolates of SARS-CoV nestle phylogenetically within the spectrum of SL-
CoVs, indicating that the virus responsible for the SARS outbreak was a member
of this coronavirus group.
Severe acute respiratory syndrome (SARS)
was caused by a newly emerged coronavirus,
now known as SARS coronavirus (SARS-CoV)
(1, 2). In spite of the early success of etio-
logical studies and molecular characterization
of this virus (3, 4), efforts to identify the ori-
gin of SARS-CoV have been less successful.
Without knowledge of the reservoir host dis-
tribution and transmission routes of SARS-
CoV, it will be difficult to prevent and control
future outbreaks of SARS.
Studies conducted previously on animals
sampled from live animal markets in Guang-
dong, China, indicated that masked palm civets
(Paguma larvata) and two other species had
been infected by SARS-CoV (5). This led to
a large-scale culling of civets to prevent fur-
ther SARS outbreaks. However, subsequent
studies have revealed no widespread infection
in wild or farmed civets (6, 7). Experimental
infection of civets with two different human
isolates of SARS-CoV resulted in overt clin-
ical symptoms, rendering them unlikely to be
the natural reservoir hosts (8). These data sug-
gest that although P. larvata may have been
the source of the human infection that pre-
cipitated the SARS outbreak, infection in this
and other common species in animal markets
was more likely a reflection of an Bartificial[
market cycle in naBve species than an indi-
cation of the natural reservoir of the virus.
Bats are reservoir hosts of several zoonotic
viruses, including the Hendra and Nipah viruses,
which have recently emerged in Australia and
East Asia, respectively (9–11). Bats may be
persistently infected with many viruses but rarely
display clinical symptoms (12). These charac-
teristics and the increasing presence of bats and
bat products in food and traditional medicine
markets in southern China and elsewhere in
Asia (13) led us to survey bats in the search
for the natural reservoir of SARS-CoV.
In this study, conducted from March to
December of 2004, we sampled 408 bats
representing nine species, six genera, and
three families from four locations in China
(Guangdong, Guangxi, Hubei, and Tianjin) af-
ter trapping them in their native habitat (Table
1). Blood, fecal, and throat swabs were col-
lected; serum samples and cDNA from fecal
or throat samples were independently analyzed,
double-blind, with different methods in our
laboratories in Wuhan and Geelong (14).
Among six genera of bat species surveyed
(Rousettus, Cynopterus, Myotis, Rhinolophus,
Nyctalus, and Miniopterus), three communal,
cave-dwelling species from the genus Rhinolo-
phus (horseshoe bats) in the family Rhino-
lophidae demonstrated a high SARS-CoV
antibody prevalence: 13 out of 46 bats (28%)
in R. pearsoni from Guangxi, 2 out of 6 bats
(33%) in R. pussilus from Guangxi, and 5 out
of 7 bats (71%) in R. macrotis from Hubei.
The high seroprevalence and wide distribution
of seropositive bats is expected for a wildlife
reservoir host for a pathogen (15).
The serological findings were corroborated
by poylmerase chain reaction (PCR) analyses
with primer pairs derived from the nucleocapsid
(N) and polymerase (P) genes (table S1). Five
fecal samples tested positive, all of them from
the genus Rhinolophus: three in R. pearsoni
from Guangxi and one each in R. macrotis and
R. ferrumequinum, respectively, from Hubei.
No virus was isolated from an inoculation of
Vero E6 cells with fecal swabs of PCR-positive
samples.
A complete genome sequence was deter-
mined directly from PCR products from one of
the fecal samples (sample Rp3) that contained
relatively high levels of genetic material. The
genome organization of this virus (Fig. 1), ten-
tatively named SARS-like coronavirus isolate
Rp3 (SL-CoV Rp3), was essentially identical to
that of SARS-CoV, with the exception of three
regions (Fig. 1, shaded boxes). The overall
nucleotide sequence identity between SL-CoV
Rp3 and SARS-CoV Tor2 was 92% and in-
creased to È94% when the three variable re-
gions were excluded. The variable regions are
located at the 5¶ end of the S gene (equivalent to
the S1 coding region of coronavirus S protein)
and the region immediately upstream of the
N gene. These regions have been identified
as Bhigh mutation[ regions among different
SARS-CoVs (5, 16, 17). The region upstream
of the N gene is known to be prone to de-
letions of various sizes (5, 16, 18).
Predicted protein products from each gene
or putative open reading frame (ORF) of SL-
CoV Rp3 and SARS-CoV Tor2 were com-
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Materials and Methods
This study was carried out with Y. enterocolitica E40 (1) carrying several mutations on
the virulence pYV plasmid, listed in Table S1.
The oligonucleotides used for the genetic constructions are listed in Table S2.
To delete the complete yopB and yopD genes, flanking regions of the yopB (pYVe227
(accession NC_002120) bp 17702-17196, primers 3854/3862) and the yopD (pYVe227
bp 15076-14861, primers 3863/3861) genes (2) were cloned by overlapping PCR into
pBluescript KS+II with SalI and XbaI restriction sites. The resulting plasmid was called
pISO82 (Table S1). The SalI-XbaI fragment of pISO82 containing the flanking regions of
the yopB and yopD genes was cloned into the same sites of the suicide vector pKNG101
(Table S1), resulting in the mutator plasmid pISO83 (Table S1). The yopB and yopD
genes on the Y. enterocolitica MRS40 pYV plasmid were deleted by allelic exchange
with pISO83 as described previously (3). The resulting Y. enterocolitica mutant pYV
plasmid was called pISO4005 (Table S1).
The lcrV mutation was complemented by plasmid pMN12 containing lcrV+
downstream of the yopE promoter (3).
The pcrV and acrV (4) sequences were amplified by PCR on genomic DNA from
Pseudomonas aeruginosa PAO1 (accession NC_002516, primers 3808/3809) and
Aeromonas salmonicida JF2267 (accession AJ516009, primers 3810/3811). The PCR
products were digested with NcoI/EcoRI and AflIII/EcoRI and cloned into the NcoI/EcoRI
sites of the expression vector pBAD/MycHisA giving plasmids pPB24 and pPB25 (Table
S1).
Bacteria were routinely grown on Luria-Bertani agar plates and in liquid Luria-
Bertani medium. Ampicillin was used at a concentration of 200 µg/ml to select for the
expression plasmids. For the induction of the yop  regulon (secretion permissive
conditions) Y. enterocolitica bacteria were inoculated to an OD600 of 0.1 and cultivated in
brain-heart infusion (BHI; Remel) supplemented with a carbon source, 20 mM MgCl2
and 20 mM sodium oxalate (BHI-Ox) for 2 hours at room temperature, then shifted to
37 °C and incubated for 4 hours (5). To keep the yop regulon in a non-induced state
(secretion non-permissive conditions) bacteria were inoculated to an OD600 of 0.1 and
cultivated in BHI supplemented with a carbon source, 20 mM MgCl2 and 5 mM CaCl2
(BHI-Ca2+) for 2 hours at room temperature, then shifted to 37 °C and incubated for 4
hours.
Expression of the different genes cloned downstream of the pBAD promoter was
induced by adding 0.2 % arabinose to the culture just before the shift to 37 °C, and again
2 hours later. The carbon source was glycerol (4 mg/ml) when expressing genes from the
pBAD promoter, and glucose (4 mg/ml) in the other cases. The supernatant of every
culture used for needle purification was analysed for secreted Yop proteins.
Secreted proteins of all the strains were analyzed by Coomassie stained SDS-
PAGE, to verify that YopB and YopD were well secreted (data not shown). Secreted
proteins were precipitated for 1 hour at 4 °C with trichloroacetic acid 10 % (w/v) final
2and separated by SDS-PAGE. In each case, proteins secreted by 3 x 108 bacteria were
loaded per lane. After electrophoresis, proteins were stained with Coomassie brilliant
blue (Pierce) or transferred to nitrocellulose membranes. Immunoblotting was carried out
using rabbit polyclonal antibodies directed against YscF (MIPA 80) and LcrV (MIPA
220). Detection was performed with secondary antibodies conjugated to horseradish
peroxidase (1:2000; Dako) before development with supersignal chemiluminescent
substrate (Pierce).
To prepare the anti-LcrV antibodies (MIPA 220), lcrV DNA was amplified from
pYV40 DNA (primers 3283/3290). The PCR product was digested with NdeI and
BamHI, and cloned into the expression vector pET28a (Novagen) giving plasmid pPB10
(Table S1). A soluble His-LcrV protein was produced in E. coli BL21 (DE3) pLysS and
purified on chelating sepharose beads (Amersham Biosciences). A rabbit was immunized
by 4 injections with a total of 1 mg of His-LcrV in 20 mM phosphate buffer (CER,
Marloie, Belgium). The serum was affinity-purified on His-LcrV immobilized on
nitrocellulose membranes. The serum was then concentrated on a ProteinG-column
(MabTrap Amersham Biosciences). The Bradford assay (BioRad) was used to determine
the concentration of purified antibodies.
To produce polyclonal anti-YscF antibodies (MIPA 223), yscF DNA was
amplified from pYV40 DNA (primers 3759/3760). The PCR product was digested with
BamHI  and XhoI, and cloned into the expression vector pGEX4T3 (Amersham
Biosciences) giving plasmid pISO66 (table S1). YscF was produced as a glutathione S-
transferase fusion protein encoded by plasmid pISO66. Expression of the protein was
induced in E. coli TOP10 by addition of isopropyl-β-D-thiogalactopyranoside (0.2 mM
final concentration), as soon as the culture reached an OD600 of 0.6. Four hours after
induction, bacteria were collected, lysed by sonication in lysis buffer (PBS, 1 % Triton-
X100, 5mM dithiotreitol, 1 mM phenylmethylsulfonylfluoride and protease inhibitor
cocktail complete Mini (Roche)), and purified by affinity chromatography with
glutathione-Sepharose beads (Amersham Biosciences). The beads were washed five
times with PBS at 4 °C. YscF was eluted from the beads by thrombin cleavage (thrombin
protease 50 units/ml in PBS) for 1 hour at room temperature. The thrombin was then
removed by incubation with benzamidine-Sepharose beads. A rabbit was immunized by 4
injections with a total of 1 mg of YscF (CER, Marloie, Belgium). The serum was purified
on a Protein G-column (MabTrap Amersham Biosciences). The Bradford assay (BioRad)
was used to determine the concentration of purified antibodies.
Hemolytic assays were carried out as described by Goure et al. (6).
To purify needles, Yersinia bacteria were cultivated in non-permissive or
permissive conditions for secretion (3, 5) using the following protocols:
Non-permissive conditions (BHI-Ca2+): Less injectisomes are built under non-permissive
conditions, due to a known feedback regulatory effect (5, 7). Bacteria from 3 litres of
culture were harvested by centrifugation (20 min at 4000 x g) and resuspended in 20 mM
TrisHCl, pH 7.5 (1/30 of the initial culture volume). The bacteria were sheared by
passing the suspension through an 18G needle using a syringe. They were then pelleted
by centrifugation (10 min at 8300 x g). The supernatant was collected and passed through
a 0.45 µm mesh filter (cellulose acetate membrane). The filtrate was concentrated 10 fold
3using an Amicon Stirred Ultraconcentration Cell # 8200 (YM30 membrane (Ultracel YM
= Regenerated Cellulose Acetate, 30K), 5 bar pressure). The supernatant was further
concentrated using a Millipore Ultrafree-15 Centrifugal filter device Biomax-10K and
centrifuged for 30 min at 20000 x g. The pellet, containing needles, was resuspended in
20 mM TrisHCl, pH 7.5 (1/48000 of the initial culture volume) and analyzed by SDS-
PAGE, immunoblotting and electron microscopy.
Permissive conditions (BHI-Ox): Bacteria from 300 ml of culture were harvested by
centrifugation (10 min at 5700 x g) and washed once with 20 mM TrisHCl, pH 7.5 (1/30
of the initial culture volume). The washing supernatant was passed through a 0.45 µm
mesh filter (cellulose acetate membrane) and centrifuged for 30 min at 20000 x g. The
resulting pellet was resuspended in 20 mM TrisHCl, pH 7.5 (1/3000 of the initial culture
volume) and analyzed by SDS-PAGE, immunoblotting and electron microscopy.
For the cross-linking experiments, purified needles were diluted 25 x in 20 mM
TrisHCl, pH 7.5 and put on ice. Glutaraldehyde (Sigma) was added to a final
concentration of 0.4 % (v/v). The cross-linking reaction was allowed to proceed for 15
minutes and was then quenched by the addition of 1 M TrisHCl, pH 8 (1/10 of the
reaction volume). The cross-linked products were analyzed by SDS-PAGE and Western
blotting.
Visualization of the needle-like structures on the cell surface of bacteria was done
by electron microscopy as described by Hoiczyk and Blobel (8). After 4 hours of
induction at 37 °C, bacteria were harvested at 2000 x g and carefully resuspended in 20
mM TrisHCl, pH 7.5. Droplets were adsorbed to freshly glow-discharged, formvar-
carbon coated grids, and negatively stained with 2 % (w/v) uranyl acetate. Bacteria were
visualized in a Philips Morgagni 268D electron microscope at an acceleration voltage of
80 kV.
For scanning transmission electron microscopy (STEM), the purified needles
were diluted with buffer (20 mM TrisHCl, pH 7.5) as required, adsorbed to thin carbon
film, washed on 4 droplets of quartz double-distilled water and stained with 2 % (w/v)
sodium phosphotungstate. Digital dark-field images were recorded using a Vacuum
Generators STEM HB5 interfaced to a modular computer system (Tietz Video and Image
Processing Systems GmbH, D-8035 Gauting). The microscope was operated at 100 kV
and a nominal magnification of 500000 x, using doses that ranged between 9000 and
13000 electrons/nm2. The contrast was reversed to show protein in bright shades in the
figures.
To calculate the averages of the tip complexes, subframes were manually selected
from the STEM dark-field images recorded at a nominal magnification of 500000 x and
angularly and translationally aligned to an arbitrary reference using the SEMPER
program package (9). A first average calculated from 52-95 aligned subframes was two-
fold symmetrized along the cylinder axis and used to calculate a refined average. Those
subframes that had a cross-correlation value > 0.65 were included in the final average; 65
of the 95 initially selected for the wt, 36 of 52 for the PcrV ortholog, and 35 of 58 for the
AcrV ortholog. A two-fold symmetry was then applied. The resolution was determined
from the Fourier ring correlation function of the independent averages calculated from
the odd and even numbered subframes applying the 0.5 criterion.
4For the immuno-electron microscopy experiments, 5 µl aliquots of the purified
needles suspended in 20 mM TrisHCl, pH 7.5 were incubated for 45 min with 2.5 µl of
antibody solution at room temperature, and diluted up to 20 x with buffer immediately
before grid preparation. In each case, both the initial antibody concentration employed
and the dilution made before adsorption were adjusted to obtain optimum imaging
conditions (sufficient needles and a low background of free antibodies) even though a
large excess of antibodies was used for the reaction. The following, affinity purified,
rabbit polyclonal antibodies were used: anti-LcrV (0.268 mg/ml, MIPA 220), anti-YopD
(0.04 mg/ml, MIPA 24), anti-YopB (0.7 mg/ml, MIPA 38) and anti-YscF (1.4 mg/ml,
MIPA 223).
5 Figures
Figure S1
Fig. S1 Transmission electron micrograph of Y. enterocolitica E40 strain ΔHOPEMT
negatively stained with 2 % uranyl acetate. Needles protrude from the cell surface and
have a distinct structure at their tip (arrow). Scale bar: 40 nm.
6Figure S2
Fig. S2 Galleries showing the tip complexes of needles detailed in Fig. 1. Scale bars: 10
nm. (A) Tip complex of wt needles formed under secretion-permissive (S+) and non-
permissive (S-) conditions. (B) Tip complex of needles formed by the lcrV mutant (∆V
needles) and the lcrV mutant complemented with lcrV+ (∆V+LcrV needles).
7Figure S3
Fig. S3 (A) Silver stained SDS-PAGE (top) and Western blots (bottom) of the needles
purified from different Y. enterocolitica strains. The black arrowheads indicate the bands
corresponding to LcrV (37.2 kDa), YopD (33.2 kDa) and YscF (9.5 kDa). The flagellin
contamination is marked by a white arrowhead. (B) Cross-linking with glutaraldehyde.
Purified needles were incubated with 0.4 % (v/v) glutaraldehyde for 15 minutes and
analyzed by SDS-PAGE and Western blotting with anti-LcrV and anti-YscF antibodies:
NC, not cross-linked; X, cross-linked. The arrowheads indicate cross-linked products of
LcrV. The lowest of these bands corresponds to a complex of about 45 kDa i.e., one LcrV
and one YscF. Cross-linking of the needle subunit YscF lead to a ladder-like pattern as
expected.
8Figure S4
Fig. S4 Images and compiled galleries showing the tip complexes of needles isolated
from yopN (∆N), yopQ (∆Q), yopBD (∆BD) mutants. Scale bars: 10 nm.
9Figure S5
Fig. S5 Anti-YscF antibody labeling of wt needles imaged by dark-field STEM. Clusters
of antibodies bind to the needle ends that do not have a tip complex, sometimes also
linking two needles together. The sides of the needles were not labelled. Presumably the
helical packing of YscF in the needle effectively buries all reactive epitopes. Scale bar:
20 nm.
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Figure S6
Fig. S6 LcrV-orthologs from P. aeruginosa and A. salmonicida transcomplement the lcrV
mutant of Y. enterocolitica (A) Coomassie stained SDS-PAGE of proteins secreted by Y.
enterocolitica ∆HOPEMNVQ (∆V), ∆HOPEMNVQ complemented with LcrV
(∆V+LcrV), ∆HOPEMNVQ complemented with PcrV from P. aeruginosa (∆V+PcrV)
and ∆HOPEMNVQ complemented with AcrV from A. salmonicida (∆V+AcrV). (B)
Lytic activity on red blood cells after 2 hours of contact with Y. enterocolitica
∆HOPEMN (LcrV), ∆HOPEMNVQ+PcrV (∆V+PcrV) and ∆HOPEMNVQ+AcrV
(∆V+AcrV). (C) Silver stained SDS-PAGE (top) and Western blotting (bottom) of the
purified needles from Y. enterocolitica ∆HOPEMNVQ transcomplemented with the
LcrV-orthologs from P. aeruginosa (PcrV; 32.2 kDa) and A. salmonicida (AcrV; 40.2
kDa). AcrV and flagellin are of similar molecular weight.
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Figure S7
Fig. S7 Profiles perpendicular to the needle axis calculated from the averages of PcrV
(A) and AcrV (B) tip structures. The locations of the profiles are the same as for the wt
tip structure shown in Fig. 3. A central channel is indicated by the dip in the profile
evident in all except the neck profile from the AcrV complex. The magnitude of the
central dip is related to the resolution of the average and to the ratio of inner to outer
radius of the cylindrical structure (16). Scale bar: 5nm in (A) and (B).
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Figure S8
Fig. S8 Hypothetical model of the function of the LcrV tip complex. (A) No contact to
host cell: LcrV forms the complex at the tip of the needle. This implies that LcrV is
exported before contact with a target cell (or before secretion is triggered by Ca2+-
chelation) and hence that LcrV has a special status in the export hierarchy. However, it is
not yet known whether LcrV is present at the tip while the needle grows or whether it is
installed at the tip when the needle has reached its final length. Although localized at the
tip of the needle, LcrV does not act as a polymerizing cap, like the hook- and filament-
caps of the flagellum (17), because the needle subunits assemble normally in its absence
(Fig 1B). YopN is not present at the tip of the needle as shown in Fig S4 and by work of
others (18) (B) Contact with host cell membrane: The tip complex assists the assembly of
the translocation pore, serving as an assembly platform.
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Tables
Plasmid Current
designation
Relevant characteristics References
pYV plasmids
pYV40 wt pYV plasmid of Y. enterocolitica E40 (10)
pIML421 ∆HOPEMT pYV40 yopE21yopH∆1-352yopO∆65-558
yopP23yopM23yopT135
(11)
pMN4003 ∆HOPEMNVQ pYV40 yopE21 yopH∆1–352yopO∆65-558
yopP23yopM23yopN45lcrV∆6-319 yopQ17
(3)
pIM417 ∆HOPEMN pYV40 yopE21 yopH∆1–352yopO∆65–558
yopP23yopM23yopN45
(12)
pIM41 ∆N pYV40 yopN45 (13)
pABL402 ∆Q pYV40 yopQ17 (14)
pISO4005 ΔBD pYV40 yopB yopD This work
Clones and vectors
pBAD/Myc-HisA Invitrogen
pET28a Novagen
pGEX4T3 Amersham
pISO66 pGEX4T3 yscF+ This work
pISO82 pBluescriptKS+IIpYVe227bp17702-
17196/bp15076-14861
This work
pISO83 pKNG101pYVe227bp17702-
17196/bp15076-14861
This work
pKNG101 Suicide vector
oriR6K,secBR+,oriTR2K,strAB
(15)
pMN12 pBBR1MCS-2 pyopElcrV+ (3)
pPB10 pET28a-lcrV+ This work
pPB24 pBAD/Myc-HisA-pcrV+ This work
pPB25 pBAD/Myc-HisA-acrV+ This work
Table S1 Plasmids used in this study.
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Codes Oligonucleotides Underlined sites
3808 ATCATGCCATGGCAGAAGTCAGAAACCTTAATGCC NcoI
3809 CCGGGCGAATTCCTAGATCGCGCTGAGAATGTC EcoRI
3810 TGCCCACATGTCAAGCACAATCCCTGACTACAAC AflIII
3811 CCGGGCGAATTCTCAAATTGCGCCAAGAATGTC EcoRI
3283 GATCGGATCCTTACCTCGTGTCATCTAG BamHI
3290 GGGAATTCCATATGATTAGAGCCTACGAA NdeI
3759 GATCGGATCCATGAGTAATTTCTCTGGGTTTAC BamHI
3760 GATCCTCGAGTTATGGGAACTTCTGTAGGATG XhoI
3854 ATCATGGTCGACATGCAACAAGAGACGACAGAC SalI
3861 ATCATGTCTAGACAGGTCTTGAGCTACTACATG  XbaI
3862 TTAACTAACCAAGGTCATAAATGGTCATGGGTTATC
AACGCACTCATG
3863 CATGAGTGCGTTGATAACCCATGACCATTTATGACCT
TGGTTAGTTAA
Table S2 Oligonucleotides used in this study.
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3.4.1 The orientation of the LcrV molecule in the tip complex 
(STEM analysis was done in collaboration with Philippe Ringler, Francoise Erne-Brand, 
Shirley A. Müller and Andreas Engel) 
(The modeling of the LcrV tip complex was done by Ansgar Philippsen) 
 
Introduction 
 
The crystal structure of the V-antigen from Y. pestis shows that this protein is dumbbell 
shaped (Fig. 17, Derewenda et al., 2004). It consists of two globular domains connected by 
two long alpha helices. Modeling of the LcrV molecule into the structure of the tip complex, 
suggested that the globular domains would form the head and the base of the tip complex (A. 
Philippsen, unpublished data). However, the molecule can be orientated in two ways, either 
with the N-terminal domain forming the base or the other way round forming the head of the 
tip complex. To determine which model was true, we decided to investigate the orientation of 
LcrV in the tip complex. We started two different approaches to answer this question.  
 
 
Fig. 17. Structure of LcrV from Y. pestis (Derewenda et al., 2004).  
 
The first approach was to find a permissive site in LcrV to insert a tag. This would allow 
to immunolabel tip complexes with antibodies binding to one specific epitope. So far only 
polyclonal anti-LcrV antibodies that bound to different epitopes in LcrV were used. As the 
crystal structure of the molecule is known, the immunolabelling would allow to determine how 
the molecule is oriented.  
The second approach takes advantage of the size differences between LcrV (37.6 kDa) 
and its orthologs, PcrV (32.3 kDa) from Pseudomonas aeruginosa and AcrV (40.2 kDa) from 
Aeromonas salmonicida. These two bacteria are endowed with a T3S system closely related 
to the T3S system of Yersinia spp. The PcrV and AcrV proteins are able to complement a 
mutation in the lcrV gene of Yersinia and form smaller and larger tip complexes respectively. 
Alignment of the three proteins reveals that the size differences are restricted to the two 
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globular domains of the proteins (residues 1-145 and 183-278), while the two long helices, α7 
and α12, that connect them are conserved (Fig. 18A, B). For example, AcrV differs from LcrV 
only by two big insertions in the second globular domain that make the whole protein over 3 
kDa larger. In order to determine the orientation of the LcrV molecule in the tip complex we 
decided to take advantage of the visible size differences between tip complexes formed by 
LcrV, PcrV and AcrV, by engineering hybrids between these three proteins. The hybrids would 
be considerably smaller or larger than wildtype LcrV in one of the globular domains. Therefore 
they should form tip complexes with slight changes in the head or the base parts, which can 
then be observed by STEM. This would tell us which domains of the molecule form which 
parts of the tip complex. 
 
 
 
Fig. 18. (A) Alignment of PcrV from P. aeruginosa, LcrV from Y. enterocolitica and AcrV from A. 
salmonicida using Multalin (www.expasy.ch). The two helices, α7 and α12, connecting the globular 
domains are marked in gray. (B) Schematic representations of the structures of the three proteins PcrV 
(green), LcrV (blue) and AcrV (red). The size differences in the globular domains in comparison to LcrV 
are indicated. 
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Results and Discussion 
 
Insertion of a 6xHis tag into LcrV 
We generated the vector pPB22 (Appendix A) carrying lcrV with a his-tag in the 
aminoterminus. To test whether the N-terminally His-tagged LcrV complements a mutation in 
the lcrV gene, plasmid pPB22 was transformed into Y. enterocolitica ∆HOPEMNV bacteria. 
Secretion was induced in vitro and the culture supernatant was analyzed. His-LcrV was 
secreted suggesting that the His-tag in the N-terminus of the protein did not interfere with its 
secretion (data not shown). This result was surprising because it is known for the effector 
proteins that already small changes in the N-terminus lead to a loss of secretion.  
To verify functional complementation, Y. enterocolitica ∆HOPEMNV complemented with 
pPB22 was tested in a red blood cell hemolysis assay. The His-tagged protein was capable of 
complementing the mutation (data not shown), indicating that the His-tag does not interfere 
with the formation of the tip complex and its function. 
An important prerequisite for the immunolabelling is to determine if the tag is accessible 
to antibodies. This was tested in an antibody protection assay with antibodies directed against 
the His-tag. The antibodies protected the erythrocytes only slightly from lysis by Y. 
enterocolitica ∆HOPEMNV + pPB22 (Fig. 19). This result suggested that the His-tag is 
probably partially buried in the structure and not accessible to antibodies. 
 
Fig. 19. Hemolysis caused by Y. enterocolitica ∆HOPEMN (A) and ∆HOPEMNV complemented with 
pPB22 (B) in the presence of anti-His antibodies. The bacteria were pre-incubated with the antibodies 
for 20 minutes at 37°C and the red blood cells were infected for 1 h at 37°C.  
 
Insertion of a FLAG-tag into LcrV 
We constructed two plasmids, pPB46 and pPB47, capable of expressing FLAG-tagged 
LcrV. The FLAG tag was inserted in a loop between strands β4 and β5 (Fig. 20). This loop 
varies between different species and strains of Yersinia and is exposed at the surface, 
according to the crystal structure. The difference between the two constructs is that in pPB46 
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the tag is inserted between aa 227 and 228 and in pPB47 the tag replaces aa 226 to 233 of 
LcrV. Both constructs were transformed into Y. enterocolitica ∆HOPEMNV and secretion was 
checked in vitro. Both constructs were secreted, suggesting that the FLAG-tag did not 
interfere with secretion (data not shown). To verify functional complementation, we tested Y. 
enterocolitica ∆HOPEMNV harboring plasmids pPB46 or pPB47 in a hemolysis assay. Both 
constructs were able to complement the mutation in the lcrV gene, even though not to the 
same level as the wildtype protein (Fig. 21). 
 
Fig. 20. Structure of LcrV of Y. pestis as published by Derewenda et al. 2004 and graphical 
representation of the loop between strands β4 and β5. The length and aminoacid composition of this 
loop varies between Y. pestis, and the two Y. enterocolitica strains KNG22703 and E40. The FLAG tag 
was either inserted in this loop (pPB46) or replaces a part of the loop (pPB47). 
 
 
Fig. 21. Hemolysis caused by Y. enterocolitica ∆HOPEMNV complemented with plasmids pPB46 and 
pPB47. Three clones were analyzed for each plasmid. 
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To determine the accessibility of the FLAG tag, we checked if anti-FLAG antibodies 
were able to protect red blood cells from hemolysis by ∆HOPEMNV bacteria expressing the 
FLAG-tagged LcrV proteins (Fig. 22). Strong inhibition of hemolysis was observed for the 
∆HOPEMNV bacteria carrying pPB46 (Fig. 22C). Already 0.1 µg of antibodies per well was 
enough to reduce hemolysis by 80%, but only high concentrations lead to complete protection. 
The FLAG antibodies were therefore more efficient in blocking hemolysis than anti-LcrV 
antibodies at low concentrations (Fig. 22D). In contrast the ∆HOPEMNV bacteria carrying 
plasmid pPB47 or pPB42 (wt LcrV as a control, Fig. 22A, B), were still able to cause more 
than 70% of hemolysis even at highest antibody concentrations. These results demonstrated 
that the FLAG tag inserted between aa 227 and 228, in the case of pPB46, is exposed at the 
surface of the protein and accessible to antibodies. In contrast to this a FLAG tag that 
replaces the aa 226 to 233 (pPB47), seems to be buried in the structure and not accessible. 
The very efficient inhibition of hemolysis observed for pPB46 makes it an ideal candidate for 
immunolabelling. Instead of using whole anti-FLAG antibodies, anti-FLAG Fabs could be 
used. Fabs are smaller and would allow a much more accurate localization of the tag. 
 
 
Fig. 22. Hemolysis caused by Y. enterocolitica ∆HOPEMNV complemented with pPB42 (wt LcrV, A), 
pPB47 (B) or pPB46 (C) in the presence of anti-FLAG antibodies. (D) Hemolysis caused by Y. 
enterocolitica ∆HOPEMN in the presence of anti-LcrV antibodies. The bacteria were pre-incubated with 
the antibodies for 20 minutes at 37° C and the red blood cells were infected for 1 h at 37°C.  
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Generation of Hybrids between LcrV, PcrV and AcrV 
In total we generated 16 different hybrids (Appendix A) between LcrV, PcrV and AcrV 
but we restricted the analysis to four constructs: pPB30, 31, 34 and 35. These plasmids would 
allow expression of different hybrid proteins (H5, H6, H8 and H10, Fig. 23), which would have 
large size differences in certain domains, in comparison to wildtype LcrV. The expression of 
the hybrid proteins was first tested in E. coli. All four hybrids were expressed and had the 
expected size (data not shown). To check if the hybrid proteins were expressed and secreted 
by Yersinia, the plasmids were transformed into Y. enterocolitica ∆HOPEMNV bacteria. 
Secretion was triggered by Ca2+ chelation and the culture supernatant was analyzed. All 
hybrid proteins were secreted into the culture supernatant in comparable amounts (Fig. 24A). 
 
Fig. 23. Schematic representation of the four Hybrid proteins (H5, H6, H9 and H10) and the 
corresponding wildtype proteins. Expression plasmids, hybrid compositions and sizes are indicated.  
 
The ability of the hybrid proteins to form functional tip complexes was tested by 
measuring pore formation in a hemolysis assay (Fig. 24B). In parallel we tested ∆HOPEMNV 
bacteria complemented with wildtype LcrV, PcrV or LcrV proteins to compare the levels of 
hemolysis. The results indicated that even though all hybrid proteins were secreted, not all 
could complement the lcrV mutation with the same efficacy. We observed that whenever the 
N-terminus was from LcrV, the hybrids caused approximately the same level of hemolysis as 
wildtype LcrV. On the other hand when the N-terminus was from PcrV the hemolysis was 
reduced to low levels as observed for wildtype PcrV. Similar results were obtained with 
hybrids composed of AcrV and LcrV. We concluded that the N-terminus of the hybrid proteins 
determined the efficacy of the hemolysis. This effect could be direct, i.e. the N-terminal 
domain itself interacts with the pore components YopB and YopD or it could be indirect, i.e. 
the N-terminus is required for the stability of the whole tip complex and thus is affecting its 
pore forming ability. To answer this question the interaction sites between the LcrV-tip 
complex and the translocators need to be defined. 
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Fig. 24. (A) Coomassie stained SDS-PAGE and western blot analysis of proteins secreted by Y. 
enterocolitica ∆HOPEMNV complemented with hybrids H5, H6, H9 and H10. The secreted hybrids 
proteins are indicated by red arrowheads. Two clones were analyzed for hybrid H9. (B) Lytic activity on 
red blood cells after 2 h of contact with Y. enterocolitica ∆HOPEMNV complemented with wildtype LcrV, 
PcrV, AcrV or the hybrid proteins H5, H6, H9 and H10. 
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In order to determine the orientation of the LcrV molecules forming the tip complex, we 
compared the size of hybrid tip complexes to the size of tip complexes formed by the LcrV, 
PcrV and AcrV wildtype proteins. Needles were prepared and purified as described before 
and subjected to analysis by STEM. Averages of all hybrid tip complexes could be produced 
(Fig. 25). As published before, tip complexes formed by LcrV consist of three distinct parts: 
the head, the neck and the base. Tip complexes formed by PcrV have a smaller base, while 
both the neck and the head are still comparable to the LcrV tip complex. Tip complexes 
formed by the LcrV-PcrV hybrid protein had the characteristic shape, consisting of a head, a 
neck and a base similar to wildtype LcrV tip complexes. However, in this hybrid protein the 
first globular domain of PcrV was replaced by the corresponding domain of LcrV, which is 
over 3.2 kDa bigger. This replacement lead to a significant increase of the base part in 
comparison to PcrV tip complexes, whilst the rest of the tip complex seemed unchanged. This 
suggested that the N-terminal globular domain forms the base. According to this the second 
globular domain forms the head of the tip complex. The results obtained with the PcrV-LcrV 
hybrid protein confirmed this hypothesis. Here the N-terminal globular domain of LcrV was 
exchanged by the smaller domain of PcrV (-3.2 kDa). As expected we observed that tip 
complexes made by this hybrid had a smaller base, resembling tip complexes formed by 
PcrV.  
Tip complexes formed by AcrV were larger and more diverse in shape. The base had a 
different shape, the neck was less pronounced and the head appeared broader than in the 
LcrV tip complex. In the LcrV-AcrV hybrid the second globular domain, which, according to our 
hypothesis, would form the head of the tip complex is almost 4 kDa larger than in LcrV. 
Consistent with this, the tip complexes formed by this protein had a “normal” base, but the 
head was larger and different in shape. The last hybrid, AcrV-LcrV, had the smallest size 
difference to the LcrV wildtype protein. The N-terminal globular domain of LcrV was replaced 
by the corresponding domain of AcrV, leading to a reduction in size of 1.5 kDa. Thus we 
expected to see a change in the base part of the tip complex. No reduction of the base could 
be observed, but the base had indeed a different shape resembling the base of the AcrV tip 
complex. 
The results presented above allow us to present a simple model of the tip complex 
formed by LcrV (Fig. 26). In this model the molecule would be oriented with the N-and C 
terminus to the needle, the first globular domain forming the base of the tip complex, the 
second globular domain forming the head of the tip complex. The two long alpha helices (α7 
and α12) connect the two globular domains and face inward. 
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Fig. 25. Tip complexes formed by Y. enterocolitica ∆HOPEMNV complemented with the four hybrid 
proteins. (A) Projection averages of tip complexes formed by wildtype PcrV and LcrV (top) and LcrV-
PcrV (H5), PcrV-LcrV (H6) hybrids (bottom). Schematic representations of all proteins are drawn next to 
the corresponding tip complexes. (B) Projection averages of tip complexes formed by wildtype AcrV and 
LcrV (top) and LcrV-AcrV (H9), AcrV-LcrV (H10) hybrids (bottom). Schematic representations of all 
proteins are drawn next to the corresponding tip complexes 
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Fig. 26. Atomic modeling of the LcrV tip complex on top of the injectisome needle (cylinder). A side-view 
and a top view are shown. 
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Materials and Methods 
 
Cloning 
The lcrV sequence was amplified by PCR on pYV40 DNA using primers 3503 and 3504. The PCR 
products were digested with NdeI and KpnI and cloned into the NdeI and KpnI sites of the vector pLJM3 
giving plasmid pPB22 (Appendix A). This plasmid encoded a N-terminally his-tagged lcrV gene under 
the yopE promoter, allowing the expression of His-LcrV in Y. enterocolitica. 
The FLAG motive was introduced into the lcrV gene using overlapping PCR. The first two PCR reactions 
were performed using the primer pairs 4230/3807 and 4231/3806 for pPB46 or primer pairs 4232/3807 
and 4233/3806 for pPB47. Plasmid pMN12 was used as DNA template. The second, overlapping PCR 
was performed on the PCR products obtained from the first two PCR reactions using primers 3806 and 
3807 for both constructs. The PCR products were digested with NcoI and EcoRI and introduced into the 
NcoI/EcoRI sites of the expression vector pBADmycHisA (Invitrogen), giving plasmid pPB46 or pPB47. 
Hybrids between lcrV, pcrV or acrV  were generated using overlapping PCR. Individual parts of every 
hybrid were amplified from the corresponding DNA sequences by PCR with the primer pairs as indicated 
(Table 2). The PCR products were mixed and served as template for the overlapping PCR which was 
performed with the appropriate primers (Table 2). The PCR product was digested with NcoI/EcoRI or 
AflIII/EcoRI and cloned into the NcoI/EcoRI sites of the expression vector pBADmycHisA (Invitrogen) 
giving plasmids pPB30, pPB31, pPB34 and pPB35.  
  
First round of PCR  Overlapping PCR Construct 
Primers 1 Template 1 Primers 2 Template 2  Primer 1 Primer 2 
pPB30 H5 3934/3806 pMN12 3935/3809 pPB24  3806 3807 
pPB31 H6 3937/3957 pPB24 3936/3807 pMN12  3957 3807 
pPB34 H9 3942/3806 pMN12 3943/3811 pPB25  3806 3811 
pPB35 H10 3945/3810 pPB25 3944/3807 pMN12  3810 3807 
 
Table 2. Primers used to generate Hybrid H5, H6, H9 and H10. MIPA numbers are indicated. 
 
Expression test in E. coli 
To check expression of proteins from the pBAD vector, plasmids were transformed into E. coli TOP10 
bacteria. Overnight cultures were inoculated to an OD600 of 0.1 in fresh LB medium containing 
appropriate antibiotics and grown at 37°C. Expression was induced for 4 h by the addition of 0.2 % 
arabinose as soon as the cultures reached an OD600 of 0.6. The bacteria were collected by centrifugation 
and analyzed by SDS-PAGE followed by Coomassie staining or western blotting. 
Expression and secretion test in Y. enterocolitica 
In vitro secretion was performed as described before by (Mueller, Broz et al., 2005). 
Functional complementation test 
Hemolysis assays were performed as described before by (Goure, Broz et al., 2005). 
STEM analysis of Hybrid tip complexes 
Needles purification and STEM analysis was done as decribed before by (Mueller, Broz et al., 2005). 
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3.4.2 Production of antibodies directed against PcrV and AcrV 
 
Introduction 
 
To complete the list of tools necessary for the analysis of the tip complex, antibodies 
against PcrV from Pseudomonas aeruginosa and AcrV from Aeromonas salmonicida were 
generated. These antibodies allow the detection of the proteins in western blots, helping the 
analysis of the hybrids between LcrV/PcrV and LcrV/AcrV. In addition it would be possible to 
label hybrid tip complexes with anti-LcrV, anti-PcrV or anti-AcrV antibodies, examine them by 
electron microscopy and thereby determine which parts of these tip complexes are formed by 
which proteins. 
 
 
Results and Discussion 
 
In order to produce antibodies directed against PcrV and AcrV, the pcrV and acrV 
sequences were amplified by PCR on genomic DNA from Pseudomonas aeruginosa PAO1 
and Aeromonas salmonicida JF2267 using the primer pairs MIPA 3808/4250 and MIPA 
3810/4251 respectively. The PCR products were digested with NcoI/EcoRI or AflIII/EcoRI and 
cloned in frame with a C-terminal 6xHis tag into the NcoI/EcoRI sites of the expression vector 
pBADmycHisA giving plasmids pPB44 and pPB45 (Appendix A).  
Plasmids pPB44 and pPB45 were transformed into E. coli TOP10. Protein expression 
was induced by the addition of 0.2 % arabinose for 4 h at 37°C. Soluble PcrV-His and AcrV-
His proteins were purified on chelating sepharose beads (Amersham Biosciences). Further 
purification was achieved by size exclusion chromatography on a Superdex 200 preparative 
column. Rabbits were immunized by 4 injections with a total of 1 mg of either PcrV-His or 
AcrV-His in 20 mM Phosphate-Buffer, 500 mM NaCl. 
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3.4.3 Determination of the Stoichiometry of needle components 
(Mass per length measurements were done by Viola Huschauer and Shirley A. Müller, purified 
YscF was provided by Isabel Sorg) 
 
Introduction 
 
To generate an accurate atomic model of the tip complex it is not only necessary to 
know the orientation of LcrV, but also how many molecules of LcrV form the tip complex. 
Therefore we decided to quantify the amount of LcrV and YscF protein in purified needles and 
calculate the ratio of LcrV:YscF per needle. Together with the known length of the needles 
and the known mass-per-length value of purified needles it should be possible to estimate the 
number of LcrV molecules per needle tip complex. 
 
 
Results and Discussion 
 
Dilutions of known amounts of purified YscF and His-LcrV were compared to the YscF 
and LcrV content in purified needle fractions (Fig. 27). Thus the molar ratio of purified wt 
needles was estimated to be around 1 LcrV to 33 +/- 7 YscF. The mass-per-length value of 
purified needles was determined to be 21.6 +/- 1.7 kDa/nm, which means 2.3 +/- 0.2 YscF 
molecules/nm (Viola Huschauer and Shirley Müller, unpublished data). Assuming that the Y. 
enterocolitica needle has a mean length of 55-60 nm, one needle would consist of 
approximately 127-138 YscF monomers. Thus we can speculate that three to six molecules of 
LcrV form a needle tip. 
 
Fig. 27. Quantification of the LcrV and YscF content in purified needle fractions. The amount of purified 
YscF and His-LcrV is indicated in ng of protein. Black arrows indicate where the protein contents of 
purified needles (NP) match known amounts of purified YscF and LcrV. The quantification was carried 
out in three independent experiments, giving a molar ratio of 32.3 +/- 7.3 molecules of YscF per 
molecule of LcrV. 
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Materials and Methods 
 
Protein purification 
The LcrV gene was amplified by PCR from the pYV plasmid DNA of the Y. enterocolitica strain MRS40, 
using the primers MIPA 3283 and 3290. The PCR product was digested with NdeI and BamHI, and 
cloned into the expression vector pET28a (Novagen). A soluble His-LcrV protein was produced in E. coli 
BL21 (DE3) pLysS and purified on chelating sepharose beads (Amersham Biosciences). 
YscF was produced as a glutathione S-transferase fusion protein encoded by plasmid pISO66. 
Expression of the protein was induced by adding 0.2 mM isopropyl-β-D-thiogalactopyranoside (final 
concentration) at an optical density of 0.6. Four hours after induction, cells were collected, lysed by 
sonication in lysisbuffer (PBS, 1% Triton-X100, 1 mM phenylmethylsulfonylfluoride, 5mM dithiotreitol, 
protease inhibitor cocktail complete Mini (Roche)), and purified by affinity chromatography with 
glutathione-Sepharose (Amersham Pharmacia Biotech). Loaded beads were washed five times with 
PBS at 4°C. YscF was eluted from the beads by thrombin cleavage (thrombin protease 50 units/ml in 
PBS) for 1 h at room temperature. Thrombin was removed by incubation with benzamidine-Sepharose 
beads.  
Quantification 
Purified needles as well as different amounts of purified His-LcrV and YscF were separated by SDS-
PAGE, transferred to nitrocellulose membranes and subjected to western blot analysis with anti-LcrV 
and anti-YscF antibodies. The intensities of the LcrV and YscF protein bands were analyzed by 
scanning the films (EPSON PERFECTION 4870 PHOTO, at 300 dpi) and subsequent quantification of 
the pixel intensities using ImageJ 1.33u (http://rsb.info.nih.gov/ij/). The number of molecules of LcrV and 
YscF in the needle fraction was determined by comparing the intensities of signals in the needle fraction 
with signals of purified His-LcrV and YscF standards.  
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3.4.4 Estimation of the size of pores made by LcrV and its orthologs 
 
Introduction 
 
Recent data, published by Goure, Broz et al. and Mueller, Broz et al. suggested that the 
tip complex formed by LcrV would act as an assembly platform for the translocation. It was 
shown that PcrV/AcrV can complement a Y. enterocolitica lcrV mutation and form different 
sized tip complexes. One could therefore hypothesize that such tip complexes would form 
smaller or bigger pores. This would explain an interesting observation published in 2001. The 
authors had complemented a lcrV mutation with pcrV from P.aeruginosa and observed that 
the pore size, measured by osmoprotection, had apparently decreased (Holmstrom et al., 
2001). 
We decided to use osmoprotection to estimate the size of pores formed by tip 
complexes made of LcrV, PcrV or AcrV. The principle of osmoprotection is to do a hemolysis 
assay in the presence of carbohydrates of increasing osmotic diameter. As long the 
carbohydrates are small enough to pass through the translocation pore, they distribute equally 
in the red blood cells and the medium and they cannot counteract the osmotic pressure due to 
hemoglobin in the red blood cells, which leads to hemolysis. Carbohydrates that are bigger 
than the translocation pore, cannot enter the red blood cells, stay in the medium and 
counteract the osmotic pressure in the red blood cell, thus preventing hemolysis. This allows 
to estimate the pore size if the diameter of the carbohydrates is known. 
 
 
Results and Discussion 
 
Y. enterocolitica ∆HOPEMNV bacteria complemented by LcrV (pPB42), PcrV (pPB24) 
or AcrV (pPB25) were tested in a hemolysis assay. Different sized carbohydrates ranging 
from 0.92 to 3.8 nm in diameter were added to the medium (Table 3). We observed that PEG 
3200 (Ø 3.2 nm) protected erythrocytes from hemolysis by pores formed by LcrV or AcrV tip 
complexes (Fig. 28). Carbohydrates smaller than PEG 3000 did not protect the erythrocytes, 
suggesting that the diameter of the pores formed by LcrV or AcrV tip complexes was between 
2.4 and 3.2 nm. The levels of hemolysis caused by Y. enterocolitica ∆HOPEMNV 
complemented with PcrV (pPB24) were too low to allow any reliable conclusions on the size of 
the pore (data not shown). 
 
 
Material and Methods 
Hemolysis was done as described as before (Goure, Broz et al., 2005). 
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Table 3. Name and osmotic diameter of the carbohydrates used in this study. Osmotic diameters as 
reported by Hakansson et al., 1996; Holmstrom, et al. 2001; Dacheux et al., 2001; Blocker et al., 1999. 
 
 
 
 
Fig. 28. Hemolysis of Y. enterocolitica ∆HOPEMNV complemented with (A) pPB42 (LcrV) or (B) pPB25 
(AcrV) in the presence of carbohydrates of increasing diameter. 
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3.4.5 The translocators YopB and YopD interact with liposomes in vitro 
(Freeze Fracture Electron microscopy was done by Mohamed Chami) 
 
Introduction 
 
The visualization and analysis of the translocation pore and its component remains one 
of the burning questions in the field of type III Secretion. So far no convincing images of the 
pore could be presented. Some very promising data were published by Schoehn et al. in 2003 
(Schoehn et al., 2003). The authors expressed and purified the translocators PopB and PopD 
of P. aeruginosa together with their chaperone PcrH. They discovered that upon a shift to 
acidic pH the chaperone gets partially detached from the translocators, which had been 
unknown so far. Further they showed that the translocators are able to bind to liposomes at 
acidic pH. Electron microscopy analysis revealed ring-like structures on and next to the 
liposomes, suggesting that the translocators oligomerize and form pore-like structures upon 
contact to membranes. Unfortunately these pictures were far from being convincing and 
represented a major drawback of the publication. Nevertheless, we decided to use the same 
strategy to investigate the Y. enterocolitica translocators YopB and YopD.  
 
 
Results and Discussion 
 
SycD allows soluble expression of PopB and PopD in E. coli 
The two hydrophobic translocators of Y. enterocolitica, YopB and YopD contain two and 
one transmembrane domain respectively. It has been reported before that both require an 
intrabacterial chaperone to be expressed and soluble (Neyt and Cornelis, 1999b; Schoehn et 
al., 2003). We constructed plasmid pPB14, capable of co-expressing both translocators 
together with their chaperone SycD, which was cloned with a N-terminal His tag (Appendix 
A). Soluble chaperone-translocator complexes could be produced in E. coli and were purified 
on chelating sepharose beads (Fig. 29). The N-terminal His-tag in SycD did not disturb the 
chaperone/translocator complex formation. 
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Fig. 29. Purification of soluble complexes between His-SycD/YopB and His-SycD/YopD. Lanes 1-8 show 
purification fractions after elution from chelating sepharose beads with 300 mM Imidazole. YopB and 
YopD elute mostly in fractions 2 and 3 together with the chaperone SycD. Low levels of the chaperone 
can still be detected in the following fractions. 
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YopB and YopD do not interact with membranes when bound to their chaperone 
To test if the translocators are able to interact with membranes, we mixed purified 
complexes His-SycD/YopB and His-SycD/YopD with artificial liposomes (15% Cholesterol, 
25% DOPS and 60% DOPC) at pH 7.4 and separated soluble from membrane bound proteins 
by floatation in an Opti-Prep gradient (45%-5%). After the centrifugation, control liposomes 
were visible as a turbid band at the top of the gradient. Liposomes that had been incubated 
with protein migrated to the same fractions as the control liposomes. Analysis of the gradient 
revealed that the proteins could only be detected in the lowest fractions of the gradient, 
indicating that no interaction with the liposomes had occurred (Fig. 30). 
 
 
 
Fig. 30. Interaction of the translocators with liposomes in the presence of the chaperone. (A) Graph 
indicating the localization of the liposomes after floatation in the OptiPrep gradient (white arrowhead). 
(B) Fractions (1-25) of the OptiPrep gradient were collected and analyzed by SDS-PAGE followed by 
Silver staining. The proteins were found in the lowest fractions of the gradient (black arrowheads). Lane 
2 shows total cell lysate. 
 
 
YopB and YopD interact with membranes upon release from the chaperone 
As mentioned before, Schoehn et al. have shown that a change to acidic pH leads to 
the release of the chaperone PcrH from the translocators PopB/PopD. In this form the 
translocators can interact with artificial membranes. We decided to use the same approach to 
study the interaction of YopB and YopD with membranes. Purified complexes His-SycD/YopB 
and His-SycD/YopD were mixed with liposomes (15% Cholesterol, 25% DOPS and 60% 
DOPC) and the solution was dialysed against sodium acetate pH 5.0. In this way we would 
allow the translocators to immeadiately interact with membranes upon the release from the 
chaperone.  
Visible aggregation and precipitation of the liposomes was observed after the dialysis in 
the protein/liposome mix, while the control liposome solution remained turbid. The dialysed 
samples were subjected to gradient floatation to separate the soluble proteins from the 
liposomes and the membrane bound protein. Again, control liposomes migrated to the top of 
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the gradient while liposomes that had been incubated with proteins were now found in the 
middle part of the gradient. This suggested that the overall density of these liposomes had 
changed due to the interaction with the proteins. The translocators YopB and YopD, as well 
as traces of the chaperone SycD, could be found in the same fractions as the liposomes (Fig. 
31). Minor amounts of all three proteins could still be found at the bottom of the gradient. This 
result indicated that upon pH-triggered release of the YopB and YopD from the chaperone, the 
translocators were able to interact with artificial membranes. No conclusion could be made 
concerning the nature of this interaction i.e. whether the proteins were inserted into the 
membranes or just adhered peripherically to the liposomes. Notably, small amounts of the 
chaperone SycD were also found in the liposome-containing fractions at acidic pH. This may 
be due to non-specific association of the chaperone to the liposomes or the membrane bound 
translocators. 
 
 
Fig. 31. Interaction of the translocators with liposomes after the release from the chaperone by pH-shift. 
(A) Graph indicating the localization of the liposomes after floatation in the OptiPrep gradient (white 
arrowhead). (B) Fractions of the OptiPrep gradient (1-25) were collected and analyzed by SDS-PAGE 
followed by Silver staining. The proteins migrate in the same fractions as the liposomes (black 
arrowheads). Lane 2 shows total cell lysate. 
 
 
The role of the lipid composition 
Several recent publications suggest that lipid rafts may play an important role during the 
infection with some bacterial pathogens endowed with a type III Secretion System (Hayward 
et al., 2005; Schoehn et al., 2003; van der Goot et al., 2004). For P. aeruginosa, Schoehn et 
al. reported that the lipid composition of liposomes was important for the in vitro interaction 
with the translocators PopB/PopD. They showed that phosphatidylserine (DOPS) is needed 
for the association of the translocators with the liposomes, while cholesterol seems to be 
necessary for the lysis of the liposomes by PopB/PopD. We decided to study the effect of the 
lipid composition in our in vitro assay as well. We have not observed any lysis of liposomes 
upon interaction with YopB/YopD in our experiments, possibly because the lipid composition 
of the liposomes used was not adequate. We generated new liposomes with different lipid 
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compositions (L1-L5, Table 4). Proteoliposomes were prepared by dialysis and isolated by 
floatation. Independently of the lipid composition we observed liposome aggregation after the 
pH shift. Control liposomes of all compositions (L1-L5) migrated to the top of the gradient after 
the floatation. Surprisingly L3 and L4 liposomes had also migrated to the top of the gradient, 
while L1, L2 and L5 liposomes were located in the middle of the gradient (Fig. 32). SDS-
PAGE and silver staining revealed that in all cases the proteins were associated with 
liposomes (Fig. 32, data not shown). The different migration properties of L3 and L4 (no 
DOPS) liposomes suggested that the proteins interacted differently with liposomes in the 
presence/absence of DOPS. In contrast to data published for P. aeruginosa, the 
presence/absence of cholesterol in the liposomes membranes did not have any effect. 
 
Table 4. Lipid composition of the different liposomes L1-L5 (w/w). 
 
 
 
Fig. 32. Interaction with liposomes of different compositions. (A) Graph indicating the localization of all 
control liposomes (L1-L5) after floatation in the OptiPrep gradient (black arrowhead). (B) Interaction of 
the translocators with liposomes (L1-L5) after the release from the chaperone by pH-shift. The graphs 
indicate the localization of the proteoliposomes (L1-L5, Black arrowheads) and the proteins (star). The 
localization of the protein was determined by SDS-PAGE analysis (data not shown). 
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Analysis of liposomes by TEM 
Schoehn et al. had prepared proteoliposomes as described above and analyzed them 
by transmission electron microscopy. They observed that PopB alone, PopD alone and an 
equimolar mix of both were able to form ring-like structures on and next to the liposomes. 
These rings had an external diameter of 8 nm and an internal diameter of 4 nm.  
We analyzed by TEM proteoliposomes incubated with YopB and YopD. We could not 
observe any ring-like structures in our samples (data not shown). This was not surprising as 
membrane proteins are hard to observe by TEM when they are inserted in a membrane.  
 
Analysis of proteoliposomes by freeze-fracture EM 
Freeze fracture electron microscopy is a technique used to study insertion of proteins 
into membranes. The sample is applied on the grid and shot into liquid propane. The rapid 
cooling prevents formation of crystalline ice and results in amorphous ice. The frozen sample 
is split with a blade and the surface is coated with heavy metal (etched). Thus a replica is 
made. After the sample has been digested away, the replica is examined by EM. We took 
advantage of this technique to study proteoliposomes with different lipid compositions (L1, L2 
and L4) that had been prepared as described before (Fig. 33). Control liposomes were well 
distributed in the sample. They had a diameter ranging from 50-500 nm. In contrast to this the 
proteoliposomes were aggregated and the size of the liposomes seemed to have decreased. 
Two distinct populations of proteins could be observed on L1 and L2 liposomes: inserted and 
membrane surface associated. The inserted proteins had a diameter of 8-10 nm suggesting 
that they were oligomers; as monomers would be too small to be detected by freeze fracture 
EM. However, the population did not appear to be homogenous, slightly smaller and bigger 
complexes could be observed. It was not possible to determine if these particles were pores 
due to the low resolution of freeze fracture EM. The second population of protein complexes 
was covering the surface of the liposomes. They may represent pre-insertion forms of the 
complexes. These might be responsible for the liposome aggregates, as they seemed to 
tether the liposomes together.  
In contrast to this the proteins in the L4 liposome sample formed bigger protein 
aggregates that could be observed distributed between the liposomes. Such kind of 
aggregates can be generally observed when precipitated proteins are analyzed by freeze-
fracture EM. Occasionally inserted complexes could be found as well, although in very low 
amounts. 
These data suggested that the negatively charged phospholipid DOPS promoted the 
association of the translocators YopB/YopD with membranes and was required for the 
insertion of proteins complexes into the liposome membranes. When DOPS was missing, the 
proteins could not interact with the membranes and tended to aggregate. The insertion of the 
complexes into the liposome membranes could alter the density of the liposomes, which 
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would explain the difference in the migration pattern of the different liposomes in the gradient, 
observed before. 
 
Fig. 33. Freeze-fracture EM analysis of proteoliposomes. (A) Control liposomes. (B-D) L1 
Proteoliposomes. (E) L2 Proteoliposomes. (F) L4 Proteoliposomes. Black arrows indicate membrane-
inserted complexes; white arrows indicate membrane-associated protein. Protein aggregates are 
indicated. Scale bars: 500 nm. Electron micrographs were provided by M. Chami and A. Engel. 
 
                                                                                                                                                 3 Results 
  
 65 
Materials and Methods 
 
Construction of the expression vector 
A section of the Y. enterocolitica translocator operon, containing the genes sycDyopByopD, was 
amplified by PCR on the pYV40 DNA with primers MIPA 3277 and MIPA 3282. The PCR product was 
digested with BamHI and NdeI and cloned into the BamHI and NdeI sites of the expression vector 
pET28a (Novagen) giving plasmid pPB14 (Appendix A), which allowed co-expression YopB and YopD 
together with N-terminally 6xHis tagged SycD.  
Protein expression and purification 
The plasmid was transformed into E. coli BL21 (DE3) pLysS. The bacteria were grown in Luria-Bertani 
medium. Protein expression was induced by the addition of 1 mM IPTG for 4 h at 37°C. Cells were 
harvested by centrifugation and lysed by 3 passes in the French pressure cell in binding buffer (20 mM 
Phosphate, 500 mM NaCl). The supernatant was cleared by centrifugation and the proteins were purified 
using chelating sepharose beads. 
Liposome preparation 
Liposomes containing five distinct ratios of lipids were produced: L1-L5. A film of dried lipids was 
prepared under Argon flow. The film was solubilized by resuspension in binding buffer (20 mM 
Phosphate, 500 mM NaCl) containing 3 % Octylglucoside and the detergent was dialysed out to allow 
formation of the liposomes. 
Preparation of proteoliposomes 
400 µg of proteins were mixed with 250 µl of liposomes. This mix was dialyzed against sodium acetate 
pH 5.0 for 6 h at room temperature. The solution was adjusted to 45% OptiPrep and transferred to an 
ultracentrifugation tube. A stepwise gradient from 35-5% OptiPrep was layered on top and centrifugated 
for 16 h at 150 000 g at 4°C. fractions of 0.5 ml were collected from the top of the gradient. Aliquots were 
analysed by SDS-PAGE and Silver staining. 
Electron microscopy 
Droplets were applied for 1 min to freshly glow-discharged, formvar-carbon coated grids, and negatively 
stained with 2% (w/v) uranyl acetate. The samples were visualized in a Philips Morgagni 268D electron 
microscope at an acceleration voltage of 80 kV.  
Freeze fracture electron microscopy 
Was done as described by (Chami et al., 2005). 
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3.4.6 Purification of the TTS translocation pore using tagged translocators 
 
Introduction 
 
The purification and visualization of the translocation pore remains so far one of the 
unsolved questions in the field of type III Secretion. Previous attempts focused on the 
purification of the hydrophobic translocators, which presumably form the translocation pore, 
and the reconstitution of the pore into artificial membranes in vitro. The disadvantage of such 
an approach is, that, even if it succeeds, it is not possible to prove that the pores formed in 
vitro are exactly the same as the translocation pores formed in vivo by the bacteria. To avoid 
this disadvantage, we decided to purify the translocation pore out of membranes of 
erythrocytes that were infected with Y. enterocolitica, using a tag on one of the translocators. 
Using this kind of approach we could be sure that the purified pores represent the functional 
and native translocation pore. The first step of this approach is to insert a tag either in YopB or 
in YopD. It is crucial that the tagged protein is still functional and thus fully able to complement 
a mutation in the corresponding gene. 
 
 
Results and Discussion 
 
Expression of YopB or YopD in E. coli  
We constructed vectors pPB1-6, capable of expressing YopB/YopD without a tag or 
with a His-tag in the amino-or carboxyterminus. Protein expression from these vectors was 
first tested in E. coli TOP10. No overexpression of the recombinant proteins could be detected 
on Coomassie stained SDS-PAGE (Fig. 34A). Western blot analysis revealed that even 
though all proteins were expressed, the levels remained very low (Fig. 34A). To clarify if the 
protein expression had a detrimental effect on the bacteria, the growth was monitored for 500 
minutes after the induction. Constructs expressing YopB lead to a stop in growth or even to 
lysis of the E. coli (Fig. 34B). This suggested that YopB had a strong toxic effect on the 
bacteria. Expression of YopD had a less drastic effect, but still lead to decreased growth (Fig. 
34C). No toxic effect is observed when they are expressed together with their chaperone 
SycD, which presumably prevents the interaction with membranes (chapter 3.4.5). 
 
 
Complementation of yopB/yopD mutants with tagged-translocators 
In order to test if constructs pPB1-6 can complement a deletion of the yopB/yopD 
genes, the plasmids were transformed into Y. enterocolitica ∆HOPEMNB or ∆HOPEMND 
bacteria and analyzed in a red blood cell hemolysis assay (Fig. 35). C-terminally tagged 
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translocators (pPB1 and pPB4) caused only low levels of hemolysis. This suggested that the 
C-terminal tag interfered with pore formation. The N-terminally tagged translocators (pPB2 
and pPB5), were able complement the respective mutation as well as the untagged proteins 
(pPB3 and pPB6). This observation was surprising, because it is known for the effector Yops 
that changes in the aminoterminus abolish the secretion. It suggests that the secretion signal 
of YopB and YopD might be different or localized in another place. 
 
 
Isolation of membranes containing tagged pores 
In order to purify pores we need enough starting material i.e. membranes containing 
translocation pores. To test the yield of tagged translocators, we performed a “large scale” 
hemolysis experiment. In contrast to a hemolysis experiment done with 5x107 RBCs the “large 
scale” hemolysis is done with 3x109 RBCs. Two strains were analyzed in parallel: Y. 
enterocolitica ∆HOPEMN and Y. enterocolitica ∆HOPEMND complemented with pPB5 (Fig. 
36). The complemented mutant caused a bit less hemolysis than the ∆HOPEMN strain. 
Membranes of the RBCs were isolated after the infection and the amounts of the translocators 
YopB and YopD in the membranes were compared. The complemented mutant inserted 
considerable amounts of translocators into the red blood cell membranes, only slightly less 
than the ∆HOPEMN strain (Fig. 36), correlating with the levels of hemolysis. Unfortunately, 
even though protease inhibitors were added, native YopD as well as His-YopD tended to be 
degraded (Fig. 36, black arrowheads). This degradation might interfere with the purification 
therefore it is necessary to find a way to avoid it. Nevertheless, if proper upscaling is 
achieved, this assay should provide enough starting material to start the purification of the 
native pore via the His-tag in YopD. As an alternative the same attempt can be done using 
His-tagged YopB. 
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Fig. 34. Expression analysis of plasmids pPB1-6 in E. coli TOP10 bacteria. (A) Coomassie stained SDS-
PAGE and western blots of total cell pellets of E. coli TOP10 bacteria harboring plasmids pPB1-6 after 4 
h of induction with 0.2 % arabinose at 37°C. (B, C) Growth curves of E. coli TOP10 bacteria harboring 
plasmids pPB1-6. Bacteria were grown at 37°C and samples were collected up to 500 minutes after 
induction. 
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Fig. 35. Hemolysis of Y. enterocolitica strains ∆HOPEMNV, ∆HOPEMNB, ∆HOPEMND and 
∆HOPEMNB/∆HOPEMND complemented with pPB1-3/pPB4-6 respectively. 
 
 
   
Fig. 36. Isolation of red blood cell membranes after infection with Y. enterocolitica ∆HOPEMN or 
∆HOPEMND complemented with pPB5. (A) Hemolysis levels caused by the two strains. (B) Western 
blots of isolated red blood cell membranes probed with anti-YopB and anti-YopD antibodies. Proteins are 
indicated (white arrowheads); YopB: 41.9 kDa, YopD: 33.7 kDa and His-YopD: 34.5 kDa. Notably, YopD 
migrates at a higher apparent molecular weight in SDS-PAGE and degradation of YopD can be 
observed (black arrowhead). 
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Material and methods 
Construction of vectors 
The yopB or yopD genes were amplified by PCR on pYV40 DNA. The PCR products were digested with 
NcoI/PstI or XhoI/PstI and cloned into the NcoI/PstI or XhoI/PstI sites of the expression vector 
pBADmycHisA (Invitrogen) giving plasmid pPB1-6. These plasmids allowed expression of YopB or YopD 
with a C-terminal 6xHis-tag, a N-terminally 6xHis-tag or no tag.  
Expression in E. coli  
The plasmids were transformed into E. coli TOP 10 and expression was induced by the addition of 0.2 % 
Arabinose at 37°C for 4 h. The bacteria were collected and the proteins were separated by SDS-PAGE. 
To produce the growth-curves, the growth was monitored from 0 to 500 min after induction by measuring 
the OD600. 
Complementation of yopB/yopD mutants with tagged-translocators 
The plasmids pPB1-3 were transformed into Y. enterocolitica ∆HOPEMNB, plasmids pPB4-6 into Y. 
enterocolitica ∆HOPEMND.  
To check the functional complementation of the mutations by the different constructs, a red blood cell 
hemolysis assay was performed as described before (Goure, Broz et al., 2005).  
“Large scale” Hemolysis 
Isolation of red blood cells membranes after infection was done as described before (Goure, Broz et al., 
2005). 
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4 Discussion 
 
What are the different roles of the three translocators within the 
translocon? 
 
Our analysis of the Y. enterocolitica type III secretion translocon allows for the first time 
to understand the function of the three translocators because it shows that the translocon 
consists of two distinct parts, the tip complex and the actual translocation pore. 
The two hydrophobic translocators, YopB and YopD in Y. enterocolitica, presumably 
form the pore in the target cell membrane. Many studies have shown that these proteins 
interact with membranes and even insert into membranes. In vitro in contact with liposomes, 
they were shown to form oligomeric, pore-like structures, which can even function as channels 
(Faudry et al., 2006). Pore-formation in vivo requires the presence of the tip complex, a 
structure present at the tip of the injectisome needle, the putative exit point of secreted 
proteins (Mueller, Broz et al., 2005). This structure is formed by the third translocator (LcrV in 
Y. enterocolitica). We speculate that it assists the hydrophobic translocators to fold correctly 
and assemble into a functional pore upon secretion (Goure, Broz et al., 2005). We assume 
that the pore stays connected to the needle via the tip complex. Thus the secretion and the 
translocation processes are coupled and the bacteria can inject effectors in one step into the 
target cell. 
 
 
How does LcrV help in the pore assembly? 
 
Yersiniae deprived of LcrV are no longer hemolytic. Analysis of erythrocytes 
membranes indicated that lcrV mutant bacteria still insert YopB and YopD into the target cell 
membranes but cannot form a functional pore (Goure, Broz et al., 2005). This suggests that 
tip complex somehow assists the assembly of the translocation pore.  
Due to the size of the needle channel, the secreted proteins have to travel through the 
needle in a partial unfolded state. The tip complex could help the translocators that emerge at 
the tip of the needle to fold in a correct way, acting as some sort of extracellular chaperone. 
Consistent with this, our data show that lcrV mutants missing the tip complex insert 
considerably less translocators into erythrocyte membranes than wildtype bacteria. This 
suggests that the tip complex could not only ensure proper folding but also the insertion of the 
translocators into the membrane. In contrast to this, we also demonstrated that in vitro YopB 
and YopD insert into membranes even in the absence of the tip complex. This may be 
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explained by the fact that in vitro the concentration of the proteins is much higher and could 
force the equilibrium towards insertion. 
Another possibility would be that the tip complex could also stabilize or retain the 
translocators in the membrane, keeping the local concentration of translocators high enough 
to allow interaction between them and formation of the translocation pore. In the absence of 
the tip complex the translocators are still inserted but they would easily diffuse or would not be 
retained in the membrane. 
We also speculate that the tip complex provides interaction sites acting as some sort of 
scaffold for pore assembly. Only on this scaffold a functional pore can be formed and via the 
tip complex the pore stays connected to the needle. This idea is supported by the fact that the 
three translocators were reported to interact with each other, suggesting that there is no 
further mediator between the tip complex and the pore. This theory is contradicted by the 
observation that in vitro purified translocators can also form functional channels (Faudry et al., 
2006). But these in vitro experiments were done with unnaturally high protein concentrations 
and do only partially reflect what happens in nature. 
 
 
Is the tip complex a conserved feature of all TTSSs? 
 
Based on our results we suggest that the tip complex might be a general feature found 
in every type III secretion system. It can assumed that tip complexes similar to the LcrV tip 
complex of Yersinia can be found on injectisome needles from P. aeruginosa and A. 
salmonicida because PcrV and AcrV form a tip complex in a Yersinia lcrV mutant background 
(Mueller, Broz et al., 2005). In addition purified needles from P. aeruginosa have also a tip 
complex at one end (C. Gebus and C.A. Mueller, unpublished results).  
EspA, the hydrophilic translocator from EPEC could be considered a functional 
homolog of LcrV. Though EspA is smaller (20.5 kDa) than LcrV (37.6 kDa) and the two 
proteins do not share significant sequence similarity, EspA has been shown to form a 
comparable structure, a helical filament at the tip of the injectisome needle.  This suggests 
that in this case the tip complex has evolved to polymerize to a long filament than a short ring.  
Recently a sheath-like structure was found to cover the distal end of the injectisome 
needles from the S. Typhimurium SPI-2 TTSS. The protein SseB, which shares homology to 
EspA from EPEC, is part of this structure. It is not clear yet if this sheet is not just an artifact, 
because in contrast to the EspA filament of EPEC, there is no need to elongate the SPI-2 
needle with a sheet. The needle is already long enough to reach the target cell membrane, 
when the bacteria were taken up into phagosomes. One possible explanation could be that 
the sheet protects the needle from the acidic pH in the phagosome, which could destabilize it. 
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No filament or tip complex has been observed for the needle complexes of S. flexneri 
and S. Typhimurium SPI-1, even though they are the best analyzed NCs of all type III 
secretion systems. It is still possible that the tip complex was either not detected or it was 
detached and lost during the purification. Only recently it could be shown that IpaD localizes to 
the distal end of the S. flexneri needles (Espina et al., 2006). As IpaD has basically the same 
function as LcrV, we can speculate that IpaD as well as its homologs SipD from S. 
Typhimurium and BipD from Burkholderia pseudomallei would form a similar tip complex. But 
only STEM analysis of purified needles will show if there is a tip complex and how it looks like. 
Taken together, it seems that in every type III secretion system the needle is topped 
with a distinct structure, be it a tip complex or a filament, which is formed by the hydrophilic 
translocator. 
 
 
Is the tip complex the connector between the pore and the translocation 
pore? Is there a need for a connecting structure? 
 
The concept of type III secretion requires that the translocation pore remains connected 
to the needle once it is assembled. Indeed no leakage of effectors into the culture medium can 
be observed during infection (Mota et al., 2005a). Based on our results we assume that the tip 
complex serves as a connector between the needle and the translocation pore, but so far this 
was not shown directly. However it is known that LcrV interacts with YopB and YopD, 
suggesting that there is no other protein in between.  Such a protein would be necessary for 
the translocation, but by now all proteins encoded on the pYV plasmid were mutated and no 
new translocators were identified.  
The situation seems to be clearer for EPEC. Here the bacteria are separated from the 
enterocytes by the thick glycokalyx layer and the needle is too short to bridge this distance. 
The EspA filament elongates the needle and allows the bacterium to reach the target cell 
membrane. Therefore it must serve as a connector between the needle and the translocation 
pore that is inserted in the target cell membrane. In addition a channel that could serve as a 
hollow conduit for the effector proteins to the target cell membrane spans the filament. 
Interestingly, STEM images of Yersinia wildtype needles also show that a channel spans all 
the way through the needle and the tip complex. 
The need for a connecting structure seems quite obvious for EPEC, but for Yersinia the 
situation is different because the needle itself is long enough to span the space between the 
bacterium and the target cell. So, why is the needle not directly connected to the translocation 
pore? An explanation could be that the tip complex may act as an adaptor between the helical 
needle and the presumably ring-like translocation pore. Indeed the recently published 
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modeling of a tip complex on top of a type III secretion needle, suggests that LcrV would 
continue the helix of the needle (Deane et al., 2006). 
 
 
Are other proteins a part of the tip complex? 
 
Silver stained SDS-PAGE analysis of purified needles revealed several other major 
bands beside LcrV, YscF and flagellin. One band was identified as YopD, but we showed that 
that it is not part of the tip complex. Several minor bands remain to be identified, therefore we 
cannot completely exclude that some other proteins could be minor components of the needle 
and the tip complex. Intriguingly, the needles from lcrV mutant bacteria are not blunt ended 
but distinctly pointed. This suggests that a pyramid-like structure could be hidden underneath 
the tip complex. Several secreted Ysc proteins could be possible candidates for this structure. 
This structure could even serve as a polymerization cap for needle assembly. A capping 
protein has been identified for the flagellar filament, but could not be found so far for the 
needle The pointed end of the needles might also just be the end of the helix viewed from the 
side, appearing higher at one side and therefore pointed. This would be in agreement with the 
modeling presented by (Deane et al., 2006). In addition when STEM images of isolated 
needle are closely observed the base of the tip complex appears higher at one side (Mueller, 
Broz et al., 2005). This difference is not visible in the final averages of the tip complex where 
the base looks even. But due to the averaging such differences disappear and the base 
seems to be even. This would suggest that LcrV just continues the helix of the needle. In 
agreement with this we were able to crosslink LcrV and YscF, suggesting a direct interaction.  
 
 
Correlation between pore formation “in vitro” and “in vivo” 
 
The analysis and visualization of the translocation pore is one of the major unsolved 
questions in the field of type III secretion. So far the only promising approaches were done in 
vitro with purified translocator proteins (Schoehn et al., 2003, P. Broz unpublished data). The 
main drawback of such approaches is that there is no way to validate that the “in vitro pore” is 
the same as the pore formed in vivo. Nevertheless these in vitro experiments provided 
interesting results and insights.  
To purify the translocators of Yersinia or Pseudomonas, they have to be expressed 
together with their native chaperone, that prevents the premature interaction of the 
translocators and the degradation. When placed at acidic pH, the translocators are partially 
released from the chaperone and form homo- or heteromeric oligomers. These oligomers are 
able to bind membranes and also to insert into membranes. They have the appearance of 
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ring-like structures with an outer diameter of around 8-10 nm and an inner diameter of 4 nm. 
Furthermore these rings may indeed act as channels as they have been shown to lead to 
release of fluorescent dyes from liposomes.  
All these observations may be related to events occurring in vivo during an infection. 
The secretion machinery removes the chaperone and the translocators are exported. The 
translocators oligomerize upon secretion and insert into the target cell membrane. In vitro they 
form ring-like structure even before they insert into membranes (Schoehn et al., 2003). Our 
freeze-fracture analysis also suggests that the oligomeric form exists already before the 
membranes insertion. But in vivo this seems rather unlikely because the needle tip is in close 
contact to the membrane. The tip complex formed by the third translocator somehow 
facilitates the oligomerization and pore formation in vivo. By acting as a scaffold it also 
imposes a fixed stoichiometry. Faudry et al. (Faudry et al., 2006) speculate that the pH 
change used in vitro to trigger interaction with membranes might mimic the action of the tip 
complex in vivo. Analyzing the hemolytic abilities of lcrV mutant bacteria at acidic pH should 
validate this explanation. 
Another drawback of the “in vitro pores”, formed by PopB and PopD, is that they seem 
to be a mixture of pore-like structures with different sizes, 3.4-6.1 nm in diameter (Faudry et 
al., 2006). In contrast to this pores formed by P. aeruginosa in vivo have a size of 2.8-3.5 nm. 
Our freeze fracture analysis of proteoliposomes formed by incubation with YopB and YopD, 
reveals transmembrane particles of varying sizes (P. Broz unpublished data). This suggests 
that even though the hydrophobic translocators have some intrinsic pore-forming properties 
that allow them to form pores at high concentration like in these in vitro assays, the tip 
complex is necessary to catalyze this reaction in vivo so that the right translocation pore is 
formed. 
 
 
What is the status of the translocators in the type III secretion 
hierarchy? 
 
The localization and the function of the three translocators implicates that they need to 
have their own status in the secretion hierarchy. The type III secretion hierarchy has never 
been experimentally established. But it is known that knock out mutations in early substrates 
that build the outer part of the injectisome, like YscF and YscP, abolish the secretion later 
substrates. It is assumed that the secreted substrates can be classified into three major 
classes. First, the early substrates that are essential for the assembly of the secretion 
apparatus itself. Upon contact with a target cell they should be followed by the hypothetical 
middle substrates, the translocators. And finally, when the translocation pore is assembled the 
late substrates, the effector proteins, can be secreted. How the three classes are 
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distinguished is unknown, but it is possible that they have different secretion signals. Indeed 
the three translocators seem to have a different secretion signal than the effectors (Fields et 
al., 1999). We observed that N-terminal tags do not affect the secretion of the translocators, 
while changes in the N-terminus interfere with the secretion of the effectors. 
But there must be some differences between LcrV and the hydrophobic translocators 
as well. We demonstrated that the LcrV tip complex is already assembled on the needle in 
non-secreting conditions, before secretion is triggered, and that YopB and YopD are not part 
of the tip complex. Therefore LcrV must be secreted right after the needle component YscF 
but before the actual translocation pore components. 
How the secretion hierarchy is established is unknown, but it is intriguing that the three 
translocators are somehow involved in the regulation of type III secretion: LcrV interacts with 
LcrG, thus controlling effector proteins secretion. SycD the chaperone of both YopB and YopD 
is also critically involved in the regulation of yop gene expression. It is possible that these 
interactions ensure the secretion of the three translocators at the right time. 
 
 
Is the tip complex involved in the trigger mechanism? 
 
It has been proposed that type III secretion is triggered by the contact between the 
needle tip and the target cell (Mota et al., 2005a). It is tempting to hypothesize that the tip 
complex might be involved in the trigger mechanism. As bacteria do not form pores, the 
secreted proteins should end up in the culture supernatant. On the contrary, it was shown that 
lcrV mutant do not secrete proteins into the culture supernatant, suggesting that the secretion 
can’t be triggered (DeBord et al., 2001). Recently it was reported that contact with liposomes 
can trigger the secretion by S. flexneri (van der Goot et al., 2004) and IpaD, an ortholog of 
LcrV, is localized at the tip of the needle in S. flexneri (Espina et al., 2006). Therefore it could 
be therefore possible that the tip complex could sense the presence of membranes and 
transmit this signal via an unknown mechanism to the machinery, triggering the secretion of 
the translocators and effectors. Deane et al. speculate that the tip complex would sense 
contact and transmit the signal via intersubunit contacts of the needle to the bacterium (Deane 
et al., 2006). So far no convincing data could be presented that would support such a model. 
The contact between the needle tip and the host membrane alone is not sufficient to 
trigger effector secretion; another prerequisite is the ability of the bacterium to form the 
translocation pore. Bacteria deprived of YopB do not secrete effectors into the medium even 
though they are in contact with eukaryotic cells (L.J. Mota unpublished data). This suggests 
that the formation of the pore by the tip complex i.e. the opening of a continuous channel 
between the bacterium and the eukaryotic cytosol leads to the secretion of the effectors and 
no special signal is required. This scenario would imply that the pore-forming translocators are 
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localized in the needle or the injectisome, ready to be secreted as soon as the tip reaches a 
membrane. 
 
 
Requirements on membrane side? 
 
As mentioned in the introduction, it has been shown for Shigella, Salmonella and EPEC 
that the lipid composition of the membrane is very important. These three pathogens require 
the presence of cholesterol in the host cell membrane to translocate effectors via the type III 
secretion system (Hayward et al., 2005). As the translocators insert directly into host cell 
membrane it was speculated that the formation of the translocation pore could depend on the 
presence of certain lipids in the host cell membrane. In addition the authors show that purified 
Salmonella SipB and Shigella IpaB are cholesterol-binding proteins and that cholesterol is the 
main binding determinant of purified SipB/IpaB to host cells (Hayward et al., 2005). As 
cholesterol is a component of lipid rafts it suggests that these pathogens can only assemble 
the translocation pore in the special lipid environment of lipid rafts. 
We were interested if the family of Ysc-type TTSSs (Yersinia, Pseudomonas) also 
requires cholesterol for translocation. Our in vitro experiments with purified translocators 
indicated that phosphatydylserine (PS) is necessary for the binding of YopB and YopD to 
liposomes and also for the insertion of the proteins into membranes. Other lipids like 
cholesterol and sphingomyelin were not necessary. In addition unpublished data from J. Mota 
show that when macrophages are depleted from cholesterol, by incubating them with 
methylcyclodextrin, the infection is not affected. 
Data published on P. aeruginosa (Faudry et al., 2006; Schoehn et al., 2003) also show 
that the translocators require negatively charged phospholipids (PS) to bind membranes and 
insert into membranes. Initially Schoehn et al. reported that PS is necessary for the binding to 
membranes but that cholesterol is required for lysis (insertion of the translocators) of 
liposomes. But it seems that the authors had observed aggregation of liposomes and 
misinterpreted this observation as liposomes lysis. Later the same group had to revise their 
result, as they could not observe liposome lysis any more. Another interesting observation is 
that purified IpaB from S. flexneri leads to the release of Calcein from liposomes that contain 
negatively charged lipids, but not from liposomes containing positively charged lipids (De 
Geyter et al., 2000). This suggests that the formation of the type III secretion translocon, in all 
systems, requires negatively charged phospholipids in the target cell membrane.  
 
Altogether it seems that the requirements on the membrane depend on the type of TTS 
system that the bacteria have acquired. Ysc-type TTSS are independent of lipid rafts, while 
they are crucial for others. This may also reflect the different infection strategies of these 
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pathogens. Some pathogens, like Yersinia and P. aeruginosa, are extracellular. To avoid 
phagocytosis by macrophages, they need to act in seconds and inject effector proteins into 
the macrophage. On the other hand, Shigella, Salmonella and EPEC invade epithelial cells. 
They can take their time to find the right spot (lipid raft) to successfully enter their target cells. 
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Action of protective antibodies 
 
For decades LcrV has been known to be the major protective antigen against plague 
infections. Later the same activity was reported for antibodies directed against the V antigens 
of P. aeruginosa and A. salmonicida. Only recently it could be shown that antibodies against 
IpaD, a functional homolog of LcrV, from S. flexneri also prevent hemolysis. Antibodies 
against EspA are found in human maternal milk and were proposed to provide protection 
against EHEC (Noguera-Obenza et al., 2003).  
Our results show that the V-antigens are forming an exposed structure at the tip of the 
injectisome needle and that antibodies bind specific to this tip complex. It is this binding that 
affects the action of the tip complex and interferes with the formation of a translocation pore. 
Further we could show that if LcrV contains a FLAG tag, anti-FLAG antibodies can also 
interfere with the function of the tip complex. This suggests that it is not a specific motif of 
LcrV that has to be bound by the antibodies, but that the sheer physical presence of the 
relatively large antibodies impairs pore formation. 
Interestingly we did not observe any protective action with antibodies directed against 
YscF, the needle subunit. This is in apparent contradiction to reports found in literature  that 
show that vaccination of animals with YscF provides significant protective immune response 
to plague infections. This contradiction may be explained by the observation that our YscF 
antibody recognizes only the lower end of the needle. During the assembly and function of the 
needle this part is never exposed, except when the needles are broken off. One could imagine 
that antibodies directed against other epitopes of YscF could possibly interfere with the 
assembly of the needle or the tip complex, which would explain the protective action observed 
in vivo.  
 
 
Therapeutic target? 
 
Our work shows that the tip complex is vital for the success of the whole TTS 
apparatus. At the same time it is the weakest point of the whole system because of its 
exposed localization. Only antibodies directed against the tip complex can efficiently disturb 
the system. Therefore the tip complex is probably the best-suited target for new infectives, as 
these would not even have to pass through the bacterial membranes to block the function of 
the TTSS. In addition our work has shown that the hemolysis assay is well suited for the study 
of the function of the translocon and could be adapted for screening of new anti-infectives that 
specifically target the TTS system system. Further analysis of the tip complex and the crystal 
structure of LcrV may be used to specifically design molecules that could interfere with the 
function of the tip complex. 
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5 Outlooks 
 
To finally understand the translocation process, we will need to understand the function of the 
tip complex and the translocation pore in detail and also how these structures are connected 
to the injectisome needle. Therefore it is necessary to determine the interaction sites between 
the different parts of the translocon and to investigate the structure of the translocation pore. It 
is also crucial to establish the chronological order of events during the assembly and the 
function of the injectisome. Here are some questions directly arousing from the present study 
and which would be relevant to address: 
 
-How is the tip complex connected to the translocation pore and the needle? Which domains 
of LcrV interact with YscF (the needle)? Which domains interact with YopB and YopD (the 
translocation pore)?  
 
-How many molecules of LcrV form the tip complex (Stoichiometry)? 
 
-Are there other proteins involved? Small, secreted Ysc proteins? What is the pyramid 
underneath the tip complex? 
 
-What is the composition and structure of the translocation pore? How does the membrane 
topology of YopB and YopD look like?  
 
-Is the tip complex involved in the trigger mechanism? How is the formation of the pore 
involved in the trigger mechanism? 
 
-What is the hierarchy of secretion and how is it established? Are the translocators secreted? 
How are the chaperones involved? What are the export signals of LcrV, YopB and YopD?  
 
-Is LcrG the chaperone of LcrV? 
 
-How are the coiled-coil domains of LcrV involved in polymerization? 
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Appendix 
 
A List of constructs 
 
MIPA 
number name  description vector resistance 
       
3921 pPB 1  yopB-his pBAD Amp 
3922 pPB 2  his-yopB pBAD Amp 
3923 pPB 3  yopB pBAD Amp 
3924 pPB 4  yopD-his pBAD Amp 
3925 pPB 5  his-yopD pBAD Amp 
3926 pPB 6  yopD pBAD Amp 
3726 pPB 9  lcrVsycDyopByopD pET28a Kan 
3727 pPB 10  his-lcrV pET28a Kan 
3728 pPB 11  his-sycD pET28a Kan 
3729 pPB 12  his-yopB pET28a Kan 
3730 pPB 13  his-yopD pET28a Kan 
3731 pPB 14  his-sycDyopByopD pET28a Kan 
3732 pPB 15  his-sycDyopB-his pET28a Kan 
3733 pPB 16  his-sycDyopB-his pET28a Kan 
3734 pPB 17  his-sycDyopB pET28a Kan 
3927 pPB 22  his-lcrV pLJM3 Kan 
3841 pPB 24  pcrV of P. aeruginosa PAO1 pBAD Amp 
3842 pPB 25  acrV of A. salmonicida JF2267 pBAD Amp 
3928 pPB 26  H1 (LcrV aa1-124, PcrV aa105-294) pBAD Amp 
3929 pPB 27  H2 (LcrV aa1-195, PcrV aa174-294) pBAD Amp 
3930 pPB 28  H3 (PcrV aa1-105, LcrV aa125-329) pBAD Amp 
3931 pPB 29  H4 (PcrV aa1-174, LcrV aa196-329) pBAD Amp 
3932 pPB 30  H5 (LcrV aa1-145, PcrV aa124-294) pBAD Amp 
3933 pPB 31  H6 (PcrV aa1-123, LcrV aa146-329) pBAD Amp 
3934 pPB 32  H7 (LcrV aa1-181, PcrV aa160-294) pBAD Amp 
3935 pPB 33  H8 (PcrV aa1-159, LcrV aa182-329) pBAD Amp 
3936 pPB 34  H9 (LcrV aa1-145, AcrV aa146-361) pBAD Amp 
3937 pPB 35  H10 (AcrV aa1-143, LcrV aa146-329) pBAD Amp 
3938 pPB 36  H11 (LcrV aa1-181, AcrV aa180-361) pBAD Amp 
3939 pPB 37  H12 (AcrV aa1-179, LcrV aa182-329) pBAD Amp 
3940 pPB 38  H13 (LcrV aa1-181, PcrV aa160-233, LcrV aa268-329) pBAD Amp 
3941 pPB 39  H14 (PcrV aa1-159, LcrV aa182-267, PcrV aa234-294) pBAD Amp 
3942 pPB 40  H15 (LcrV aa1-181, AcrV aa180-300, LcrV aa301-361) pBAD Amp 
3943 pPB 41  H16 (AcrV aa1-179, LcrV aa182-267, AcrV aa301-361) pBAD Amp 
3944 pPB 42  lcrV pBAD Amp 
3945 pPB 43  lcrV del aa218-243 pBAD Amp 
3946 pPB 44  pcrV-his pBAD Amp 
3947 pPB 45  acrV-his pBAD Amp 
3948 pPB 46  LcrV with FLAG tag between aa227-228  pBAD Amp 
3949 pPB 47  LcrV with FLAG tag replacing aa226-233 pBAD Amp 
3950 pPB 48  His-LcrV aa1-156 (his-G1) pBAD Amp 
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3951 pPB 49  His-LcrV aa1-192 (his-G1A1) pBAD Amp 
3952 pPB 50  His-LcrV aa1-289 (his-G1A1G2) pBAD Amp 
3953 pPB 51  His-LcrV aa1-329 (his-G1A1G2A2) pBAD Amp 
3954 pPB 52  His-LcrV aa193-289 (his-G2) pBAD Amp 
3955 pPB 53  His-LcrV aa193-329 (his-G2A2) pBAD Amp 
3956 pPB 54  His-LcrV aa157-329 (his-A1G2A2) pBAD Amp 
3957 pPB 55  His-LcrV aa290-329 (his-A2) pBAD Amp 
3958 pPB 56  His-LcrV aa157-192 (his-A1) pBAD Amp 
3959 pPB 57  His-LcrV aa157-289 (his-A1G2) pBAD Amp 
3960 pPB 58  his-lcrV pBAD Amp 
3961 pPB 59  his-pcrV pBAD Amp 
3962 pPB 60  his-acrV pBAD Amp 
3963 pPB 61  His-H5  pBAD Amp 
3964 pPB 62  His-H6 pBAD Amp 
3965 pPB 63  His-H9 pBAD Amp 
3966 pPB 64  His-H10 pBAD Amp 
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